BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington MK, Carneiro F, Cree IA. The 2019 WHO classification of tumours of the digestive system. Histopathology.  2019. [PMID: 31433515 DOI: 10.1111/his.13975] [Cited by in Crossref: 924] [Cited by in F6Publishing: 1031] [Article Influence: 231.0] [Reference Citation Analysis]
Number Citing Articles
1 Lui TKL, Hang DV, Tsao SKK, Hui CKY, Mak LLY, Ko MKL, Cheung KS, Thian MY, Liang R, Tsui VWM, Yeung CK, Dao LV, Leung WK. Computer-assisted detection versus conventional colonoscopy for proximal colonic lesions: a multicenter, randomized, tandem-colonoscopy study. Gastrointest Endosc 2023;97:325-334.e1. [PMID: 36208795 DOI: 10.1016/j.gie.2022.09.020] [Reference Citation Analysis]
2 Hong SB, Hong S, Choi SH, Park SY, Shim JH, Kim SY, Lee SS, Kim S. Multiple arterial-phase MRI with gadoxetic acid improves diagnosis of hepatocellular carcinoma ≤3.0 cm. Liver Int 2023;43:462-70. [PMID: 36317670 DOI: 10.1111/liv.15470] [Reference Citation Analysis]
3 Tikhonova VS, Karmazanovsky GG, Kondratyev EV, Gruzdev IS, Mikhaylyuk KA, Sinelnikov MY, Revishvili AS. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade. Eur Radiol 2023;33:1152-61. [PMID: 35986774 DOI: 10.1007/s00330-022-09046-1] [Reference Citation Analysis]
4 Paradis V, Zucman-Rossi J. Pathogenesis of primary liver carcinomas. J Hepatol 2023;78:448-9. [PMID: 36064762 DOI: 10.1016/j.jhep.2022.05.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chou A, Sioson L, Sheen A, Ahadi MS, Gill AJ. Up-regulation of ALK is associated with altered Wnt/beta-catenin pathway in adult pancreatoblastoma. Pathology 2023;55:129-33. [PMID: 35794050 DOI: 10.1016/j.pathol.2022.04.005] [Reference Citation Analysis]
6 Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023;77:659-702. [PMID: 36083140 DOI: 10.1002/hep.32771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Huang D, Wu J, Zhong H, Li Y, Han Y, He Y, Chen Y, Lin S, Pang H. [(68)Ga]Ga-FAPI PET for the evaluation of digestive system tumors: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2023;50:908-20. [PMID: 36326867 DOI: 10.1007/s00259-022-06021-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cai H, Feng X, Yin R, Zhao Y, Guo L, Fan X, Liao J. MIST: multiple instance learning network based on Swin Transformer for whole slide image classification of colorectal adenomas. J Pathol 2023;259:125-35. [PMID: 36318158 DOI: 10.1002/path.6027] [Reference Citation Analysis]
9 Mo S, Zong L, Chen X, Ban X, Li M, Lu Z, Yu S, Chen J. Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors. Arch Pathol Lab Med 2023;147:193-201. [PMID: 35671167 DOI: 10.5858/arpa.2021-0377-OA] [Reference Citation Analysis]
10 Chen F, Zhang S, Ma X, Chen Y, Wang Z, Zhu Y, Bai C, Fu C, Grimm R, Shao C, Lu J, Shen F, Chen L. Prediction of tumor budding in patients with rectal adenocarcinoma using b-value threshold map. Eur Radiol 2023;33:1353-63. [PMID: 35997838 DOI: 10.1007/s00330-022-09087-6] [Reference Citation Analysis]
11 Xie J, Hong D, Li D, Jiang C, Xu B, Liu M, Wang W. Multiple ligation-assisted endoscopic submucosal resection combined with endoscopic ultrasonography: a novel method to treat rectal neuroendocrine tumors. Eur J Gastroenterol Hepatol 2023;35:174-80. [PMID: 36574308 DOI: 10.1097/MEG.0000000000002486] [Reference Citation Analysis]
12 Hope TA, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald LK, Graham MM, Jacene HA, Heath CL, Mittra ES, Wright CL, Fendler WP, Herrmann K, Taïeb D, Kjaer A. SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors. J Nucl Med 2023;64:204-10. [PMID: 36725249 DOI: 10.2967/jnumed.122.264860] [Reference Citation Analysis]
13 Camera L, Boccadifuoco F, Modica R, Messerini L, Faggiano A, Romeo V, Gaudieri V, Colao A, Maurea S, Brunetti A. Gastrinomas and Non-functioning Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Syndrome Type-1 (MEN-1).. [DOI: 10.21203/rs.3.rs-2508035/v1] [Reference Citation Analysis]
14 Molfetta R, Paolini R. The Controversial Role of Intestinal Mast Cells in Colon Cancer. Cells 2023;12:459. [DOI: 10.3390/cells12030459] [Reference Citation Analysis]
15 Abdelrahman AM, Yin J, Alva-ruiz R, Yonkus JA, Leiting JL, Lynch IT, Fogliati A, Campbell NA, Carlson DM, Roberts LR, Gores GJ, Smoot RL, Graham RP, Halfdanarson TR, Truty MJ. Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States. Cancers 2023;15:840. [DOI: 10.3390/cancers15030840] [Reference Citation Analysis]
16 Nakshabandi AA, Lee JH. Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities. Expert Rev Gastroenterol Hepatol 2023;:1-13. [PMID: 36683580 DOI: 10.1080/17474124.2023.2170875] [Reference Citation Analysis]
17 Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese MC, Simonetti I, Catalano O, Gabelloni M, Pradella S, Danti G, Flammia F, Borgheresi A, Agostini A, Bruno F, Palumbo P, Ottaiano A, Izzo F, Giovagnoni A, Barile A, Gandolfo N, Miele V. Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence. Biology 2023;12:213. [DOI: 10.3390/biology12020213] [Reference Citation Analysis]
18 Zhao L, Yang Q. Imaging manifestations and pathological features of neuroendocrine carcinoma of the gallbladder. Shijie Huaren Xiaohua Zazhi 2023; 31(2): 73-79 [DOI: 10.11569/wcjd.v31.i2.73] [Reference Citation Analysis]
19 Zhang X, Wang YC, Liu CJ. Application of single-cell transcriptome sequencing in gastric cancer. Shijie Huaren Xiaohua Zazhi 2023; 31(2): 48-55 [DOI: 10.11569/wcjd.v31.i2.48] [Reference Citation Analysis]
20 Clement DSVM, Leerdam MEV, de Jong S, Weickert MO, Ramage JK, Tesselaar MET, Srirajaskanthan R. Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours. Cancers 2023;15:782. [DOI: 10.3390/cancers15030782] [Reference Citation Analysis]
21 Zheng Z, Hu Y, Ren Y, Mo G, Wan H. Correlation between metastatic patterns and age in patients with metastatic primary liver cancer: A population-based study. PLoS One 2023;18:e0267809. [PMID: 36706100 DOI: 10.1371/journal.pone.0267809] [Reference Citation Analysis]
22 Zhang L, Jin R, Yang X, Ying D. A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1087700] [Reference Citation Analysis]
23 Kloth C, Haggenmüller B, Beck A, Wagner M, Kornmann M, Steinacker JP, Steinacker-stanescu N, Vogele D, Beer M, Juchems MS, Schmidt SA. Diagnostic, Structured Classification and Therapeutic Approach in Cystic Pancreatic Lesions: Systematic Findings with Regard to the European Guidelines. Diagnostics 2023;13:454. [DOI: 10.3390/diagnostics13030454] [Reference Citation Analysis]
24 Wang B, Ma R, Rao B, Xu H. Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei. BMC Cancer 2023;23:90. [PMID: 36703100 DOI: 10.1186/s12885-023-10545-7] [Reference Citation Analysis]
25 Schult AL, Hoff G, Holme Ø, Botteri E, Seip B, Ranheim Randel K, Darre-Næss O, Owen T, Nilsen JA, Nguyen DH, Johansen K, de Lange T. Colonoscopy quality improvement after initial training: A cross-sectional study of intensive short-term training. Endosc Int Open 2023;11:E117-27. [PMID: 36712907 DOI: 10.1055/a-1994-6084] [Reference Citation Analysis]
26 Zhang H, He Y, Wu X, Huang P, Qin W, Wang F, Ye J, Huang X, Liao Y, Chen H, Guo L, Shi X, Luo L. PathNarratives: Data annotation for pathological human-AI collaborative diagnosis. Front Med 2023;9. [DOI: 10.3389/fmed.2022.1070072] [Reference Citation Analysis]
27 Batts TL, Sasaki E, Miller M, Sparago J, Bauer RW, Paulsen D, Boudreaux B, Liu CC, Byrum SD, Johnston AN. Neoplastic signatures: Comparative proteomics of canine hepatobiliary neuroendocrine tumors to normal niche tissue. PLoS One 2023;18:e0280928. [PMID: 36696389 DOI: 10.1371/journal.pone.0280928] [Reference Citation Analysis]
28 Ding J, Qiu J, Hao Z, Huang H, Liu Q, Liu W, Ren C, Hacker M, Zhang T, Wu W, Huo L, Li X. Prognostic value of preoperative [(68) Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics. Eur J Nucl Med Mol Imaging 2023. [PMID: 36695823 DOI: 10.1007/s00259-022-06100-4] [Reference Citation Analysis]
29 Zhong Y, Zhang H, Wang X, Sun Z, Ge Y, Dou W, Hu S. CT and MR imaging features of mixed neuroendocrine-non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor. Insights Imaging 2023;14:15. [PMID: 36690735 DOI: 10.1186/s13244-023-01366-0] [Reference Citation Analysis]
30 He X, Fan R, Sun J, Ren Y, Zhao X, Rui W, Yuan Y, Zou D. A model for predicting degree of malignancy in patients with intraductal papillary mucinous neoplasm. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1087852] [Reference Citation Analysis]
31 Kryachko AA, Durleshter VM, Chuguzov KD, Kryachko AA. Benign neoplasms of the colon: problems and solutions. jour 2023. [DOI: 10.31146/1682-8658-ecg-207-11-227-233] [Reference Citation Analysis]
32 Hu X, Li C, Wang Q, Wu X, Chen Z, Xia F, Cai P, Zhang L, Fan Y, Ma K. Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma. Diagnostics 2023;13:413. [DOI: 10.3390/diagnostics13030413] [Reference Citation Analysis]
33 Yutsevich OK, Pirogov SS, Volchenko NN, Perfiliev IB, Ryabov AB, Kaprin AD. Modern endoscopy in the diagnosis of early esophago-gastric junction cancer. jour 2023. [DOI: 10.31146/1682-8658-ecg-207-11-141-147] [Reference Citation Analysis]
34 Januszewicz W, Turkot MH, Malfertheiner P, Regula J. A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When? Cancers 2023;15:664. [DOI: 10.3390/cancers15030664] [Reference Citation Analysis]
35 Gheytanchi E, Tajik F, Razmi M, Babashah S, Cho WCS, Tanha K, Sahlolbei M, Ghods R, Madjd Z. Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis. Cancer Cell Int 2023;23:10. [PMID: 36670440 DOI: 10.1186/s12935-023-02851-8] [Reference Citation Analysis]
36 Liverani C, Spadazzi C, Ibrahim T, Pieri F, Foca F, Calabrese C, De Vita A, Miserocchi G, Cocchi C, Vanni S, Ercolani G, Cavaliere D, Ranallo N, Chiadini E, Prisinzano G, Severi S, Sansovini M, Martinelli G, Bongiovanni A, Mercatali L. HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors. Front Endocrinol 2023;13. [DOI: 10.3389/fendo.2022.1045038] [Reference Citation Analysis]
37 Konsek-komorowska SJ, Pęczkowska M, Kolasińska-ćwikła AD, Cichocki A, Konka M, Roszkowska-purska K, Ćwikła JB. Analysis of Patients with NET G1/G2 Neuroendocrine Tumors of the Small Intestine in the Course of Carcinoid Heart Disease—A Retrospective Study. JCM 2023;12:790. [DOI: 10.3390/jcm12030790] [Reference Citation Analysis]
38 Badwei N, Mostafa A. A rare Egyptian case report of rectal neuroendocrine tumour polyp.. [DOI: 10.21203/rs.3.rs-2476670/v1] [Reference Citation Analysis]
39 Gao C, Fan Z, Yang J, Shi M, Li Y, Zhan H. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms. Pancreatology 2023:S1424-3903(23)00034-0. [PMID: 36710224 DOI: 10.1016/j.pan.2023.01.009] [Reference Citation Analysis]
40 Rossi G, Petrone MC, Healey AJ, Arcidiacono PG. Gastric cancer in 2022: Is there still a role for endoscopic ultrasound? World J Gastrointest Endosc 2023; 15(1): 1-9 [PMID: 36686065 DOI: 10.4253/wjge.v15.i1.1] [Reference Citation Analysis]
41 Zappi A, Persano I, Galvani L, Parlagreco E, Andrini E, Campana D, Brizzi MP, Lamberti G, La Salvia A. Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review. J Clin Med 2023;12. [PMID: 36675645 DOI: 10.3390/jcm12020717] [Reference Citation Analysis]
42 Murakami Y, Tanabe H, Ono Y, Sugiyama Y, Kobayashi Y, Kunogi T, Sasaki T, Takahashi K, Ando K, Ueno N, Kashima S, Yuzawa S, Moriichi K, Mizukami Y, Fujiya M, Okumura T. Local recurrence after successful endoscopic submucosal dissection for rectal mucinous mucosal adenocarcinoma: A case report. World J Gastrointest Oncol 2023; 15(1): 186-194 [PMID: 36684048 DOI: 10.4251/wjgo.v15.i1.186] [Reference Citation Analysis]
43 Zhao YH, Zheng Y, Sha J, Hua HJ, Li KD, Lu Y, Dang YN, Zhang GX. A Prediction Model Based on the Risk Factors Associated with Pathological Upgrading in Patients with Early-Stage Gastric Neoplasms Diagnosed by Endoscopic Forceps Biopsy. Gut Liver 2023;17:78-91. [PMID: 36052614 DOI: 10.5009/gnl220060] [Reference Citation Analysis]
44 Gherghe M, Lazar AM, Simion L, Irimescu IN, Sterea MC, Mutuleanu MD, Anghel RM. Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours. Diagnostics (Basel) 2023;13. [PMID: 36673128 DOI: 10.3390/diagnostics13020318] [Reference Citation Analysis]
45 Lugat A, Frampas É, Touchefeu Y, Mirallié É, Bras ML, Senellart H, Rauscher A, Fleury V, Campion L, Rohmer V, Couturier OF, Lebtahi R, Rouzet F, Ruszniewski P, Kraeber-Bodéré F, Bourgeois M, Ansquer C. Prospective Multicentric Assessment of (68)Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET. Cancers (Basel) 2023;15. [PMID: 36672462 DOI: 10.3390/cancers15020513] [Reference Citation Analysis]
46 Milana F, Polidoro MA, Famularo S, Lleo A, Boldorini R, Donadon M, Torzilli G. Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence. Cancers (Basel) 2023;15. [PMID: 36672457 DOI: 10.3390/cancers15020508] [Reference Citation Analysis]
47 Sivapathasundaram A, Golse N, Pascale A, Durand E, Sebagh M, Besson FL. Is 18F-FDG/18F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma: A Tertiary Center Dedicated Study. Clin Nucl Med 2023. [PMID: 36728133 DOI: 10.1097/RLU.0000000000004574] [Reference Citation Analysis]
48 Möller K, Safai Zadeh E, Görg C, Dong Y, Cui X, Lim A, Molo CD, Serra C, Martín Algíbez A, Berzigotti A, Piscaglia F, Faiss S, Dietrich CF. Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges. Journal of Translational Internal Medicine 2023;10:308-327. [DOI: 10.2478/jtim-2022-0068] [Reference Citation Analysis]
49 Silva JF, Lopes S, Macedo G. An unexpected cause of common bile duct obstruction diagnosed by endoscopic ultrasound guided fine-needle biopsy. Rev Esp Enferm Dig 2023;115. [PMID: 36633171 DOI: 10.17235/reed.2023.9393/2022] [Reference Citation Analysis]
50 Haasnoot KJC, Baldaque-Silva F, Koch A, Figueiredo Ferreira M, Santos-Antunes J, Dias E, Omae M, van Tilburg L, Dang H, Lemmers A, Boonstra JJ, Moons LMG. Low risk of local recurrence after a successful en bloc endoscopic submucosal dissection for noninvasive colorectal lesions with positive horizontal resection margins (R-ESD study). Endoscopy 2023. [PMID: 36228648 DOI: 10.1055/a-1960-3552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Gheorghișan-Gălățeanu AA, Ilieșiu A, Lambrescu IM, Țăpoi DA. The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors-An Overview of the Latest Classifications. Int J Mol Sci 2023;24. [PMID: 36674939 DOI: 10.3390/ijms24021418] [Reference Citation Analysis]
52 Ngo VTH, Meyers MP, Qureshi K, Farooq MU. Anti-Hu-Associated Encephalomyelitis as a Presentation of Primary Extrapulmonary Small Cell Carcinoma of the Small Bowel: A Case Report. Cureus 2023. [DOI: 10.7759/cureus.33605] [Reference Citation Analysis]
53 Yang DH, Cheng J, Tian XF, Zhang Q, Yu LY, Qiu YJ, Lu XY, Lou WH, Dong Y, Wang WP. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis. Diagnostics (Basel) 2023;13. [PMID: 36673048 DOI: 10.3390/diagnostics13020238] [Reference Citation Analysis]
54 Ziogas IA, Rallis KS, Tasoudis PT, Moris D, Schulick RD, Del Chiaro M. Management and outcomes of mixed adenoneuroendocrine carcinoma of the ampulla of Vater: A systematic review and pooled analysis of 56 patients. Eur J Surg Oncol 2023:S0748-7983(23)00027-6. [PMID: 36646615 DOI: 10.1016/j.ejso.2023.01.005] [Reference Citation Analysis]
55 Song H, Yang S, Zhang Y, Hua Y, Kleeff J, Liu Q, Liao Q. Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases. Front Oncol 2022;12:1007317. [PMID: 36698410 DOI: 10.3389/fonc.2022.1007317] [Reference Citation Analysis]
56 Huang Y, Suguro R, Hu W, Zheng J, Liu Y, Guan M, Zhou N, Zhang X. Nitric oxide and thyroid carcinoma: A review. Front Endocrinol (Lausanne) 2022;13:1050656. [PMID: 36699047 DOI: 10.3389/fendo.2022.1050656] [Reference Citation Analysis]
57 Meira-Júnior JD, Yogolare GG, Magalhães DP, Namur GN, Campos FG, Segatelli V, Nahas SC, Jukemura J. PANCREATIC SOLID-PSEUDOPAPILLARY NEOPLASM IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS. Arq Bras Cir Dig 2023;35:e1718. [PMID: 36629695 DOI: 10.1590/0102-672020220002e1718] [Reference Citation Analysis]
58 Foersch S, Glasner C, Woerl AC, Eckstein M, Wagner DC, Schulz S, Kellers F, Fernandez A, Tserea K, Kloth M, Hartmann A, Heintz A, Weichert W, Roth W, Geppert C, Kather JN, Jesinghaus M. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer. Nat Med 2023. [PMID: 36624314 DOI: 10.1038/s41591-022-02134-1] [Reference Citation Analysis]
59 Peisl S, Burckhardt O, Egger B. Limitations and prospects in the management of IPMN: a retrospective, single-center observational study. BMC Surg 2023;23:3. [PMID: 36611137 DOI: 10.1186/s12893-023-01902-1] [Reference Citation Analysis]
60 Fortunati E, Bonazzi N, Zanoni L, Fanti S, Ambrosini V. Molecular imaging Theranostics of Neuroendocrine Tumors. Semin Nucl Med 2023:S0001-2998(22)00115-5. [PMID: 36623974 DOI: 10.1053/j.semnuclmed.2022.12.007] [Reference Citation Analysis]
61 Kono Y, Higashi R, Mizushima H, Shimizu D, Katayama T, Kosaka M, Hirata I, Hirata T, Gotoda T, Miyahara K, Moritou Y, Kunihiro M, Nakagawa M, Ichimura K, Okada H. Usefulness of Acetic Acid Spray with Narrow-Band Imaging for Identifying the Margin of Sessile Serrated Lesions. Dig Dis Sci 2023. [PMID: 36609732 DOI: 10.1007/s10620-022-07816-x] [Reference Citation Analysis]
62 Lieu DQ, Anh TN, Hoa TT, Phuong VT, Duc NM. An extremely rare case of intrahepatic sarcomatoid cholangiocarcinoma. Radiol Case Rep 2023;18:968-73. [PMID: 36636481 DOI: 10.1016/j.radcr.2022.12.001] [Reference Citation Analysis]
63 Constantin A, Achim F, Turcu T, Birceanu A, Evsei A, Socea B, Predescu D. Giant Gallbladder Tumor, Unusual Cancer-Case Report and Short Review of Literature. Diagnostics (Basel) 2023;13. [PMID: 36673003 DOI: 10.3390/diagnostics13020194] [Reference Citation Analysis]
64 Su CC, Chen BS, Chen HH, Sung WW, Wang CC, Tsai MC. Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures. Healthcare (Basel) 2023;11. [PMID: 36673528 DOI: 10.3390/healthcare11020159] [Reference Citation Analysis]
65 Rinke A, Denzer UW. Kolorektale NEN (ohne Fernmetastasen). Springer Reference Medizin 2023. [DOI: 10.1007/978-3-662-63317-5_48] [Reference Citation Analysis]
66 Centonze G, Maisonneuve P, Simbolo M, Lagano V, Grillo F, Fabbri A, Prinzi N, Garzone G, Filugelli M, Pardo C, Mietta A, Pusceddu S, Sabella G, Bercich L, Mangogna A, Rolli L, Grisanti S, Benvenuti MR, Pastorino U, Roz L, Scarpa A, Berruti A, Capella C, Milione M. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry. Histopathology 2023;82:324-39. [PMID: 36239545 DOI: 10.1111/his.14819] [Reference Citation Analysis]
67 Sapuppo E, Brunetti O, Tessitore D, Brandi G, Di Giovanni N, Fadda G, Luchini C, Martini M, Quaresmini D, Russo A, Santarpia M, Scarpa A, Scartozzi M, Tuccari G, Franchina T, Silvestris N. Rare histotypes of epithelial biliary tract tumors: A literature review. Crit Rev Oncol Hematol 2023;181:103892. [PMID: 36481306 DOI: 10.1016/j.critrevonc.2022.103892] [Reference Citation Analysis]
68 Ahn B, Kim JY, Hong SM. Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor. Arch Pathol Lab Med 2023;147:100-16. [PMID: 35533360 DOI: 10.5858/arpa.2021-0475-OA] [Reference Citation Analysis]
69 DelSignore M, Jeong T, Denmark G, Feldman D, Shih A, Zukerberg L, Chung DC. Incidence and natural history of gastric high-grade dysplasia in patients with familial adenomatous polyposis syndrome. Gastrointest Endosc 2023;97:25-34.e6. [PMID: 36113625 DOI: 10.1016/j.gie.2022.09.002] [Reference Citation Analysis]
70 Linguanti F, Abenavoli EM, Briganti V, Danti G, Lavacchi D, Matteini M, Vaggelli L, Novelli L, Grosso AM, Mungai F, Mini E, Antonuzzo L, Miele V, Sciagrà R, Berti V. Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study. Ann Nucl Med 2023;37:1-9. [PMID: 36309948 DOI: 10.1007/s12149-022-01797-7] [Reference Citation Analysis]
71 Minczeles NS, de Herder WW, Feelders RA, Verburg FA, Hofland J, Brabander T. Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in Neuroendocrine Tumor Patients. J Nucl Med 2023;64:40-6. [PMID: 35680417 DOI: 10.2967/jnumed.122.263856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Zhang M, Tan C, Wang X, Ding X, Zhang B, Yang Z, Wang Y, Sheng W, Huang D. Digital Image Analysis of Ki67 Heterogeneity Improves the Diagnosis and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms. Modern Pathology 2023;36:100017. [DOI: 10.1016/j.modpat.2022.100017] [Reference Citation Analysis]
73 Zimmermann-Fraedrich K, Sehner S, Rösch T, Aschenbeck J, Schröder A, Schubert S, Liceni T, Aminalai A, Spitz W, Möhler U, Heller F, Berndt R, Bartel-Kowalski C, Niemax K, Burmeister W, Schachschal G. Second-generation distal attachment cuff for adenoma detection in screening colonoscopy: a randomized multicenter study. Gastrointest Endosc 2023;97:112-20. [PMID: 36030888 DOI: 10.1016/j.gie.2022.08.030] [Reference Citation Analysis]
74 Wang L, Saeedi BJ, Mahdi Z, Krasinskas A, Robinson B. Analysis of KRAS Mutations in Gastrointestinal Tract Adenocarcinomas Reveals Site-Specific Mutational Signatures. Modern Pathology 2023. [DOI: 10.1016/j.modpat.2022.100014] [Reference Citation Analysis]
75 Digiacomo G, Serra RP, Turrini E, Tiri A, Cavazzoni A, Alfieri R, Bertolini P. State of the art and perspectives in pediatric hepatocellular carcinoma. Biochem Pharmacol 2023;207:115373. [PMID: 36513143 DOI: 10.1016/j.bcp.2022.115373] [Reference Citation Analysis]
76 Ziogas IA, Tasoudis PT, Borbon LC, Sherman SK, Breheny PJ, Chandrasekharan C, Dillon JS, Bellizzi AM, Howe JR. Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis. Ann Surg Oncol 2023;30:148-60. [PMID: 36227392 DOI: 10.1245/s10434-022-12643-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Podany P, Meiklejohn K, Garritano J, Holt EH, Barbieri A, Prasad M, Gilani SM. Grading system for medullary thyroid carcinoma; an institutional experience. Annals of Diagnostic Pathology 2023. [DOI: 10.1016/j.anndiagpath.2023.152112] [Reference Citation Analysis]
78 Leonhardt CS, Hinz U, Kaiser J, Hank T, Tjaden C, Bergmann F, Hackert T, Büchler MW, Strobel O. Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma. Eur J Surg Oncol 2023;49:113-21. [PMID: 35965217 DOI: 10.1016/j.ejso.2022.08.003] [Reference Citation Analysis]
79 Shah HJ, Ruppell E, Bokhari R, Aland P, Lele VR, Ge C, Mcintosh LJ. Current and upcoming radionuclide therapies in the direction of precision oncology: A narrative review. European Journal of Radiology Open 2023;10:100477. [DOI: 10.1016/j.ejro.2023.100477] [Reference Citation Analysis]
80 López MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, Quispe L, Zevallos A, Buleje JL, Cho CE, Sarmiento M, Pinto JA, Fajardo W. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol 2023;181:103841. [PMID: 36240980 DOI: 10.1016/j.critrevonc.2022.103841] [Reference Citation Analysis]
81 Eschrich J, Kobus Z, Geisel D, Halskov S, Roßner F, Roderburg C, Mohr R, Tacke F. The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma-State of the Art and Future Perspectives. Cancers (Basel) 2023;15. [PMID: 36612297 DOI: 10.3390/cancers15010301] [Reference Citation Analysis]
82 王 翰. A Case Analysis and Literature Review of Combined Hepatocellular-Cholangiocarcinoma after Operation. ACM 2023;13:824-830. [DOI: 10.12677/acm.2023.131120] [Reference Citation Analysis]
83 Keller HR, Senapathi SH, Morada A, Bertsch D, Cagir B. Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine. Am J Surg 2023;225:58-65. [PMID: 36216612 DOI: 10.1016/j.amjsurg.2022.09.053] [Reference Citation Analysis]
84 Fukagawa K, Takahashi Y, Yamamichi N, Kageyama-Yahara N, Sakaguchi Y, Obata M, Cho R, Sakuma N, Nagao S, Miura Y, Tamura N, Ohki D, Mizutani H, Yakabi S, Minatsuki C, Niimi K, Tsuji Y, Yamamichi M, Shigi N, Tomida S, Abe H, Ushiku T, Koike K, Fujishiro M. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type. Gastric Cancer 2023;26:44-54. [PMID: 36094595 DOI: 10.1007/s10120-022-01334-5] [Reference Citation Analysis]
85 Ziogas IA, Dillon JS, Chandrasekharan C, Howe JR. ASO Author Reflections: Surgical Resection Should be Considered in the Multidisciplinary Care of Patients with Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms. Ann Surg Oncol 2023;30:161-2. [PMID: 36209329 DOI: 10.1245/s10434-022-12644-4] [Reference Citation Analysis]
86 Vera R, Ibarrola-de Andrés C, Adeva J, Pérez-Rojas J, García-Alfonso P, Rodríguez-Gil Y, Macarulla T, Serrano-Piñol T, Mondéjar R, Madrigal-Rubiales B. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer. Rev Esp Patol 2023;56:32-44. [PMID: 36599598 DOI: 10.1016/j.patol.2022.06.004] [Reference Citation Analysis]
87 Holmberg M, Radkiewicz C, Strömberg C, Öman M, Ghorbani P, Löhr JM, Sparrelid E. Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study. Pancreatology 2023;23:90-7. [PMID: 36522260 DOI: 10.1016/j.pan.2022.12.003] [Reference Citation Analysis]
88 Di Mauro D, Saunders S, Orabi A, Myintmo A, Reece-smith A, Wajed S, Manzelli A. Incidental Gallbladder Cancer: The Role of Routine Versus Selective Histopathological Examination of Gallbladder Specimens After Cholecystectomy. Gallbladder Cancer 2023. [DOI: 10.1007/978-981-19-6442-8_5] [Reference Citation Analysis]
89 Zhuang X, Zhang S, Chen G, Luo Z, Hu H, Huang W, Guo Y, Ouyang Y, Peng L, Qing Q, Chen H, Li B, Chen J, Wang X. Risk factors and clinical outcomes of incomplete endoscopic resection of small rectal neuroendocrine tumors in southern China: a 9-year data analysis. Gastroenterol Rep (Oxf) 2023;11:goac084. [PMID: 36632622 DOI: 10.1093/gastro/goac084] [Reference Citation Analysis]
90 Kinami S, Yamada S, Takamura H. Confusion and prospects for carcinogenesis of gastric adenoma and dysplasia: What is the correct answer currently? World J Gastroenterol 2022; 28(48): 6900-6908 [DOI: 10.3748/wjg.v28.i48.6900] [Reference Citation Analysis]
91 Wang F, Wang J, Li Y, Wang X, Yu D, Zhang X. Correlation of four-phase CT findings of rectal neuroendocrine neoplasms with different World Health Organization grades. Abdom Radiol (NY) 2022. [PMID: 36576516 DOI: 10.1007/s00261-022-03771-3] [Reference Citation Analysis]
92 Ungefroren H, Konukiewitz B, Wellner UF, Schrader J, Keck T. The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses. Cancers (Basel) 2022;15. [PMID: 36612156 DOI: 10.3390/cancers15010160] [Reference Citation Analysis]
93 Li B, Zhang F, Niu Q, Liu J, Yu Y, Wang P, Zhang S, Zhang H, Wang Z. A molecular classification of gastric cancer associated with distinct clinical outcomes and validated by an XGBoost-based prediction model. Mol Ther Nucleic Acids 2023;31:224-40. [PMID: 36700042 DOI: 10.1016/j.omtn.2022.12.014] [Reference Citation Analysis]
94 Oh SJ, Kim JW, Oh CH. Sessile serrated lesion presenting as large pedunculated polyp in the rectum: A case report. Medicine (Baltimore) 2022;101:e32287. [PMID: 36595848 DOI: 10.1097/MD.0000000000032287] [Reference Citation Analysis]
95 Auvray Kuentz M, Hautefeuille V, de Mestier L, Coutzac C, Lecomte T, Nardon V, Artru P, Turpin A, Drouillard A, Malka D, Tran-Minh ML, Trouilloud I, Lièvre A, Williet N, Pernot S, Touchefeu Y, Taieb J, Hammel P, Zaanan A. Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. Int J Cancer 2022. [PMID: 36562310 DOI: 10.1002/ijc.34414] [Reference Citation Analysis]
96 Sun CC, Li L, Tao HQ, Jiang ZC, Wang L, Wang HJ. The role of NLRP3 inflammasome in digestive system malignancy. Front Cell Dev Biol 2022;10:1051612. [PMID: 36619871 DOI: 10.3389/fcell.2022.1051612] [Reference Citation Analysis]
97 Bilal Masokano I, Pei Y, Chen J, Liu W, Xie S, Liu H, Feng D, He Q, Li W. Development and validation of MRI-based model for the preoperative prediction of macrotrabecular hepatocellular carcinoma subtype. Insights Imaging 2022;13:201. [PMID: 36544029 DOI: 10.1186/s13244-022-01333-1] [Reference Citation Analysis]
98 Arrivi G, Verrico M, Roberto M, Barchiesi G, Faggiano A, Marchetti P, Mazzuca F, Tomao S. Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis. Cancer Manag Res 2022;14:3507-23. [PMID: 36575665 DOI: 10.2147/CMAR.S372776] [Reference Citation Analysis]
99 Kim J, Tomita N, Suriawinata AA, Hassanpour S. Detection of Colorectal Adenocarcinoma and Grading Dysplasia on Histopathologic Slides Using Deep Learning. Am J Pathol 2022:S0002-9440(22)00399-6. [PMID: 36563748 DOI: 10.1016/j.ajpath.2022.12.003] [Reference Citation Analysis]
100 Baile-Maxía S, Mangas-Sanjuán C, Ladabaum U, Hassan C, Rutter MD, Bretthauer M, Medina-Prado L, Sala-Miquel N, Pomares OM, Zapater P, Jover R. Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas. Clin Gastroenterol Hepatol 2022:S1542-3565(22)01170-3. [PMID: 36549471 DOI: 10.1016/j.cgh.2022.12.005] [Reference Citation Analysis]
101 Abdelsattar S, Sweed D, Kamel HFM, Kasemy ZA, Gameel AM, Elzohry H, Ameen O, Elgizawy EI, Sallam A, Mosbeh A, Abdallah MS, Khalil FO, Al-Amodi HS, El-Hefnway SM. The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients. Biomolecules 2022;13. [PMID: 36671388 DOI: 10.3390/biom13010003] [Reference Citation Analysis]
102 Nikolic AL, Gullifer J, Johnson MA, Hii MW. Oesophageal neuroendocrine tumours-case series of a rare malignancy. J Surg Case Rep 2022;2022:rjac582. [PMID: 36570553 DOI: 10.1093/jscr/rjac582] [Reference Citation Analysis]
103 Kader R, Cid-Mejias A, Brandao P, Islam S, Hebbar S, Puyal JG, Ahmad OF, Hussein M, Toth D, Mountney P, Seward E, Vega R, Stoyanov D, Lovat LB. Polyp characterization using deep learning and a publicly accessible polyp video database. Dig Endosc 2022. [PMID: 36527309 DOI: 10.1111/den.14500] [Reference Citation Analysis]
104 Ramon Cierco Jimenez, Teresa Lee, Nicolás Rosillo, Reynalda Cordova, Ian A Cree, Angel Gonzalez, Blanca Iciar Indave Ruiz. Machine learning computational tools to assist the performance of systematic reviews: A mapping review. BMC Med Res Methodol 2022;22:322. [PMID: 36522637 DOI: 10.1186/s12874-022-01805-4] [Reference Citation Analysis]
105 Loosen SH, Kostev K, Eschrich J, Krieg S, Krieg A, Luedde T, Jann H, Roderburg C. Clinical characteristics of 662 patients with pancreatic neuroendocrine tumors receiving antitumoral therapy. Medicine (Baltimore) 2022;101:e32044. [PMID: 36550801 DOI: 10.1097/MD.0000000000032044] [Reference Citation Analysis]
106 Choi JH, Paik WH. Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics. J Clin Med 2022;11. [PMID: 36556070 DOI: 10.3390/jcm11247456] [Reference Citation Analysis]
107 Xu L, Xiao T, Xu L, Yao W. Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA. Front Oncol 2022;12:977992. [PMID: 36591499 DOI: 10.3389/fonc.2022.977992] [Reference Citation Analysis]
108 Peregorodiev IN, Kharbediya EK, Bokhyan VV, Delektorskaya VV, Kozlov NA, Melkonyan GG, Stilidi IS. Mixed neuroendocrine and non-neuroendocrine neoplasia (MiNEN) of the stomach. jour 2022;100:470-473. [DOI: 10.30629/0023-2149-2022-100-9-10-470-473] [Reference Citation Analysis]
109 Intarawichian P, Sangpaibool S, Prajumwongs P, Sa-Ngiamwibool P, Sangkhamanon S, Kunprom W, Thanee M, Loilome W, Khuntikeo N, Titapun A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Eurboonyanun K, Promsorn J, Koonmee S, Wee A, Aphivatanasiri C. Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. Front Oncol 2022;12:1004220. [PMID: 36582790 DOI: 10.3389/fonc.2022.1004220] [Reference Citation Analysis]
110 Di Chiaro P, Nacci L, Brandini S, Polletti S, Donati B, Gualdrini F, Frige G, Mazzarella L, Ciarrocchi A, Zerbi A, Spaggiari P, Barozzi I, Diaferia GR, Natoli G. Coexisting morpho-biotypes unveil the regulatory bases of phenotypic plasticity in pancreatic ductal adenocarcinoma.. [DOI: 10.1101/2022.12.12.520054] [Reference Citation Analysis]
111 Lv TR, Wang JM, Ma WJ, Hu YF, Dai YS, Jin YW, Li FY. The consistencies and inconsistencies between distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Front Oncol 2022;12:1042493. [PMID: 36578941 DOI: 10.3389/fonc.2022.1042493] [Reference Citation Analysis]
112 Mugaanyi J, Lu C, Huang J, Lu C. Undifferentiated Pancreatic Carcinomas, Clinical Features and Therapeutic Options: What We Know. Cancers (Basel) 2022;14. [PMID: 36551588 DOI: 10.3390/cancers14246102] [Reference Citation Analysis]
113 Maniscalco L, Varello K, Morello E, Montemurro V, Olimpo M, Giacobino D, Abbamonte G, Gola C, Iussich S, Bozzetta E. Investigating a Prognostic Factor for Canine Hepatocellular Carcinoma: Analysis of Different Histological Grading Systems and the Role of PIVKA-II. Vet Sci 2022;9. [PMID: 36548850 DOI: 10.3390/vetsci9120689] [Reference Citation Analysis]
114 Luo M, Liu X, Yong J, Ou B, Xu X, Zhao X, Liang M, Zhao Z, Ruan J, Luo B. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS. Eur Radiol 2022. [DOI: 10.1007/s00330-022-09322-0] [Reference Citation Analysis]
115 Shimada Y, Nagaba Y, Okawa H, Ehara K, Okada S, Naito M, Yokomori H. Immunohistochemical analysis of the distribution of RANKL: a case of disseminated carcinomatosis of bone marrow as the first presentation of relapse in curatively resected colorectal cancer. Med Mol Morphol 2022. [DOI: 10.1007/s00795-022-00342-9] [Reference Citation Analysis]
116 Wang L, Liu Z, Liu J, Ma L, Li X, Yao L, Li Q, Zhou P. Endoscopic submucosal dissection for lesions involving the anastomosis after upper gastrointestinal surgery. Surg Endosc 2022. [DOI: 10.1007/s00464-022-09776-9] [Reference Citation Analysis]
117 Zhang Z, Li Q, Sun S, Li Z, Cui ZG, Zhang M, Liu Q, Zhang Y, Xiong S, Zhang S. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma. World J Surg Oncol 2022;20:383. [PMID: 36464671 DOI: 10.1186/s12957-022-02847-0] [Reference Citation Analysis]
118 Wang M, Yin T, Huang P, Qin T, Chen D, Xu S, Gong J, Tian R, Guo X, Qin R. PIN1 As A Marker of Metastasis and Survival in Pancreatic Neuroendocrine Tumor Identified by Single-cell Sequencing and Proteomic Profiling.. [DOI: 10.21203/rs.3.rs-2325792/v1] [Reference Citation Analysis]
119 Roseland ME, Francis IR, Shampain KL, Stein EB, Wasnik AP, Millet JD. Gastric neuroendocrine neoplasms: a primer for radiologists. Abdom Radiol (NY) 2022;47:3993-4004. [PMID: 35411433 DOI: 10.1007/s00261-022-03509-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
120 Martin S, Iravani A, Shetty AS, Zulfiqar M, Morani A, Yano M, Bhosale PR, Itani M. Neuroendocrine neoplasm imaging: protocols by site of origin. Abdom Radiol (NY) 2022;47:4081-95. [PMID: 36307597 DOI: 10.1007/s00261-022-03713-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Morishita S, Yoshida S, Kamatani Y, Suzuhigashi S, Kitou M, Nasu T. Primary grade 2 neuroendocrine tumor of the ileal mesentery: a case report. surg case rep 2022;8:146. [DOI: 10.1186/s40792-022-01482-x] [Reference Citation Analysis]
122 Gao X, Huang S, Wang Y, Peng Q, Li W, Zou Y, Han Z, Cai J, Luo Y, Ye Y, Li A, Bai Y, Chen Y, Liu S, Li Y. Modified Cap-Assisted Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Rectal Neuroendocrine Tumors ≤10 mm: A Randomized Noninferiority Trial. Am J Gastroenterol 2022;117:1982-9. [PMID: 36455222 DOI: 10.14309/ajg.0000000000001914] [Reference Citation Analysis]
123 Renzulli M, Braccischi L, D'Errico A, Pecorelli A, Brandi N, Golfieri R, Albertini E, Vasuri F. State-of-the-art review on the correlations between pathological and magnetic resonance features of cirrhotic nodules. Histol Histopathol 2022;37:1151-65. [PMID: 35770721 DOI: 10.14670/HH-18-487] [Reference Citation Analysis]
124 Ouvrard E, Mestier L, Boursier C, Lachachi B, Sahakian N, Chevalier E, Mikail N, Carullo J, Bando-Delaunay A, Walter T, Malouf GG, Addeo P, Poncet G, Sebag F, Lebtahi R, Goichot B, Taïeb D, Imperiale A. (18)F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors. J Nucl Med 2022;63:1865-70. [PMID: 35589408 DOI: 10.2967/jnumed.122.263984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
125 Rajamohan N, Khasawneh H, Singh A, Suman G, Johnson GB, Majumder S, Halfdanarson TR, Goenka AH. PET/CT and PET/MRI in neuroendocrine neoplasms. Abdom Radiol (NY) 2022;47:4058-72. [PMID: 35426497 DOI: 10.1007/s00261-022-03516-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
126 Altshuler E, Riner AN, Herremans KM, George TJ, Rogers SC, Paniccia A, Hughes SJ, Fabregas JC, Nassour I. Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma. J Gastrointest Oncol 2022;13:3207-15. [PMID: 36636088 DOI: 10.21037/jgo-22-434] [Reference Citation Analysis]
127 Hau SO, Williamsson C, Andersson B, Eberhard J, Jirström K. Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study.. [DOI: 10.21203/rs.3.rs-2314940/v1] [Reference Citation Analysis]
128 Gupta A, Lubner MG, Liu JB, Richards ES, Pickhardt PJ. Small bowel neuroendocrine neoplasm: what surgeons want to know. Abdom Radiol (NY) 2022;47:4005-15. [PMID: 35312820 DOI: 10.1007/s00261-022-03485-6] [Reference Citation Analysis]
129 Tur-martínez J, Sorribas M, Secanella L, Peláez N, Gornals J, Serrano T, Busquets J, Fabregat J. Opciones en el tratamiento quirúrgico de la neoplasia neuroendocrina de la ampolla de Váter: experiencia en un centro de referencia. Cirugía Española 2022. [DOI: 10.1016/j.ciresp.2022.10.004] [Reference Citation Analysis]
130 White BE, Rous B, Chandrakumaran K, Wong K, Bouvier C, Van Hemelrijck M, George G, Russell B, Srirajaskanthan R, Ramage JK. Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study. The Lancet Regional Health - Europe 2022;23:100510. [DOI: 10.1016/j.lanepe.2022.100510] [Reference Citation Analysis]
131 Sasaki A, Inada Y, Yamaguchi E, Okamoto R, Motomura Y. Efficacy and Safety of Endoscopic Mucosal Resection with the Two-Person Method. Journal of Digestive Endoscopy 2022;13:229-234. [DOI: 10.1055/s-0042-1756484] [Reference Citation Analysis]
132 Kong G, Hicks RJ. PRRT for higher-grade neuroendocrine neoplasms: What is still acceptable? Curr Opin Pharmacol 2022;67:102293. [PMID: 36195008 DOI: 10.1016/j.coph.2022.102293] [Reference Citation Analysis]
133 Jafari P, Husain AN, Setia N. All Together Now. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.09.012] [Reference Citation Analysis]
134 Sogutlu F, Pekerbas M, Biray Avci C. Epigenetic signatures in gastric cancer: current knowledge and future perspectives. Expert Rev Mol Diagn 2022;22:1063-75. [PMID: 36522183 DOI: 10.1080/14737159.2022.2159381] [Reference Citation Analysis]
135 Vilkoite I, Mežmale L, Tolmanis I, Meri HA, Veide L, Dzērve Z, Anarkulova L, Nevidovska K, Lejnieks A. Comparison of nice classification for optical diagnosis of colorectal polyps and morphology of removed lesions depending on localisation in colon. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2022;76:650-656. [DOI: 10.2478/prolas-2022-0100] [Reference Citation Analysis]
136 Yi Z, Gu J, Li T, Yao J, Wang J, Chen H, Mei Z, Wu H, Li H, Ma Z, Deng Z, Tuo B, Zhao L, Liu X. A rare case of mimicry of insulinoma: presenting mainly in terms of clinical symptoms, imaging and molecular markers.. [DOI: 10.21203/rs.3.rs-2263254/v1] [Reference Citation Analysis]
137 Torén W, Sasor A, Ansari D, Andersson R. Histopathological investigation of colon liver metastases - which factors affect survival after surgery? Scand J Gastroenterol 2022;:1-7. [PMID: 36440692 DOI: 10.1080/00365521.2022.2151319] [Reference Citation Analysis]
138 Delabie P, Baudin É, Hentic O, Afchain P, Rusu T, Montravers F. Diagnostic performance and impact on patient management of [68Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut. Medicine (Baltimore) 2022;101:e31512. [PMID: 36451394 DOI: 10.1097/MD.0000000000031512] [Reference Citation Analysis]
139 Chan DL, Hayes AR, Karfis I, Conner A, Furtado O’mahony L, Mileva M, Bernard E, Roach P, Marin G, Pavlakis N, Schembri G, Gnanasegaran G, Marin C, Vanderlinden B, Navalkissoor S, Caplin ME, Flamen P, Toumpanakis C, Bailey DL. Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score. Br J Cancer 2022. [DOI: 10.1038/s41416-022-02061-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Tur-Martínez J, Sorribas M, Secanella L, Peláez N, Gornals J, Serrano T, Busquets J, Fabregat J. Surgical options for the treatment of neuroendocrine neoplasms of the ampulla of Vater: a reference centre experience. Cir Esp (Engl Ed) 2022:S2173-5077(22)00419-7. [PMID: 36436802 DOI: 10.1016/j.cireng.2022.11.010] [Reference Citation Analysis]
141 Li Y, Fan Z, Zhang F, Yang J, Shi M, Liu S, Meng Y, Zhan H. Neoadjuvant therapy in pancreatic neuroendocrine neoplasms: A systematic review and meta-analysis. Front Oncol 2022;12:981575. [PMID: 36505835 DOI: 10.3389/fonc.2022.981575] [Reference Citation Analysis]
142 Zhang S, Huo L, Feng Y, Zhang J, Wu Y, Liu Y, Lu L, Jia N, Liu W. Preoperative differentiation of hepatocellular carcinoma with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma on contrast-enhanced MRI. Front Oncol 2022;12:986713. [PMID: 36505850 DOI: 10.3389/fonc.2022.986713] [Reference Citation Analysis]
143 Faé IG, Ruiz GZL, Irffi GP, Almeida Junior RS, Conceição PA, Falchetto EB, Passaglia LG, Brasileiro Filho G, Gelape CL, Oliveira CRA. Intracardiac Metastasis of Colonic Adenocarcinoma 12 Years After Primary Tumor Control and Without Any Sign of Other Metastasis: A Case Report. Arq Bras Cardiol 2022;119:991-5. [PMID: 36541996 DOI: 10.36660/abc.20211014] [Reference Citation Analysis]
144 PelvEx Collaborative. Minimum standards of pelvic exenterative practice: PelvEx Collaborative guideline. Br J Surg 2022;109:1251-63. [PMID: 36170347 DOI: 10.1093/bjs/znac317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Ye J, Lin Y, Gao X, Lu L, Huang X, Huang S, Bai T, Wu G, Luo X, Li Y, Liang R. Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma. Cancers (Basel) 2022;14. [PMID: 36428813 DOI: 10.3390/cancers14225721] [Reference Citation Analysis]
146 Malik IA, Rajput M, Werner R, Fey D, Salehzadeh N, von Arnim CAF, Wilting J. Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer. BMC Cancer 2022;22:1193. [DOI: 10.1186/s12885-022-10247-6] [Reference Citation Analysis]
147 Wang L, Liu ZQ, Liu JZ, Ma LY, Li XQ, Yao L, Li QL, Zhou PH. Endoscopic submucosal dissection for anastomotic lesions after colorectal surgery. J Gastroenterol Hepatol 2022. [PMID: 36398853 DOI: 10.1111/jgh.16063] [Reference Citation Analysis]
148 Liu Z, Su R, Ahsan A, Liu C, Liao X, Tian D, Su M. Esophageal Squamous Cancer from 4NQO-Induced Mice Model: CNV Alterations. Int J Mol Sci 2022;23. [PMID: 36430789 DOI: 10.3390/ijms232214304] [Reference Citation Analysis]
149 Siciliano MC, Tornambè S, Cevenini G, Sorrentino E, Granai M, Giovannoni G, Marrelli D, Biviano I, Roviello F, Yoshiyama H, Leoncini L, Lazzi S, Mundo L. EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative. Infect Agents Cancer 2022;17:57. [DOI: 10.1186/s13027-022-00469-5] [Reference Citation Analysis]
150 Bartusik-aebisher D, Osuchowski M, Adamczyk M, Stopa J, Cieślar G, Kawczyk-krupka A, Aebisher D. Advancements in photodynamic therapy of esophageal cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1024576] [Reference Citation Analysis]
151 Zhang R, Guo Y, Wang Y, Hu L, Fang C, Yang Y, Yang X, Chen L, Chen J, Wang W, Sun X. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system. Cancer Medicine 2022. [DOI: 10.1002/cam4.5437] [Reference Citation Analysis]
152 Nie D, Lan Q, Huang Y, Fang C, Cao Y, Chen Y. Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study. BMC Gastroenterol 2022;22:458. [DOI: 10.1186/s12876-022-02543-z] [Reference Citation Analysis]
153 Ow TW, Sukocheva OA, Tran V, Lin R, Lee SZ, Chu M, Angelica B, Rayner CK, Tse E, Iyngkaran G, Bampton PA. Quality of colonoscopy performed by medical or surgical specialists and trainees in five Australian hospitals. World J Gastrointest Endosc 2022; 14(11): 672-683 [DOI: 10.4253/wjge.v14.i11.672] [Reference Citation Analysis]
154 Teixeira SA, Luzzi MDC, Martin ACBM, Duarte TT, Leal MDO, Teixeira GR, Reis MT, Junior CRA, Santos K, Melendez ME, Silva DDCSAD, Bernécule PN, Firmino HVL, Alves ALV, Guimarães DP, Borduqui JV, Laus AC, Mançano BM, Reis RM. The Barretos Cancer Hospital Animal Facility: Implementation and Results of a Dedicated Platform for Preclinical Oncology Models. Veterinary Sciences 2022;9:636. [DOI: 10.3390/vetsci9110636] [Reference Citation Analysis]
155 Tsounis D, Villiotou V, Melpidou A, Pantsiou C, Argyrou A, Giannopoulou C, Grigoratou A, Rontogianni D, Mantzaris GJ, Papatheodoridis G. Oxidative imbalance increases the risk for colonic polyp and colorectal cancer development. World J Gastrointest Oncol 2022; 14(11): 2208-2223 [DOI: 10.4251/wjgo.v14.i11.2208] [Reference Citation Analysis]
156 Zhan H, Meng Y, Fan Z, Yang J, Li Y, Liu S, Gao C. The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis.. [DOI: 10.21203/rs.3.rs-2252618/v1] [Reference Citation Analysis]
157 Hu S, Kang Y, Xie Y, Yang T, Yang Y, Jiao J, Zou Q, Zhang H, Zhang Y. 18F-FDG PET/CT-based radiomics nomogram for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma: a two-center study. Abdom Radiol 2022. [DOI: 10.1007/s00261-022-03722-y] [Reference Citation Analysis]
158 Kosmala A, Serfling SE, Schlötelburg W, Lindner T, Michalski K, Schirbel A, Higuchi T, Hartrampf PE, Buck AK, Weich A, Werner RA. Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors. Clin Nucl Med 2022;Publish Ahead of Print. [DOI: 10.1097/rlu.0000000000004480] [Reference Citation Analysis]
159 Venugopal A, Michalczyk A, Khasraw M, Ackland ML. EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms. IJMS 2022;23:13645. [DOI: 10.3390/ijms232113645] [Reference Citation Analysis]
160 Gebauer N, Ziehm M, Gebauer J, Riecke A, Meyhöfer S, Kulemann B, von Bubnoff N, Steinestel K, Bauer A, Witte HM. The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System. Cancers 2022;14:5465. [DOI: 10.3390/cancers14215465] [Reference Citation Analysis]
161 Zhang G, Chen BW, Yang XB, Wang HY, Yang X, Xie FC, Chen XQ, Yu LX, Shi J, Lu YY, Zhao HT. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study. World J Gastroenterol 2022; 28(41): 5968-5981 [DOI: 10.3748/wjg.v28.i41.5968] [Reference Citation Analysis]
162 Taniguchi K, Ota M, Yamada T, Serizawa A, Kotake S, Ito S, Suzuki K, Yamamoto M. Tumor Depth Prediction of Gastric Cancer With a T4 Score. Cancer Diagn Progn 2022;2:641-7. [PMID: 36340460 DOI: 10.21873/cdp.10154] [Reference Citation Analysis]
163 Wang X, Hu S, Su F, Lin J, Duan J, Tan H, Tan H. The efficacy of oxaliplatin, surufatinib, and camrelizumab on neuroendocrine carcinoma: a case report and literature review. Ann Transl Med 2022;10:1254. [PMID: 36544653 DOI: 10.21037/atm-22-4789] [Reference Citation Analysis]
164 Sa-Ngiamwibool P, Aphivatanasiri C, Sangkhamanon S, Intarawichian P, Kunprom W, Thanee M, Prajumwongs P, Loilome W, Khuntikeo N, Titapun A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Eurboonyanun K, Promsorn J, Wee A, Koonmee S. Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. HPB (Oxford) 2022;24:1944-56. [PMID: 35810105 DOI: 10.1016/j.hpb.2022.06.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
165 Didden P, van Eijck van Heslinga RAH, Schwartz MP, Arensman LR, Vleggaar FP, de Graaf W, Koch AD, Doukas M, Lacle MM, Moons LMG. Relevance of polyp size for primary endoscopic full-thickness resection of suspected T1 colorectal cancers. Endoscopy 2022;54:1062-70. [PMID: 35255517 DOI: 10.1055/a-1790-5539] [Reference Citation Analysis]
166 Matsuo S, Amano T, Miyamatsu Y, Hayashi D, Yamashita S, Momosaki S, Kawabe K, Nakamizo A. Discrepancy in the Ki67 labeling index of brain and orbital metastatic lesions from gastrointestinal neuroendocrine tumors: A case report. Neurocirugía (English Edition) 2022;33:345-349. [DOI: 10.1016/j.neucie.2021.04.010] [Reference Citation Analysis]
167 van Amstel P, Mahieu A, Bakx R, de Vries R, Raphael MF, Derikx JP, van Heurn LE, Gorter RR. Management and outcome of high-risk neuroendocrine tumors of the appendix in children; A systematic review. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.10.021] [Reference Citation Analysis]
168 Smolkova B, Kataki A, Earl J, Ruz-caracuel I, Cihova M, Urbanova M, Buocikova V, Tamargo S, Rovite V, Niedra H, Schrader J, Kohl Y. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103865] [Reference Citation Analysis]
169 Li J, Chen C, Chen B, Guo T. High FN1 expression correlates with gastric cancer progression. Pathology - Research and Practice 2022;239:154179. [DOI: 10.1016/j.prp.2022.154179] [Reference Citation Analysis]
170 Cappello F, Angerilli V, Santo LD, Munari G, Sabbadin M, Mele ML, Pennelli G, Luchini C, Parente P, Lazzi S, Fassan M. MORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF COLORECTAL SESSILE SERRATED LESIONS WITH DYSPLASIA. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154214] [Reference Citation Analysis]
171 Seufferlein T, Mayerle J, Böck S, Brunner T, Ettrich TJ, Grenacher L, Gress TM, Hackert T, Heinemann V, Kestler A, Sinn M, Tannapfel A, Wedding U, Uhl W. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL. Z Gastroenterol 2022;60:e812-909. [PMID: 36368658 DOI: 10.1055/a-1856-7346] [Reference Citation Analysis]
172 Du R, Xiao JW. Prognostic impact of number of examined lymph nodes on survival of patients with appendiceal neuroendocrine tumors. World J Clin Cases 2022; 10(30): 10906-10920 [DOI: 10.12998/wjcc.v10.i30.10906] [Reference Citation Analysis]
173 Angelioudaki I, Theochari M, Koniaris E, Kataki A, Stoupis L, Mitrousias A, Tzingounis A, Dafnios N, Zografos G, Kifiri G, Konstadoulakis MM. Autophagy Flux is Induced in Gastroenteropancreatic Neuroendocrine Neoplasms. EMJ Oncol 2022. [DOI: 10.33590/emjoncol/10117618] [Reference Citation Analysis]
174 van de Weerd S, Smit MA, Roelands J, Mesker WE, Bedognetti D, Kuppen PJK, Putter H, Tollenaar RAEM, Roodhart JML, Hendrickx W, Medema JP, van Krieken JHJM. Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients. Int J Mol Sci 2022;23. [PMID: 36293565 DOI: 10.3390/ijms232012707] [Reference Citation Analysis]
175 Mochizuki K, Kudo SE, Kato K, Kudo K, Ogawa Y, Kouyama Y, Takashina Y, Ichimasa K, Tobo T, Toshima T, Hisamatsu Y, Yonemura Y, Masuda T, Miyachi H, Ishida F, Nemoto T, Mimori K. Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer. PLoS One 2022;17:e0273566. [PMID: 36264865 DOI: 10.1371/journal.pone.0273566] [Reference Citation Analysis]
176 Wu H, Yu Z, Liu Y, Guo L, Teng L, Guo L, Liang L, Wang J, Gao J, Li R, Yang L, Nie X, Su D, Liang Z. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract. Cancer Commun (Lond) 2022;42:1367-86. [PMID: 36264285 DOI: 10.1002/cac2.12372] [Reference Citation Analysis]
177 Fu AB, Xiang SF, He QJ, Ying MD. Kelch-like proteins in the gastrointestinal tumors. Acta Pharmacol Sin 2022. [PMID: 36266566 DOI: 10.1038/s41401-022-01007-0] [Reference Citation Analysis]
178 Tian HK, Zhang Z, Ning ZK, Liu J, Liu ZT, Huang HY, Zong Z, Li H. Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma. World J Clin Cases 2022; 10(29): 10451-10466 [DOI: 10.12998/wjcc.v10.i29.10451] [Reference Citation Analysis]
179 Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet 2022;400:1345-62. [PMID: 36084663 DOI: 10.1016/S0140-6736(22)01200-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
180 Watson MM, Watson DC, Maddern GJ, Wichmann MW; South Australian Rural Surgical Research Group. Quality of rural colonoscopy outperforms key performance indicators in a multi-centre prospective clinical study. ANZ J Surg 2022. [PMID: 36225114 DOI: 10.1111/ans.18072] [Reference Citation Analysis]
181 Gao J, Xu S, Ju H, Pan Y, Zhang Y. The potential application of MR-derived ADCmin values from 68Ga-DOTATATE and 18F-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors.. [DOI: 10.21203/rs.3.rs-2131748/v1] [Reference Citation Analysis]
182 Yu S, Ge M, Zhang C, Chen L, Zhao L. Diagnosis and treatment of pancreatic glucagonoma presenting with multiple metastases and recurring postoperatively: Report of two patients.. [DOI: 10.21203/rs.3.rs-2127424/v1] [Reference Citation Analysis]
183 Jiang D, Chen ZX, Ma FX, Gong YY, Pu T, Chen JM, Liu XQ, Zhao YJ, Xie K, Hou H, Wang C, Geng XP, Liu FB. Online calculator for predicting the risk of malignancy in patients with pancreatic cystic neoplasms: A multicenter, retrospective study. World J Gastroenterol 2022; 28(37): 5469-5482 [DOI: 10.3748/wjg.v28.i37.5469] [Reference Citation Analysis]
184 Lelièvre M, Triumbari EKA, Brixi H, Perrier M, Cadiot G, Deguelte S, Morland D. Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors. Endocrine 2022. [PMID: 36203032 DOI: 10.1007/s12020-022-03160-2] [Reference Citation Analysis]
185 Xu C, Li F, Liu Z, Yan C, Xiao J. A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer. Front Immunol 2022;13:1019764. [DOI: 10.3389/fimmu.2022.1019764] [Reference Citation Analysis]
186 Wu Z, Qiu X, Zhi Y, Shi X, Lv G. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database. Front Oncol 2022;12:993524. [DOI: 10.3389/fonc.2022.993524] [Reference Citation Analysis]
187 Shi C, Yu Y, Yan J, Hu C. The added value of radiomics from dual-energy spectral CT derived iodine-based material decomposition images in predicting histological grade of gastric cancer. BMC Med Imaging 2022;22:173. [PMID: 36192686 DOI: 10.1186/s12880-022-00899-y] [Reference Citation Analysis]
188 Vincenti L, Andriola V, Cazzato G, Colagrande A, Fiore F. Goblet Cell Carcinoma of the Appendix with Synchronous Adenocarcinoma of the Cecum: Distinct or Related Entities? Diseases 2022;10:77. [DOI: 10.3390/diseases10040077] [Reference Citation Analysis]
189 Wang P, Song Q, Lu M, Xia Q, Wang Z, Zhao Q, Ma X. Establishment and validation of a postoperative predictive model for patients with colorectal mucinous adenocarcinoma. World J Surg Oncol 2022;20:330. [PMID: 36192778 DOI: 10.1186/s12957-022-02791-z] [Reference Citation Analysis]
190 Ainechi D, Misawa M, Barua I, Larsen SLV, Paulsen V, Garborg KK, Aabakken L, Tønnesen CJ, Løberg M, Kalager M, Kudo SE, Hotta K, Ohtsuka K, Saito S, Ikematsu H, Saito Y, Matsuda T, Itoh H, Mori K, Bretthauer M, Mori Y. Impact of artificial intelligence on colorectal polyp detection for early-career endoscopists: an international comparative study. Scand J Gastroenterol 2022;57:1272-7. [PMID: 35605150 DOI: 10.1080/00365521.2022.2070436] [Reference Citation Analysis]
191 Polymeris A, Kogia C, Kazakou P, Psachna S, Lilis D, Drakou M, Michalakis K, Ioannidis D. A rare case of poorly differentiated mixed neuroendocrine-nonneuroendocrine tumor of the caecum with long term survival: A case report. Endocrine Regulations 2022;56:249-253. [DOI: 10.2478/enr-2022-0026] [Reference Citation Analysis]
192 Cai J, Liu Y, Wang C, Yin X. Differentiation between solid pseudopapillary tumor of the pancreas and acinar cell carcinoma of the pancreas based on computed tomography features. Asian Journal of Surgery 2022. [DOI: 10.1016/j.asjsur.2022.10.013] [Reference Citation Analysis]
193 Wan L, Peng W, Zou S, Shi Q, Wu P, Zhao Q, Ye F, Zhao X, Zhang H. Predicting perineural invasion using histogram analysis of zoomed EPI diffusion-weighted imaging in rectal cancer. Abdom Radiol (NY) 2022;47:3353-63. [PMID: 35779094 DOI: 10.1007/s00261-022-03579-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Aphivatanasiri C, Sa-ngiamwibool P, Sangkhamanon S, Intarawichian P, Kunprom W, Thanee M, Prajumwongs P, Khuntikeo N, Titapun A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Eurboonyanun K, Promsorn J, Loilome W, Wee A, Koonmee S. Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. Front Med 2022;9. [DOI: 10.3389/fmed.2022.893252] [Reference Citation Analysis]
195 Satala CB, Jung I, Kovacs Z, Stefan-Van Staden RI, Molnar C, Bara T, Patrichi AI, Gurzu S. V-set and immunoglobulin domain containing 1 (VSIG1) as an emerging target for epithelial-mesenchymal transition of gastric cancer. Sci Rep 2022;12:16241. [PMID: 36171238 DOI: 10.1038/s41598-022-19883-1] [Reference Citation Analysis]
196 Jiang J, Ding Y, Lu J, Chen Y, Chen Y, Zhao W, Chen W, Kong M, Li C, Teng X, Zhou Q, Xu N, Zhou D, Zhou Z, Wang H, Teng L. Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach. Int J Biol Sci 2022;18:5554-74. [PMID: 36147475 DOI: 10.7150/ijbs.71449] [Reference Citation Analysis]
197 Mitra S, Sekar A, Khosla D, Gupta V, Vaiphei K. Immunohistochemistry based molecular subtyping of pancreatic neuroendocrine tumor correlates with clinicopathological outcome: A single institute retrospective study.. [DOI: 10.21203/rs.3.rs-2088495/v1] [Reference Citation Analysis]
198 Fan X, Yu L, Qi X, Lin X, Zhao J, Wang D, Zhang J, Liu L. Primary Investigation of Deep Learning Models for Japanese “Group Classification” of Whole-Slide Images of Gastric Endoscopic Biopsy. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/6899448] [Reference Citation Analysis]
199 Gorciac V, Barboi OB, Negura I, Sorodoc L, Lionte C. An unusual association of folic acid deficiency with gastric neuroendocrine tumor type I. Turk J Int Med 2022. [DOI: 10.46310/tjim.1098540] [Reference Citation Analysis]
200 Qian Y, Gong Y, Luo G, Liu Y, Wang R, Zou X, Deng S, Lin X, Chen Y, Wang X, Yu X, Cheng H, Liu C. Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas. World J Surg Oncol 2022;20:310. [PMID: 36155113 DOI: 10.1186/s12957-022-02720-0] [Reference Citation Analysis]
201 Krieger TG, Sudy A, Schicktanz F, Tosti L, Liebig J, Konukiewitz B, Rouault M, Niesnerová A, Qian X, Weichert W, Eils R, Steiger K, Conrad C. Transcriptionally defined morphological subtypes of pancreatic ductal adenocarcinoma.. [DOI: 10.1101/2022.09.23.509133] [Reference Citation Analysis]
202 Urso L, Panareo S, Castello A, Ambrosio MR, Zatelli MC, Caracciolo M, Tonini E, Valpiani G, Boschi A, Uccelli L, Cittanti C, Bartolomei M. Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial. Pharmaceutics 2022;14:2009. [DOI: 10.3390/pharmaceutics14102009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Pozas J, Alonso-Gordoa T, Román MS, Santoni M, Thirlwell C, Grande E, Molina-Cerrillo J. Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations. Biochim Biophys Acta Rev Cancer 2022;1877:188804. [PMID: 36152904 DOI: 10.1016/j.bbcan.2022.188804] [Reference Citation Analysis]
204 Lau TS, Bossen L, Guldager Kring Rasmussen D, Karsdal M, Genovese F, Arveschoug AK, Gronbaek H, Dam G. Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumours. Scand J Clin Lab Invest 2022;:1-8. [PMID: 36129406 DOI: 10.1080/00365513.2022.2119598] [Reference Citation Analysis]
205 Sweed D, Sweed E, Moaz I, Mosbeh A, Fayed Y, Elhamed SMA, Sweed E, Macshut M, Abdelsattar S, Kilany S, Saied SA, Badr R, Abdallah MS, Ehsan N. The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02764-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
206 Li X, Ma Q, Chang C, Li H, Cao D. First-line treatment of camrelizumab combined with chemotherapy in advanced gastroenteropancreatic neuroendocrine carcinoma: Study protocol for a prospective, multicenter, phase II study. Front Oncol 2022;12:958905. [DOI: 10.3389/fonc.2022.958905] [Reference Citation Analysis]
207 Capuano N, Foggia P, Greco L, Ritrovato P. A Linked Data Application for Harmonizing Heterogeneous Biomedical Information. Applied Sciences 2022;12:9317. [DOI: 10.3390/app12189317] [Reference Citation Analysis]
208 Lu L, Zhang C, Yu X, Zhang L, Feng Y, Wu Y, Xia J, Chen X, Zhang R, Zhang J, Jia N, Zhang S, Granito A. The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/4691172] [Reference Citation Analysis]
209 Zhuo ZL, Xian HP, Sun YJ, Long Y, Liu C, Liang B, Zhao XT. Long noncoding RNA ZNFX1-AS1 promotes the invasion and proliferation of gastric cancer cells by regulating LIN28 and CAPR1N1. World J Gastroenterol 2022; 28(34): 4973-4992 [DOI: 10.3748/wjg.v28.i34.4973] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Iabichino G, Di Leo M, Arena M, Rubis Passoni GG, Morandi E, Turpini F, Viaggi P, Luigiano C, De Luca L. Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(34): 4943-4958 [DOI: 10.3748/wjg.v28.i34.4943] [Reference Citation Analysis]
211 Kornietskaya A, Evdokimova S, Kachmazov A, Fedenko A, Bolotina L, Sidorov D, Volchenko N, Goeva N, Govaleshko A, Kaprin A. Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report. Front Oncol 2022;12:970142. [DOI: 10.3389/fonc.2022.970142] [Reference Citation Analysis]
212 Li XP, Wang YY, Sun YS, Zhang LJ, Zhao XY, Liu ZQ, Jiang HM, Zha JD, Zhang XJ, Yan JN, Pan HY. Preoperative and postoperative clinical signatures of postgastrectomy venous thromboembolism (VTE) in patients with gastric cancer: A retrospective cohort study. Asian J Surg 2022:S1015-9584(22)01197-6. [PMID: 36089437 DOI: 10.1016/j.asjsur.2022.08.083] [Reference Citation Analysis]
213 Nagy GA, Neag MA, Drasovean R, Crisan D, Chira RI. Duodenal Ampulla Neuroendocrine Tumor with GISTs of the Proximal Jejunum: A Case Report. IJMS 2022;23:10351. [DOI: 10.3390/ijms231810351] [Reference Citation Analysis]
214 Fu M, Yu L, Yang L, Chen Y, Chen X, Hu Q, Sun H. Predictive value of the preoperative prognostic nutritional index for postoperative progression in patients with pancreatic neuroendocrine neoplasms. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.945833] [Reference Citation Analysis]
215 Rosery V, Mika S, Schmid KW, Reis H, Stuschke M, Treckmann J, Markus P, Schumacher B, Albers D, Mende B, Lahner H, Wiesweg M, Schuler M, Siveke JT, Kasper S. Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy. J Cancer Res Clin Oncol 2022. [PMID: 36071236 DOI: 10.1007/s00432-022-04314-5] [Reference Citation Analysis]
216 Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O. Advances in the management of peritoneal malignancies. Nat Rev Clin Oncol 2022. [PMID: 36071285 DOI: 10.1038/s41571-022-00675-5] [Reference Citation Analysis]
217 Guo Y, Li Q, Ren W, Wu H, Wang C, Li X, Xue B, Qiu Y, Zhang J, Chen J, Fang L. Quantitative Proteomics Reveals Down-Regulated Glycolysis/Gluconeogenesis in the Large-Duct Type Intrahepatic Cholangiocarcinoma. J Proteome Res 2022. [PMID: 36066509 DOI: 10.1021/acs.jproteome.2c00472] [Reference Citation Analysis]
218 Sandra I, Cazacu IM, Croitoru VM, Mihaila M, Herlea V, Diculescu MM, Dima SO, Croitoru AE. Circulating Angiogenic Markers in Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review. CIMB 2022;44:4001-4014. [DOI: 10.3390/cimb44090274] [Reference Citation Analysis]
219 Zhang Z, Liu L, Li Y, Liu Z, Zhang C, Zhao Y, Zhu M, Wan B, Deng H, Xie X, Tian K, Guo Z, Yang H, Liao J, Zhu H, Liu L, Wang M, Ma X, Liu T, Huang N, Gao Y, Zhao J, Liao F, Li F, Wang X, Yuan R, Liu X, Chang L. Therapeutic experience of a pancreatic mixed serous neuroendocrine neoplasm invading peripancreatic vessels: A case report. Medicine 2022;101:e30323. [DOI: 10.1097/md.0000000000030323] [Reference Citation Analysis]
220 Köhler F, Wiegering A. 54/m mit muzinösem Aszites. Chirurgie 2022. [DOI: 10.1007/s00104-022-01712-w] [Reference Citation Analysis]
221 Wang X, Xi X, Chen Y. Primary squamous cell carcinoma of the stomach with HP infection: A rare case report. Asian J Surg 2022:S1015-9584(22)01183-6. [PMID: 36064486 DOI: 10.1016/j.asjsur.2022.08.081] [Reference Citation Analysis]
222 Pizzanelli S, Cauchin E, Bossard C, Galmiche L. Un polype colique qui change. Annales de Pathologie 2022. [DOI: 10.1016/j.annpat.2022.07.025] [Reference Citation Analysis]
223 Saleh M, Bhosale PR, Yano M, Itani M, Elsayes AK, Halperin D, Bergsland EK, Morani AC. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms. Abdom Radiol (NY) 2022;47:3078-100. [PMID: 33095312 DOI: 10.1007/s00261-020-02833-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
224 Norwood DA, Montalvan EE, Dominguez RL, Morgan DR. Gastric Cancer: Emerging Trends in Prevention, Diagnosis, and Treatment. Gastroenterol Clin North Am 2022;51:501-18. [PMID: 36153107 DOI: 10.1016/j.gtc.2022.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Szidonya L, Park EA, Kwak JJ, Mallak N. Molecular and Anatomic Imaging of Neuroendocrine Tumors. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2022.06.009] [Reference Citation Analysis]
226 Tutino R, Rizzo G, Kamdem Mambou LJ, Colli F, Cocorullo G. Pancreatic mucinous cystic neoplasm: a potentially lethal disease. Chirurgia 2022;35. [DOI: 10.23736/s0394-9508.21.05313-4] [Reference Citation Analysis]
227 Virarkar M, Wong VK, Morani AC, Tamm EP, Bhosale P. Update on quantitative radiomics of pancreatic tumors. Abdom Radiol (NY) 2022;47:3118-60. [PMID: 34292365 DOI: 10.1007/s00261-021-03216-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
228 Pandey L, Elhence A, Gupta S, Joseph D, Pasricha R, Gupta M. Small-cell carcinoma of the gall bladder: Report of three cases and review of the literature. Medical Journal Armed Forces India 2022;78:S330-S334. [DOI: 10.1016/j.mjafi.2020.04.003] [Reference Citation Analysis]
229 Capretti G, Nebbia M, Gavazzi F, Nappo G, Ridolfi C, Sollai M, Spaggiari P, Bozzarelli S, Carrara S, Luberto A, Zerbi A. Invasive IPMN relapse later and more often in lungs in comparison to pancreatic ductal adenocarcinoma. Pancreatology 2022;22:782-8. [PMID: 35701318 DOI: 10.1016/j.pan.2022.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Kim KM, Ahn A, Park HS, Jang KY, Moon WS, Kang MJ, Ha GW, Lee MR, Chung MJ. Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-10039-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Ohki D, Tsuji Y, Tanaka M, Ushiku T, Fujishiro M. A case of a tiny neuroendocrine carcinoma in a large flat-elevated rectal tumor causing multiple liver metastases. Clin J Gastroenterol 2022. [DOI: 10.1007/s12328-022-01691-9] [Reference Citation Analysis]
232 Rennie AT, Halbreich SL. Rare Case of Gallbladder Neuroendocrine Carcinoma. Cureus 2022. [DOI: 10.7759/cureus.28531] [Reference Citation Analysis]
233 Kumar P, Kumar S, Vaiphei K, Kumar R. Primary hepatic neuroendocrine tumor with sarcoid like granulomas: A case report. IJPO 2022;9:292-295. [DOI: 10.18231/j.ijpo.2022.071] [Reference Citation Analysis]
234 Gong TT, Wang W. Clinical Characteristics of Patients with Surgically Resected Pancreatic Cysts: A Retrospective Analysis of 136 Patients. J Ultrasound Med 2022. [PMID: 36029231 DOI: 10.1002/jum.16085] [Reference Citation Analysis]
235 Corbett V, Hallenbeck P, Rychahou P, Chauhan A. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics. Front Mol Biosci 2022;9:930207. [DOI: 10.3389/fmolb.2022.930207] [Reference Citation Analysis]
236 Vera R, Ibarrola-de-Andrés C, Adeva J, Pérez-Rojas J, García-Alfonso P, Rodríguez-Gil Y, Macarulla T, Serrano-Piñol T, Mondéjar R, Madrigal-Rubiales B. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer. Clin Transl Oncol 2022. [PMID: 36008616 DOI: 10.1007/s12094-022-02873-0] [Reference Citation Analysis]
237 Kyang LS, Dewhurst SL, See VA, Alzahrani NA, Morris DL. Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis. Int J Hyperthermia 2022;39:1106-14. [PMID: 35993246 DOI: 10.1080/02656736.2022.2112625] [Reference Citation Analysis]
238 Ruiz-saavedra S, Zapico A, del Rey CG, Gonzalez C, Suárez A, Díaz Y, de los Reyes-gavilán CG, González S. Dietary Xenobiotics Derived from Food Processing: Association with Fecal Mutagenicity and Gut Mucosal Damage. Nutrients 2022;14:3482. [DOI: 10.3390/nu14173482] [Reference Citation Analysis]
239 Zheng C, Xu G, Tang D, Ni M, Cheng Y, Du M, Wang Y, Xu Y, Jiang J, Xiang Y, Sun Q, Chen L, Fan X, Huang Q, Zhou Y, Zou X, Wang L. A Retrospective Cohort Study of Factors Influencing Lymph Node Metastasis in Patients With Early Gastric Papillary Adenocarcinoma. Clin Transl Gastroenterol 2022;13:e00519. [PMID: 36000982 DOI: 10.14309/ctg.0000000000000519] [Reference Citation Analysis]
240 Roderburg C, Essing T, Kehmann L, Krieg S, Labuhn S, Kandler J, Luedde T, Loosen SH. Current Trends in Inpatient Care and In-Hospital Mortality of Cholangiocarcinoma in Germany: A Systematic Analysis between 2010 and 2019. Cancers (Basel) 2022;14:4038. [PMID: 36011031 DOI: 10.3390/cancers14164038] [Reference Citation Analysis]
241 Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, Ibrahim T, Byers LA, Sasano H, Umejiego J, Pavel M. DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms. Oncologist 2022;27:940-51. [PMID: 35983951 DOI: 10.1093/oncolo/oyac161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
242 Escobar KM, Vicente-villardon JL, Villacís Gonzalez RE, Castillo Cordova PH, Sánchez Rodríguez JM, De la Cruz-velez M, Siteneski A. Neuroendocrine Tumors: An Analysis of Prevalence, Incidence, and Survival in a Hospital-Based Study in Ecuador. Healthcare 2022;10:1569. [DOI: 10.3390/healthcare10081569] [Reference Citation Analysis]
243 Zhou C, Lu X, Wang Y, Qian X, Yang C, Zeng M. Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. Eur Radiol 2022. [PMID: 35976399 DOI: 10.1007/s00330-022-09065-y] [Reference Citation Analysis]
244 La Salvia A, Persano I, Parlagreco E, Audisio A, Cani M, Brizzi MP. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon. Med Oncol 2022;39:168. [PMID: 35972607 DOI: 10.1007/s12032-022-01764-2] [Reference Citation Analysis]
245 Chopde A, Gupta V, Jadhav A, Kumar R, Ramadwar M, Patkar S, Goel M. Neuroendocrine Tumours of Extrahepatic Biliary Tract: Report of Four Cases with Literature Review. Indian J Surg Oncol 2022. [DOI: 10.1007/s13193-022-01621-8] [Reference Citation Analysis]
246 Xia C, Yin H, Zhang K, Wang Z, Yang X, Huang H. The global research status and trends of the application of endoscopic ultrasonography in pancreatic tumors over the last decades: A bibliometric study. Front Oncol 2022;12:980415. [DOI: 10.3389/fonc.2022.980415] [Reference Citation Analysis]
247 Zhang W, Gao H, Liu W, Qin Y, Ye Z, Lou X, Wang F, Zhang Y, Chen X, Chen J, Yu X, Zhuo Q, Xu X, Ji S. A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival. Front Endocrinol 2022;13:941210. [DOI: 10.3389/fendo.2022.941210] [Reference Citation Analysis]
248 Agarwal P, Mohamed A. Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues. Curr Treat Options Oncol 2022. [PMID: 35939200 DOI: 10.1007/s11864-022-00998-6] [Reference Citation Analysis]
249 Fu M, Yu L, Yang L, Chen Y, Chen X, Hu Q, Sun H. Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China. Front Endocrinol 2022;13:885895. [DOI: 10.3389/fendo.2022.885895] [Reference Citation Analysis]
250 Chen WJ, Wolff E, Varma CR, Shoela R. Biliary Intraepithelial Neoplasia With Gallbladder Adenoma and Cirrhosis: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.27780] [Reference Citation Analysis]
251 Liao H, Li Y, Yang Y, Liu H, Zhang J, Liang H, Yan G, Liu Y. Comparison of Multiple Radiomics Models for Identifying Histological Grade of Pancreatic Ductal Adenocarcinoma Preoperatively Based on Multiphasic Contrast-Enhanced Computed Tomography: A Two-Center Study in Southwest China. Diagnostics 2022;12:1915. [DOI: 10.3390/diagnostics12081915] [Reference Citation Analysis]
252 Woo LT, Ding YF, Mao CY, Qian J, Zhang XM, Xu N. Long-term survival of gastric mixed neuroendocrine-non-neuroendocrine neoplasm: Two case reports. World J Clin Cases 2022; 10(22): 7936-7943 [DOI: 10.12998/wjcc.v10.i22.7936] [Reference Citation Analysis]
253 Zavrtanik H, Luzar B, Tomažič A. Intra-ampullary papillary-tubular neoplasm combined with ampullary neuroendocrine carcinoma: A case report. World J Clin Cases 2022; 10(22): 8045-8053 [DOI: 10.12998/wjcc.v10.i22.8045] [Reference Citation Analysis]
254 Ma S, Li C, Ma Y, Wang X, Zhang D, Lu Z. A retrospective study on the clinical and pathological features of hepatic sarcomatoid carcinoma: Fourteen cases of a rare tumor. Medicine (Baltimore) 2022;101:e30005. [PMID: 35945746 DOI: 10.1097/MD.0000000000030005] [Reference Citation Analysis]
255 Bhatt A, Mishra S, Glehen O. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review. Indian J Surg Oncol 2022. [DOI: 10.1007/s13193-022-01612-9] [Reference Citation Analysis]
256 Chiti G, Grazzini G, Flammia F, Matteuzzi B, Tortoli P, Bettarini S, Pasqualini E, Granata V, Busoni S, Messserini L, Pradella S, Massi D, Miele V. Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade. Radiol med 2022;127:928-938. [DOI: 10.1007/s11547-022-01529-x] [Reference Citation Analysis]
257 Khader A, Braschi-Amirfarzan M, McIntosh LJ, Gosangi B, Wortman JR, Wald C, Thomas R. Importance of tumor subtypes in cancer imaging. Eur J Radiol Open 2022;9:100433. [PMID: 35909389 DOI: 10.1016/j.ejro.2022.100433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Thompson ED, Zhang ML, Vandenbussche CJ. The Diagnostic Challenge of Evaluating Small Biopsies from the Pancreatobiliary System. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.05.001] [Reference Citation Analysis]
259 Ren T, Zhang W, Li S, Deng L, Xue C, Li Z, Liu S, Sun J, Zhou J. Combination of clinical and spectral-CT parameters for predicting lymphovascular and perineural invasion in gastric cancer. Diagnostic and Interventional Imaging 2022. [DOI: 10.1016/j.diii.2022.07.004] [Reference Citation Analysis]
260 Fukunaga Y, Fukuda A, Omatsu M, Namikawa M, Sono M, Masuda T, Araki O, Nagao M, Yoshikawa T, Ogawa S, Hiramatsu Y, Muta Y, Tsuda M, Maruno T, Nakanishi Y, Ferrer J, Tsuruyama T, Masui T, Hatano E, Seno H. Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway. Gastroenterology 2022;163:466-480.e6. [PMID: 35483445 DOI: 10.1053/j.gastro.2022.04.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Hackeng WM, Assi HA, Westerbeke FH, Brosens LA, Heaphy CM. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.05.007] [Reference Citation Analysis]
262 Dogan I, Tastekin D, Karabulut S, Sakar B. Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors. J Dig Dis 2022;23:493-9. [PMID: 36081250 DOI: 10.1111/1751-2980.13123] [Reference Citation Analysis]
263 Nieuwenhuis EA, van Munster SN, Meijer SL, Brosens LAA, Jansen M, Weusten BLAM, Alvarez Herrero L, Alkhalaf A, Schenk E, Schoon EJ, Curvers WL, Koch AD, van de Ven SEM, Verheij EPD, Nagengast WB, Westerhof J, Houben MHMG, Tang T, Bergman JJGHM, Pouw RE; Dutch Barrett Expert Centers. Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinoma. Gastrointest Endosc 2022;96:237-247.e3. [PMID: 35288149 DOI: 10.1016/j.gie.2022.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
264 Lemos Garcia J, Rosa I, Saraiva S, Marques I, Fonseca R, Lage P, Francisco I, Silva P, Filipe B, Albuquerque C, Claro I. Routine Immunohistochemical Analysis of Mismatch Repair Proteins in Colorectal Cancer—A Prospective Analysis. Cancers 2022;14:3730. [DOI: 10.3390/cancers14153730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Choi JH, Ro JY. Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach. Biomedicines 2022;10:1826. [DOI: 10.3390/biomedicines10081826] [Reference Citation Analysis]
266 Yang H, Messina-pacheco J, Corredor ALG, Gregorieff A, Liu J, Nehme A, Najafabadi HS, Riazalhosseini Y, Gao B, Gao Z. An integrated model of acinar to ductal metaplasia-related N7-methyladenosine regulators predicts prognosis and immunotherapy in pancreatic carcinoma based on digital spatial profiling. Front Immunol 2022;13:961457. [DOI: 10.3389/fimmu.2022.961457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Namasivayam V, Koh CJ, Tsao S, Lee J, Ling KL, Khor C, Lim T, Li JW, Yip BC, Hussain I, Chua TS, Toh BC, Ong HS, Wang LM, So JB, Teh M, Yeoh KG, Ang TL. Academy of Medicine, Singapore clinical guideline on endoscopic surveillance and management of gastric premalignant lesions. Ann Acad Med Singap 2022;51:417-435. [DOI: 10.47102/annals-acadmedsg.2021433] [Reference Citation Analysis]
268 Karlafti E, Charalampidou M, Fotiadou G, Abba Deka I, Raptou G, Kyriakidis F, Panidis S, Ioannidis A, Protopapas AA, Netta S, Paramythiotis D. Ampullary Large-Cell Neuroendocrine Carcinoma, a Diagnostic Challenge of a Rare Aggressive Neoplasm: A Case Report and Literature Review. Diagnostics 2022;12:1797. [DOI: 10.3390/diagnostics12081797] [Reference Citation Analysis]
269 Neumann O, Burn TC, Allgäuer M, Ball M, Kirchner M, Albrecht T, Volckmar A, Beck S, Endris V, Goldschmid H, Lehmann U, Seker-cin H, Uhrig S, Roessler S, Budczies J, Fröhling S, Longerich T, Wagner AH, Vogel A, Schirmacher P, Stenzinger A, Kazdal D. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. Br J Cancer. [DOI: 10.1038/s41416-022-01908-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
270 Bancheno WM, Adidam SR, Melaku MA. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review. Medicine (Baltimore) 2022;101:e29616. [PMID: 35866784 DOI: 10.1097/MD.0000000000029616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Qian Y, Gong Y, Liu Y, Chen Y, Wang R, Dai Z, Zou X, Tasiheng Y, Luo G, Lin X, Wang X, Cheng H, Yu X, Liu C, Song J. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/7353572] [Reference Citation Analysis]
272 Li S, Tang J, Wang J, Liu X, Zhou Y, Gu P. Metastasis of Mixed Adenoneuroendocrine Carcinoma of the Uterine Cervix to Thyroid Gland. Ear Nose Throat J 2022;:1455613221113817. [PMID: 35861212 DOI: 10.1177/01455613221113817] [Reference Citation Analysis]
273 Mun J, Hur W, Ku N. Roles of Keratins in Intestine. IJMS 2022;23:8051. [DOI: 10.3390/ijms23148051] [Reference Citation Analysis]
274 Pan Q, Yang W, Zhang Z, Shao Z. Rare Bone Metastasis of Neuroendocrine Tumors of Unknown Origin: A Case Report and Literature Review. Orthop Surg 2022. [PMID: 35856167 DOI: 10.1111/os.13384] [Reference Citation Analysis]
275 Zhang G, Li B, Yin X, Gao S, Shen S, Wang H, Shi X, Liu W, Zheng K, Jing W, Zhang Y, He T, Li G, Hu X, Guo S, Jin G. Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases. Int J Surg 2022;104:106786. [PMID: 35868619 DOI: 10.1016/j.ijsu.2022.106786] [Reference Citation Analysis]
276 Vidal Panduro DA, Zegarra Buitron E, Cochella Tizon OJ, Morales Luna DA. Neuroendocrine Carcinoma of the Gallbladder. Cureus 2022. [DOI: 10.7759/cureus.27022] [Reference Citation Analysis]
277 Da Fonseca LG, Hashizume PH, de Oliveira IS, Izquierdo-sanchez L, Saud LRDC, Xerfan MP, Alves VAF, de Mello ES, Herman P, Banales JM, Oliveira CP, Carrilho FJ. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Cancers 2022;14:3483. [DOI: 10.3390/cancers14143483] [Reference Citation Analysis]
278 Cuny T, van Koetsveld PM, Mondielli G, Dogan F, de Herder WW, Barlier A, Hofland LJ. Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment. Cancers 2022;14:3481. [DOI: 10.3390/cancers14143481] [Reference Citation Analysis]
279 Wang Y, Huang B, Fu Q, Wang J, Ye M, Hu M, Qu K, Liu K, Hu X, Wei S, Sun K, Xiao W, Zhang B, Li H, Li J, Zhang Q, Liang T. Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade. Ann Surg Oncol 2022. [PMID: 35849293 DOI: 10.1245/s10434-022-12107-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
280 Levy S, Arthur JD, Banks M, Kok NFM, Fenwick SW, Diaz-Nieto R, van Leerdam ME, Cuthbertson DJ, Valk GD, Kuhlmann KFD, Tesselaar MET. Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers. Ann Surg Oncol 2022. [PMID: 35842528 DOI: 10.1245/s10434-022-12030-0] [Reference Citation Analysis]
281 Fionda C, Scarno G, Stabile H, Molfetta R, Di Censo C, Gismondi A, Paolini R, Sozzani S, Santoni A, Sciumè G. NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis. Int J Mol Sci 2022;23:7859. [PMID: 35887206 DOI: 10.3390/ijms23147859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Weng CY, Sun SP, Cai C, Xu JL, Lv B. Endoscopic submucosal dissection for early signet ring cell gastric cancer: A systematic review and meta-analysis. World J Clin Cases 2022; 10(20): 6915-6926 [DOI: 10.12998/wjcc.v10.i20.6915] [Reference Citation Analysis]
283 Huang K, Lan Z, Chen W, Zhang J, Wang J, Zhu H, Xu B, Zhang L, Lu T, Guo Y, Wen Z. Hepatectomy and pneumectomy combined with targeted therapy for primary hepatic neuroendocrine carcinoma: Case report and review of the literature. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.920276] [Reference Citation Analysis]
284 Ren SJ, Wang X, Ke NW, Tan QQ, Yang F, Yao WQ, Tan CL, Liu XB. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single center experience. Asian J Surg 2022:S1015-9584(22)00975-7. [PMID: 35850904 DOI: 10.1016/j.asjsur.2022.07.029] [Reference Citation Analysis]
285 Ramachandran A, Madhusudhan KS. Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(26): 3008-3026 [DOI: 10.3748/wjg.v28.i26.3008] [Reference Citation Analysis]
286 Festa S, Zerboni G, Derikx LAAP, Ribaldone DG, Dragoni G, Buskens C, van Dijkum EN, Pugliese D, Panzuto F, Krela-Kaźmierczak I, Mintz HR, Shitrit AB, Chaparro M, Gisbert JP, Kopylov U, Teich N, Vainer E, Nagtegaal I, Hoentjen F, Garcia MJ, Filip R, Foteinogiannopoulou K, Koutroubakis IE, Argollo M, van Wanrooij RLJ, Laja H, Lobaton T, Truyens M, Molnar T, Savarino E, Aratari A, Papi C, Goren I. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series. J Crohns Colitis 2022;16:940-5. [PMID: 34864927 DOI: 10.1093/ecco-jcc/jjab217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 O'Connell E, Reynolds IS, Lindner AU, Salvucci M, O'Grady T, Bacon O, Cho S, McDonough E, Longley D, Ginty F, McNamara DA, Burke JP, Prehn JHM. Apoptotic and Necroptotic Mediators are Differentially Expressed in Mucinous and Non-Mucinous Colorectal Cancer. Front Oncol 2022;12:815001. [PMID: 35912268 DOI: 10.3389/fonc.2022.815001] [Reference Citation Analysis]
288 Papparella S, Crescio MI, Baldassarre V, Brunetti B, Burrai GP, Cocumelli C, Grieco V, Iussich S, Maniscalco L, Mariotti F, Millanta F, Paciello O, Rasotto R, Romanucci M, Sfacteria A, Zappulli V. Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study. Veterinary Sciences 2022;9:357. [DOI: 10.3390/vetsci9070357] [Reference Citation Analysis]
289 Doornebal EJ, Harris N, Riva A, Jagatia R, Pizanias M, Prachalias A, Menon K, Preziosi M, Zamalloa A, Miquel R, Zen Y, Orford MR, Eaton S, Heaton N, Ramage J, Palma E, Srirajaskanthan R, Chokshi S. Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment. Front Endocrinol 2022;13:909180. [DOI: 10.3389/fendo.2022.909180] [Reference Citation Analysis]
290 Palmer K, Weerasuriya S, Chandrakumaran K, Rous B, White BE, Paisey S, Srirajaskanthan R, Ramage JK. Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry. Front Oncol 2022;12:915028. [DOI: 10.3389/fonc.2022.915028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Li Z, Ren H, Zhao L, Zhang X, Wang T, Sun C, Niu P, Wang W, Fei H, Guo C, Chen Y, Zhao D. Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER. Current Oncology 2022;29:4879-4892. [DOI: 10.3390/curroncol29070387] [Reference Citation Analysis]
292 Borbon LC, Tran CG, Sherman SK, Ear PH, Chandrasekharan C, Bellizzi AM, Dillon JS, O'Dorisio TM, Howe JR. Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Ann Surg Oncol 2022. [PMID: 35802214 DOI: 10.1245/s10434-022-12100-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
293 Hasegawa S, Kobayashi N, Wild D, Kaul F, Okubo N, Suzuki A, Kurita Y, Takano S, Nakajima A, Ichikawa Y. Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors. Cancers 2022;14:3317. [DOI: 10.3390/cancers14143317] [Reference Citation Analysis]
294 Orchard P, Preece R, Thomas MG, Dixon SW, Wong NACS, Chambers AC, Messenger DE. Demographic trends in the incidence of malignant appendiceal tumours in England between 1995 and 2016: Population-based analysis. BJS Open 2022;6. [DOI: 10.1093/bjsopen/zrac103] [Reference Citation Analysis]
295 Tulessin M, Sarker RSJ, Griger J, Leibing T, Geraud C, Weichert W, Steiger K, Mogler C. Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver Tumorigenesis. Cells 2022;11:2129. [DOI: 10.3390/cells11142129] [Reference Citation Analysis]
296 Melone V, Salvati A, Palumbo D, Giurato G, Nassa G, Rizzo F, Palo L, Giordano A, Incoronato M, Vitale M, Mian C, Di Biase I, Cristiano S, Narciso V, Cantile M, Di Mauro A, Tatangelo F, Tafuto S, Modica R, Pivonello C, Salvatore M, Colao A, Weisz A, Tarallo R. Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03511-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
297 Zhang P, Xiao Z, Xu H, Zhu X, Wang L, Huang D, Liang Y, Ni Q, Chen J, Yu X, Luo G. Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasms. Endocrine 2022. [PMID: 35790660 DOI: 10.1007/s12020-022-03100-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Massa I, Ghignone F, Ugolini G, Ercolani G, Montroni I, Capelli P, Garulli G, Catena F, Lucchi A, Ansaloni L, Gentili N, Danesi V, Montella MT, Altini M; ESCA Collaborative Group. Emilia-Romagna Surgical Colorectal Cancer Audit (ESCA): a value-based healthcare retro-prospective study to measure and improve the quality of surgical care in colorectal cancer. Int J Colorectal Dis 2022. [PMID: 35779080 DOI: 10.1007/s00384-022-04203-w] [Reference Citation Analysis]
299 Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, van Grieken N, Vogel A, Smyth E. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
300 Liu X, Ni X, Li Y, Yang C, Wang Y, Ma C, Zhou C, Lu X. Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI. Front Oncol 2022;12:934045. [DOI: 10.3389/fonc.2022.934045] [Reference Citation Analysis]
301 Pedrazzani C, Conti C, Di Vittori A, Turri G, Bernardoni L, Mafficini A, Luchini C, Gabbrielli A, Scarpa A, Guglielmi A. Video technical notes for approaching a unique case of Juvenile Polyposis with massive gastric ingrowth. Asian Journal of Surgery 2022. [DOI: 10.1016/j.asjsur.2022.07.058] [Reference Citation Analysis]
302 Katabathina VS, Khanna L, Surabhi VR, Minervini M, Shanbhogue K, Dasyam AK, Prasad SR. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma. Radiographics 2022;:210106. [PMID: 35776676 DOI: 10.1148/rg.210206] [Reference Citation Analysis]
303 Fuchs TL, Chou A, Ahadi M, Sheen A, Sioson L, Mittal A, Samra J, Gill AJ. Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systems. Pathology 2022. [DOI: 10.1016/j.pathol.2022.05.008] [Reference Citation Analysis]
304 Minegishi Y, Kudo SE, Miyata Y, Nemoto T, Mori K, Misawa M; Showa University and Nagoya University Ai Research Group. Comprehensive Diagnostic Performance of Real-Time Characterization of Colorectal Lesions Using an Artificial Intelligence-Assisted System: A Prospective Study. Gastroenterology 2022;163:323-325.e3. [PMID: 35398043 DOI: 10.1053/j.gastro.2022.03.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
305 Molasy B, Zemła P, Mrowiec S, Grudzińska E, Kuśnierz K. Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors. TCRM 2022;Volume 18:745-52. [DOI: 10.2147/tcrm.s361332] [Reference Citation Analysis]
306 Sessa A, Mulé S, Brustia R, Regnault H, Galletto Pregliasco A, Rhaiem R, Leroy V, Sommacale D, Luciani A, Calderaro J, Amaddeo G. Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge. JHC 2022;Volume 9:661-70. [DOI: 10.2147/jhc.s364703] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Reizine E, Mulé S, Luciani A. Focal Benign Liver Lesions and Their Diagnostic Pitfalls. Radiologic Clinics of North America 2022. [DOI: 10.1016/j.rcl.2022.05.005] [Reference Citation Analysis]
308 Moradi N, Ohadian Moghadam S, Heidarzadeh S. Application of next-generation sequencing in the diagnosis of gastric cancer. Scand J Gastroenterol 2022;57:842-55. [PMID: 35293278 DOI: 10.1080/00365521.2022.2041717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Liu DH, Šefčovičová N, Emmerson J, Spaans LN, Saito Y, Hutchins G, Nankivell MG, Langley RE, Allum W, Cunningham D, Langer R, Grabsch HI. Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials. European Journal of Cancer 2022;170:140-8. [DOI: 10.1016/j.ejca.2022.04.026] [Reference Citation Analysis]
310 Fei Z, Wang Y, Gu Y, Xie R, Hao Q, Jiang Y. CircKIF5B Promotes Hepatocellular Carcinoma Progression by Regulating the miR-192 Family/XIAP Axis. Front Oncol 2022;12:916246. [DOI: 10.3389/fonc.2022.916246] [Reference Citation Analysis]
311 Zheng BH, Zhang C, Wan WZ, Sun WT, Cheng X, Ni XJ, Ni XL, Suo T, Liu H, Shen S, Liu HB. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database. BMC Surg 2022;22:253. [PMID: 35768809 DOI: 10.1186/s12893-022-01689-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Cho SH, Park BS, Son GM, Kim HS, Kim SJ, Park SB, Choi CW, Kim HW, Shin DH, Yun MS. Differences in Factors Predicting Lymph Node Metastasis Between pT1 Rectal Cancer and pT1 Colon Cancer: A Retrospective Study. Am Surg 2022;:31348221111517. [PMID: 35766839 DOI: 10.1177/00031348221111517] [Reference Citation Analysis]
313 Yao B, Feng Y, Zhao K, Liang Y, Huang P, Zang J, Song J, Li M, Wang X, Shu H, Shi R. Artificial intelligence assisted cytological detection for early esophageal squamous epithelial lesions by using low-grade squamous intraepithelial lesion as diagnostic threshold. Cancer Med 2023;12:1228-36. [PMID: 35766144 DOI: 10.1002/cam4.4984] [Reference Citation Analysis]
314 Mcguinness MJ, Woodhouse B, Harmston C, Parker K, Kramer N, Findlay M, Print C, Merrie A, Lawrence B. Survival of patients with small bowel neuroendocrine neoplasms in Auckland, Aotearoa New Zealand. ANZ Journal of Surgery. [DOI: 10.1111/ans.17851] [Reference Citation Analysis]
315 Toyoshima O, Nishizawa T, Yoshida S, Watanabe H, Odawara N, Sakitani K, Arano T, Takiyama H, Kobayashi H, Kogure H, Fujishiro M. Brown slits for colorectal adenoma crypts on conventional magnifying endoscopy with narrow band imaging using the X1 system. World J Gastroenterol 2022; 28(24): 2748-2757 [DOI: 10.3748/wjg.v28.i24.2748] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Krogh S, Grønbæk H, Knudsen AR, Kissmeyer-nielsen P, Hummelshøj NE, Dam G. Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients. Front Endocrinol 2022;13:925632. [DOI: 10.3389/fendo.2022.925632] [Reference Citation Analysis]
317 Kong ZZ, Zhang L. Esophagogastric junctional neuroendocrine tumor with adenocarcinoma: A case report. World J Clin Cases 2022; 10(18): 6241-6246 [DOI: 10.12998/wjcc.v10.i18.6241] [Reference Citation Analysis]
318 Shi J, Yang X, Wang X, Luo Y, Zhou W, Luo H, Bianba Z, Nima Z, Wang Q, Wang H, Liao R, Ciren Q, Li M, Pang J. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer. Biomed Res Int 2022;2022:2684065. [PMID: 35734348 DOI: 10.1155/2022/2684065] [Reference Citation Analysis]
319 Tang M, Zhao Y, Zhao J, Wei S, Liu M, Zheng N, Geng D, Han S, Zhang Y, Zhong G, Li S, Zhang X, Wang C, Yan H, Cao X, Li L, Bai X, Ji J, Feng XH, Qin J, Liang T, Zhao B. Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes. Sci Adv 2022;8:eabn5683. [PMID: 35731873 DOI: 10.1126/sciadv.abn5683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Gerber TS, Goeppert B, Hausen A, Witzel HR, Bartsch F, Schindeldecker M, Gröger L, Ridder DA, Cahyadi O, Esposito I, Gaida MM, Schirmacher P, Galle PR, Lang H, Roth W, Straub BK. N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas. Cancers 2022;14:3091. [DOI: 10.3390/cancers14133091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Cree IA. The WHO Classification of Haematolymphoid Tumours. Leukemia 2022. [PMID: 35732830 DOI: 10.1038/s41375-022-01625-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
322 Marano L, Ambrosio MR, Resca L, Carbone L, Carpineto Samorani O, Petrioli R, Savelli V, Costantini M, Malaspina L, Polom K, Biviano I, Marrelli D, Roviello F. The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer. Front Oncol 2022;12:897218. [PMID: 35719955 DOI: 10.3389/fonc.2022.897218] [Reference Citation Analysis]
323 Mehdorn AS, Richter F, Hess K, Beckmann JH, Egberts JH, Linecker M, Becker T, Braun F. The Role of ICG in Robot-Assisted Liver Resections. J Clin Med 2022;11:3527. [PMID: 35743595 DOI: 10.3390/jcm11123527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
324 Yu Z, Wang A, Hu C, Yu T, Chen J. Type-1 Grade 2 Multi-Focal Gastric Neuroendocrine Tumors Secondary to Chronic Autoimmune Gastritis. Front Med 2022;9:856125. [DOI: 10.3389/fmed.2022.856125] [Reference Citation Analysis]
325 Zhu F, Wang Y, Zhou J, Meng N, Wang Y, Jiang B, Wang S. The Histopathological Types and Distribution Characteristics of Gastric Mixed Tumors. Front Oncol 2022;12:873005. [DOI: 10.3389/fonc.2022.873005] [Reference Citation Analysis]
326 Innocenti T, Danti G, Lynch EN, Dragoni G, Gottin M, Fedeli F, Palatresi D, Biagini MR, Milani S, Miele V, Galli A. Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms. World J Clin Cases 2022; 10(17): 5667-5679 [DOI: 10.12998/wjcc.v10.i17.5667] [Reference Citation Analysis]
327 Yoshihara A, Nishihama K, Inoue C, Okano Y, Eguchi K, Tanaka S, Maki K, Fridman D'Alessandro V, Takeshita A, Yasuma T, Uemura M, Suzuki T, Gabazza EC, Yano Y. Adrenocorticotropic hormone-secreting pancreatic neuroendocrine carcinoma with multiple organ infections and widespread thrombosis: A case report. World J Clin Cases 2022; 10(17): 5723-5731 [DOI: 10.12998/wjcc.v10.i17.5723] [Reference Citation Analysis]
328 Aparicio-López D, Palomares-Cano A, Hörndler-Algarate C, Serrablo-Requejo A, Serradilla-Martín M. Mucinous cystic liver neoplasm with invasive component and sarcomatous differentiation. Acta Chir Belg 2022;:1-4. [PMID: 35647933 DOI: 10.1080/00015458.2022.2082061] [Reference Citation Analysis]
329 Bremer SCB, Bittner G, Elakad O, Dinter H, Gaedcke J, König AO, Amanzada A, Ellenrieder V, Freiherr von Hammerstein-Equord A, Ströbel P, Bohnenberger H. Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis. Cancers (Basel) 2022;14:2828. [PMID: 35740494 DOI: 10.3390/cancers14122828] [Reference Citation Analysis]
330 Quero G, Laterza V, Fiorillo C, Menghi R, De Sio D, Schena CA, Rosa F, Tortorelli AP, Di Cesare L, Cina C, Bensi M, Salvatore L, Alfieri S. The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation. Langenbecks Arch Surg 2022. [PMID: 35670860 DOI: 10.1007/s00423-022-02563-z] [Reference Citation Analysis]
331 Kunprom W, Aphivatanasiri C, Sa-Ngiamwibool P, Sangkhamanon S, Intarawichian P, Bamrungkit W, Thanee M, Prajumwongs P, Loilome W, Khuntikeo N, Titapun A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Eurboonyanun K, Promsorn J, Koonmee S. Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand. Front Public Health 2022;10:816028. [PMID: 35651852 DOI: 10.3389/fpubh.2022.816028] [Reference Citation Analysis]
332 Li ZF, Lu HZ, Chen YT, Bai XF, Wang TB, Fei H, Zhao DB. Mixed large and small cell neuroendocrine carcinoma of the stomach: A case report and review of literature. World J Clin Cases 2022; 10(16): 5502-5509 [DOI: 10.12998/wjcc.v10.i16.5502] [Reference Citation Analysis]
333 Li Y, Zhong YX, Xu Q, Tian YT. Protective effects of female reproductive factors on gastric signet-ring cell carcinoma. World J Clin Cases 2022; 10(16): 5217-5229 [DOI: 10.12998/wjcc.v10.i16.5217] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
334 Cigrovski Berkovic M, Ulamec M, Marinovic S, Balen I, Mrzljak A. Malignant insulinoma: Can we predict the long-term outcomes? World J Clin Cases 2022; 10(16): 5124-5132 [DOI: 10.12998/wjcc.v10.i16.5124] [Reference Citation Analysis]
335 Zhou Y, Yin S, Zhao L, Zhang X, Li M, Ding J, Yan K, Jing X. CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma. Front Oncol 2022;12:897090. [PMID: 35651804 DOI: 10.3389/fonc.2022.897090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Shi H, Wang C, Wu J, Qin B, Jiang J, Liu N, Song Y, Qin Y, Ma S. Underwater endoscopic mucosal resection for rectal neuroendocrine tumors (with videos): a single center retrospective study. BMC Gastroenterol 2022;22:276. [PMID: 35655173 DOI: 10.1186/s12876-022-02350-6] [Reference Citation Analysis]
337 Chen S, Zhang M, Wang J, Xu M, Hu W, Wee L, Dekker A, Sheng W, Zhang Z. Automatic Tumor Grading on Colorectal Cancer Whole-Slide Images: Semi-Quantitative Gland Formation Percentage and New Indicator Exploration. Front Oncol 2022;12:833978. [PMID: 35646672 DOI: 10.3389/fonc.2022.833978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
338 Takeda Y, Kobayashi N, Kessoku T, Okubo N, Suzuki A, Tokuhisa M, Miwa H, Udaka N, Ichikawa Y. Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder. Clin J Gastroenterol 2022. [PMID: 35653037 DOI: 10.1007/s12328-022-01645-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Nannar J, Anciro A, Nanda AK. Collision tumor at the rectum consisting of a neuroendocrine carcinoma and adenocarcinoma: A case report. Annals of Medicine and Surgery 2022;78:103748. [DOI: 10.1016/j.amsu.2022.103748] [Reference Citation Analysis]
340 Bösch F, Ghadimi M, Angele MK. Personalisierte Resektionsverfahren bei neuroendokrinen Neoplasien des Pankreas. Zentralbl Chir 2022;147:264-269. [DOI: 10.1055/a-1823-1275] [Reference Citation Analysis]
341 Thomas M, Wahba R, Chiapponi C, Stippel DL, Bruns C. Zufallsbefund NEN Appendix. Zentralbl Chir 2022;147:244-248. [DOI: 10.1055/a-1798-0646] [Reference Citation Analysis]
342 Sparano C, Petrone L, Maggi M, Antonuzzo L. I tumori neuroendocrini ben differenziati di grado 3 del pancreas: definizione e gestione clinica. L'Endocrinologo 2022;23:233-237. [DOI: 10.1007/s40619-022-01062-z] [Reference Citation Analysis]
343 Holmberg M, Linder S, Kordes M, Liljefors M, Ghorbani P, Löhr JM, Sparrelid E. Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia - A comparison with pancreatic ductal adenocarcinoma. Pancreatology 2022;22:598-607. [PMID: 35501218 DOI: 10.1016/j.pan.2022.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Weng Y, Ran J, Peng Y, Xiang Y, Xu L. Comparison of characteristics between true rectal neuroendocrine tumors and rectal hyperplastic polyps among patients with endoscope-diagnosed rectal neuroendocrine tumors. J Gastrointest Oncol 2022;13:1121-31. [PMID: 35837162 DOI: 10.21037/jgo-22-369] [Reference Citation Analysis]
345 Arantes VN, Ramos JA, White JR, Parra-Blanco A. Clinical effectiveness of short course oral prednisone for stricture prevention after semi-circumferential esophageal endoscopic submucosal dissection. Endosc Int Open 2022;10:E753-61. [PMID: 35692934 DOI: 10.1055/a-1789-0266] [Reference Citation Analysis]
346 Nguyen H, Nguyen NC, Thieu TTM, Luong TH, Tran NM, Nguyen DH, Nguyen AK. Complete resection for a giant recurrent biliary cystadenoma: A surgical case report and review of literature. Annals of Medicine and Surgery 2022;78:103785. [DOI: 10.1016/j.amsu.2022.103785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
347 Eng C, Ciombor KK, Cho M, Dorth JA, Rajdev LN, Horowitz DP, Gollub MJ, Jácome AA, Lockney NA, Muldoon RL, Washington MK, O'Brian BA, Benny A, Lebeck Lee CM, Benson AB 3rd, Goodman KA, Morris VK. Anal Cancer: Emerging Standards in a Rare Rare Disease. J Clin Oncol 2022;:JCO2102566. [PMID: 35649196 DOI: 10.1200/JCO.21.02566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Gherghe M, Lazăr AM, Stanciu AE, Mutuleanu MD, Sterea MC, Petroiu C, Galeș LN. The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? Cancers (Basel) 2022;14:2725. [PMID: 35681704 DOI: 10.3390/cancers14112725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
349 Peng D, Feng L, Li H, Picardi E. Identification of Novel circRNA-Based ceRNA Network Involved in the Pathogenesis of Gastric Cancer. International Journal of Genomics 2022;2022:1-10. [DOI: 10.1155/2022/5281846] [Reference Citation Analysis]
350 Talaat IM, Yakout NM, Soliman AS, Venkatachalam T, Vinod A, Eldohaji L, Nair V, Hareedy A, Kandil A, Abdel-rahman WM, Hamoudi R, Saber-ayad M. Evaluation of Galanin Expression in Colorectal Cancer: An Immunohistochemical and Transcriptomic Study. Front Oncol 2022;12:877147. [DOI: 10.3389/fonc.2022.877147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
351 Ohmoto A, Fujiwara Y, Horita N, Nakano K, Takahashi S. Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00499-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Li YL, Cheng ZX, Yu FH, Tian C, Tan HY. Advances in medical treatment for pancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(20): 2163-2175 [DOI: 10.3748/wjg.v28.i20.2163] [Reference Citation Analysis]
353 Li X, Chu Y, Song Q, Hu Q, Xu Y. The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/3308801] [Reference Citation Analysis]
354 Dai M, Mullins CS, Lu L, Alsfasser G, Linnebacher M. Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg 2022; 14(5): 383-396 [DOI: 10.4240/wjgs.v14.i5.383] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
355 Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Surgical outcomes of gastro-entero-pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma. J Surg Oncol 2022. [PMID: 35616186 DOI: 10.1002/jso.26928] [Reference Citation Analysis]
356 Krug S, Schrader J, Rinke A. Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NET. Cancers (Basel) 2022;14:2628. [PMID: 35681608 DOI: 10.3390/cancers14112628] [Reference Citation Analysis]
357 Elesawy Y, Khaled E, Biomy B, Elsheikh S, El-yasergy D. The Role of Maspin Expression as Diagnostic Tissue Marker in Pancreaticoduodenal Malignant Tumors and Benign Lesions. Open Access Maced J Med Sci 2022;10:1042-1050. [DOI: 10.3889/oamjms.2022.9765] [Reference Citation Analysis]
358 Rzayev RT, Kamalov YR, Kryzhanovskaya EY, Tatarkina MA, Kovaleva AL. Successful living donor liver transplantation of the left lateral sector with simultaneous atypical resection of the S2 for focal nodular hyperplasia. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;32:53-59. [DOI: 10.22416/1382-4376-2022-32-1-53-59] [Reference Citation Analysis]
359 Iwasaki K, Barroga E, Enomoto M, Tsurui K, Shimoda Y, Matsumoto M, Miyoshi K, Ota Y, Matsubayashi J, Nagakawa Y. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms. World J Surg Oncol 2022;20:165. [PMID: 35610656 DOI: 10.1186/s12957-022-02625-y] [Reference Citation Analysis]
360 Hiltunen N, Rintala J, Väyrynen JP, Böhm J, Karttunen TJ, Huhta H, Helminen O. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Cancers 2022;14:2552. [DOI: 10.3390/cancers14102552] [Reference Citation Analysis]
361 Manneh Kopp R, Espinosa-Olarte P, Alonso-Gordoa T. Diagnosis in Neuroendocrine Neoplasms: From Molecular Biology to Molecular Imaging. Cancers (Basel) 2022;14:2514. [PMID: 35626118 DOI: 10.3390/cancers14102514] [Reference Citation Analysis]
362 Zou J, Wang S, Chai N, Yue H, Ye P, Guo P, Li F, Wei B, Ma G, Wei W, Linghu E. Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations. J Nanobiotechnology 2022;20:233. [PMID: 35585597 DOI: 10.1186/s12951-022-01431-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Calomino N, Fusario D, Cencini E, Lazzi S. Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract. BMJ Case Rep 2022;15:e247607. [PMID: 35584861 DOI: 10.1136/bcr-2021-247607] [Reference Citation Analysis]
364 Canakis A, Lee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc 2022; 14(5): 267-290 [DOI: 10.4253/wjge.v14.i5.267] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
365 Liang Y, Xu F, Wang Z, Tan C, Zhang N, Wei X, Jiang X, Wu H. A gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Eur J Radiol 2022;153:110356. [PMID: 35623312 DOI: 10.1016/j.ejrad.2022.110356] [Reference Citation Analysis]
366 Li M, Kong J, Wang L, Yan H, Liang W, Wang N, Zhao J. Defective expression of C20orf54 in esophageal dysplasia: a possible biomarker of esophageal carcinoma for early detection. World J Surg Oncol 2022;20:155. [PMID: 35549728 DOI: 10.1186/s12957-022-02612-3] [Reference Citation Analysis]
367 León-díaz AM, Camelo-pardo G, Sanabria-lozano DF, Beltrán-tirado MA. Adenocarcinoma de apéndice, un diagnóstico diferencial en pacientes con dolor abdominal. Reporte de caso. MedUNAB 2022;25:52-58. [DOI: 10.29375/01237047.4102] [Reference Citation Analysis]
368 Skorupan N, Ahmad MI, Steinberg SM, Trepel JB, Cridebring D, Han H, Von Hoff DD, Alewine C. A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas. Future Oncol 2022. [PMID: 35535581 DOI: 10.2217/fon-2021-1609] [Reference Citation Analysis]
369 Kostiainen I, Karppinen N, Simonen P, Rosengård-Bärlund M, Lindén R, Tarkkanen M, Gordin D, Rapola J, Schalin-Jäntti C, Matikainen N. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours. Endocrine 2022. [PMID: 35536452 DOI: 10.1007/s12020-022-03065-0] [Reference Citation Analysis]
370 Massironi S, Rossi RE, Milanetto AC, Andreasi V, Campana D, Nappo G, Partelli S, Gallo C, Scaravaglio M, Zerbi A, Panzuto F, Pasquali C, Falconi M, Invernizzi P, On Behalf Of ItaNet Italian Association For Neuroendocrine Tumours Study Group. Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? J Clin Med 2022;11:2658. [PMID: 35566783 DOI: 10.3390/jcm11092658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
371 Qasemi Rad M, Pouresmaeil V, Hosseini Mojahed F, Amirabadi A, Aalami AH. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer. Mol Biol Rep 2022. [PMID: 35511316 DOI: 10.1007/s11033-022-07465-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
372 Papaefthymiou A, Laskaratos FM, Koffas A, Manolakis A, Gkolfakis P, Coda S, Sodergren M, Suzuki N, Toumpanakis C. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors. Curr Treat Options Oncol 2022. [PMID: 35511346 DOI: 10.1007/s11864-022-00986-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
373 Ye H, Yuan Y, Chen P, Zheng Q. Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection. Surg Endosc 2022. [PMID: 35507062 DOI: 10.1007/s00464-022-09190-1] [Reference Citation Analysis]
374 Coelho S, Costa C, Santos AP, Souteiro P, Oliveira J, Oliveira J, Azevedo I, Torres I, Bento MJ. Pancreatic neuroendocrine neoplasms: survival trend analysis of a comprehensive center. Endocrine Oncology 2022;2:32-41. [DOI: 10.1530/eo-22-0043] [Reference Citation Analysis]
375 Lira-treviño A, Carranza Mendoza I, Borbolla Arizti J, Soriano-ríos A, Uscanga-domínguez L, Peláez-luna M. Pancreatic cystic lesions. Differential diagnosis and treatment strategy. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.05.002] [Reference Citation Analysis]
376 Wu H, Xin L, Lin JH, Wang QH, Li B, Jin ZD, Hu LH, Zou WB, Qi K, Yang T, Li ZS, Liao Z. Association between sedation and small neoplasm detection during diagnostic esophagogastroduodenoscopy: a propensity score-matched retrospective study. Scand J Gastroenterol 2022;57:603-9. [PMID: 34983263 DOI: 10.1080/00365521.2021.2023212] [Reference Citation Analysis]
377 Zeng P, Ma L, Liu J, Song Z, Liu J, Yuan H. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas. European Journal of Radiology 2022;150:110261. [DOI: 10.1016/j.ejrad.2022.110261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
378 Feng LH, Su T, Lu Y, Ren S, Huang L, Qin X, Liao T. A model for predicting the overall survival of gastroenteropancreatic neuroendocrine neoplasms after surgery. Scand J Gastroenterol 2022;57:581-8. [PMID: 35001789 DOI: 10.1080/00365521.2021.2024247] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
379 Lee JWJ, Zhu F, Srivastava S, Tsao SK, Khor C, Ho KY, Fock KM, Lim WC, Ang TL, Chow WC, So JBY, Koh CJ, Chua SJ, Wong ASY, Rao J, Lim LG, Ling KL, Chia CK, Ooi CJ, Rajnakova A, Yap WM, Salto-Tellez M, Ho B, Soong R, Chia KS, Teo YY, Teh M, Yeoh KG. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP). Gut 2022;71:854-63. [PMID: 33975867 DOI: 10.1136/gutjnl-2021-324057] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
380 Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know? JHC 2022;Volume 9:379-87. [DOI: 10.2147/jhc.s364742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
381 Ranallo N, Bocchini M, Menis J, Pilotto S, Severi S, Liverani C, Bongiovanni A. Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin. Expert Rev Anticancer Ther 2022. [PMID: 35477310 DOI: 10.1080/14737140.2022.2071703] [Reference Citation Analysis]
382 Stankiewicz R, Grąt M. Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg 2022; 14(4): 276-285 [DOI: 10.4240/wjgs.v14.i4.276] [Reference Citation Analysis]
383 Cibulskaitė G, Stulpinas R, Poškus E, Tulytė S, Mickys U. Colorectal Neoplasm with Predominant Neuroendocrine Immunophenotype: Where does Adenocarcinoma End? LS 2022;21:56-64. [DOI: 10.15388/lietchirur.2022.21.58] [Reference Citation Analysis]
384 Sharma R, Earla B, Baidoo K, Zeiger MA, Madigan JP, Escorcia FE, Sadowski SM. Upregulation of Somatostatin Receptor Type 2 in a Receptor-Deficient In Vivo Pancreatic Neuroendocrine Tumor Model Improves Tumor Response to Targeted 177Lu-DOTATATE.. [DOI: 10.1101/2022.04.25.489401] [Reference Citation Analysis]
385 Luo R, Huang W, Chen L, Liu Y, Xu L, Zhang X, Xu C, Hou Y. SP70 is a potential biomarker to identify gastric fundic gland neoplasms. World J Surg Oncol 2022;20:132. [PMID: 35468832 DOI: 10.1186/s12957-022-02564-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Chen HY, Lee WH, Hsu HL, Chou YT, Su FL, Wu IH, Chao TH. Arterial stiffness is associated with high-risk colorectal adenomas and serrated lesions: A cross-sectional study in a Taiwanese population. J Cardiol 2022:S0914-5087(22)00073-9. [PMID: 35469715 DOI: 10.1016/j.jjcc.2022.03.013] [Reference Citation Analysis]
387 Armwood AR, Mayer J, Walth GB, Rissi DR. Pathology in Practice. J Am Vet Med Assoc 2022;:1-3. [PMID: 35460547 DOI: 10.2460/javma.20.03.0165] [Reference Citation Analysis]
388 Yuan ZB, Fang HB, Feng QK, Li T, Li J. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study. World J Gastroenterol 2022; 28(15): 1574-1587 [DOI: 10.3748/wjg.v28.i15.1574] [Reference Citation Analysis]
389 Kaliszewski K, Ludwig M, Greniuk M, Mikuła A, Zagórski K, Rudnicki J. Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Cancers (Basel) 2022;14:2028. [PMID: 35454934 DOI: 10.3390/cancers14082028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
390 Yang S, Gu X, Tao R, Huo J, Hu Z, Sun F, Ni J, Wang X. Relationship between histological mixed-type early gastric cancer and lymph node metastasis: A systematic review and meta-analysis. PLoS ONE 2022;17:e0266952. [DOI: 10.1371/journal.pone.0266952] [Reference Citation Analysis]
391 Danilova NV, Mikhailov IA, Kalinin DV, Oleynikova NA, Chayka AV, Khomyakov VM, Kakotkin VV, Yudin MY, Vychuzhanin DV, Andreeva YY, Malkov PG. [Study of gastric adenocarcinomas association with the Epstein-Barr virus-encoded small RNAs]. Arkh Patol 2022;84:5-12. [PMID: 35417943 DOI: 10.17116/patol2022840215] [Reference Citation Analysis]
392 Inoue K, Yoshida N, Kobayashi R, Tomita Y, Hashimoto H, Sugino S, Hirose R, Dohi O, Yasuda H, Yasuda R, Murakami T, Inada Y, Itoh Y, Ryozawa S. The Efficacy of Tumor Characterization for Colorectal Lesions with Blue Light Imaging of a Compact Light-Emitting Diode Endoscopic System Compared to a Laser Endoscopic System: A Pilot Study. Gastroenterology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/9998280] [Reference Citation Analysis]
393 Shi Z, Zhu C, Zhang Y, Wang Y, Hou W, Li X, Lu J, Guo X, Xu F, Jiang X, Wang Y, Liu J, Jin M. Deep learning for automatic diagnosis of gastric dysplasia using whole-slide histopathology images in endoscopic specimens. Gastric Cancer 2022. [PMID: 35394573 DOI: 10.1007/s10120-022-01294-w] [Reference Citation Analysis]
394 Muñoz de Nova JL, Hernando J, Sampedro Núñez M, Vázquez Benítez GT, Triviño Ibáñez EM, del Olmo García MI, Barriuso J, Capdevila J, Martín-Pérez E. Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy. World J Gastroenterol 2022; 28(13): 1304-1314 [DOI: 10.3748/wjg.v28.i13.1304] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Kumar A, Kumar B, Muthu GS, Mitra S. 68Ga-DOTANOC PET/CT Detects a Rare Case of Metastatic Neuroendocrine Neoplasm of the Gallbladder. Clin Nucl Med 2022. [PMID: 35384899 DOI: 10.1097/RLU.0000000000004142] [Reference Citation Analysis]
396 Gao Y, Cai B, Yin L, Song G, Lu Z, Guo F, Chen J, Xi C, Wei J, Wu J, Gao W, Jiang K, Miao Y. Undifferentiated Carcinoma of Pancreas with Osteoclast-Like Giant Cells: One Center’s Experience of 13 Cases and Characteristic Pre-Operative Images. CMAR 2022;Volume 14:1409-19. [DOI: 10.2147/cmar.s349625] [Reference Citation Analysis]
397 Hirabayashi K, Saika T, Nakamura N. Background features in the cytology of pancreatic neoplasms. DEN Open 2022;2. [DOI: 10.1002/deo2.105] [Reference Citation Analysis]
398 Deng J, Zhou S, Wang Z, Huang G, Zeng J, Li X. Comparison of Prognosis and Lymph Node Metastasis in T1-Stage Colonic and Rectal Carcinoma: A Retrospective Study. IJGM 2022;Volume 15:3651-62. [DOI: 10.2147/ijgm.s354120] [Reference Citation Analysis]
399 Ginghina O, Hudita A, Zamfir M, Spanu A, Mardare M, Bondoc I, Buburuzan L, Georgescu SE, Costache M, Negrei C, Nitipir C, Galateanu B. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient's Stratification. Front Oncol 2022;12:856575. [PMID: 35356214 DOI: 10.3389/fonc.2022.856575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
400 Kamigaichi Y, Yamashita K, Oka S, Tamari H, Shimohara Y, Nishimura T, Inagaki K, Okamoto Y, Tanaka H, Yuge R, Urabe Y, Arihiro K, Tanaka S. Clinical outcomes of endoscopic resection for rectal neuroendocrine tumors: Advantages of endoscopic submucosal resection with a ligation device compared to conventional EMR and ESD. DEN Open 2022;2. [DOI: 10.1002/deo2.35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Giehl-brown E, Weitz J, Distler M. Das Ampullenkarzinom – prognostische und therapeutische Unterschiede zum duktalen Adenokarzinom des Pankreas. Zentralbl Chir 2022;147:160-167. [DOI: 10.1055/a-1775-9024] [Reference Citation Analysis]
402 Fujieda H, Yamaguchi R, Watanabe S, Aizu K, Kobayashi S, Sato F, Toyoda Y, Iwata T, Kageyama Y, Moriyama M. A Pediatric Case of Neuroendocrine Tumor of the Appendix Diagnosed after Appendicitis Surgery. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2022;55:276-281. [DOI: 10.5833/jjgs.2020.0181] [Reference Citation Analysis]
403 Chen X, Sun S, Lu Y, Shi X, Wang Z, Chen X, Han G, Zhao J, Gao Y, Wang X. Promising role of liver transplantation in patients with combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis. Ann Transl Med 2022;10:434. [PMID: 35571416 DOI: 10.21037/atm-21-5391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
404 Wen Y, Chen Y, Ren F. Gastric mixed neuroendocrine-nonneuroendocrine neoplasm misdiagnosed by preoperative pathology: A case report. Asian Journal of Surgery 2022. [DOI: 10.1016/j.asjsur.2022.03.124] [Reference Citation Analysis]
405 Lira-treviño A, Carranza Mendoza I, Borbolla Arizti J, Soriano-ríos A, Uscanga-domínguez L, Peláez-luna M. Lesiones quísticas de páncreas. Diagnóstico diferencial y estrategia de tratamiento. Revista de Gastroenterología de México 2022;87:188-197. [DOI: 10.1016/j.rgmx.2021.11.001] [Reference Citation Analysis]
406 Maldonado-garcía E, Álvarez-barragán A, Acevedo-aguirre C, Galicia-alemán B, Arellano-gutiérrez G. Tumor neuroendocrino de válvula ileocecal: reporte de un caso y revisión de la literatura. Revista de Gastroenterología de México 2022;87:261-263. [DOI: 10.1016/j.rgmx.2021.04.007] [Reference Citation Analysis]
407 Ahn B, Jung JK, Jung H, Ryu YM, Kim YW, Song TJ, Park DH, Hwang DW, Cho H, Kim SY, Hong SM. Double Ki-67 and synaptophysin labeling in pancreatic neuroendocrine tumor biopsies. Pancreatology 2022;22:427-34. [PMID: 35292233 DOI: 10.1016/j.pan.2022.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
408 Healey AJ. Cystic neoplasms of the pancreas. Surgery (Oxford) 2022;40:249-257. [DOI: 10.1016/j.mpsur.2022.01.005] [Reference Citation Analysis]
409 Sasaki M, Tanaka M, Asukai K, Koguchi H, Inoue Y, Moriyama M, Tsukahara T, Kawahara T, Hayashi E, Hattori Y, Hasegawa I, Kataoka H. Malignant gastrointestinal neuroectodermal tumor presenting with small intestinal obstruction: A case report. DEN Open 2022;2. [DOI: 10.1002/deo2.119] [Reference Citation Analysis]
410 Kierans AS, Gavlin A, Wehrli N, Flisnik LM, Eliades S, Pittman ME. Utility of gadolinium for identifying the malignant potential of pancreatic cystic lesions. Abdom Radiol (NY) 2022;47:1351-9. [PMID: 35195765 DOI: 10.1007/s00261-022-03446-z] [Reference Citation Analysis]
411 Ehrlichman PD, Vijayvergia N. Unlocking the Code to Management of Neuroendocrine Neoplasms: A Clinician's Perspective. JCO Oncol Pract 2022;18:267-9. [PMID: 34731030 DOI: 10.1200/OP.21.00628] [Reference Citation Analysis]
412 Gallardo-gómez M, Costas-ríos L, Garcia-prieto CA, Álvarez-rodríguez L, Bujanda L, Barrero M, Castells A, Balaguer F, Jover R, Esteller M, Baiges AT, Fojón JG, Cubiella J, De Chiara L. Serum DNA methylome of the colorectal cancer serrated pathway.. [DOI: 10.1101/2022.03.25.22272961] [Reference Citation Analysis]
413 Gerbaudo VH, Latif MA. A Step Forward in PET-Based Quantitation of G3 Neuroendocrine Tumor Aggressiveness - The FDZ Score…. Acad Radiol 2022:S1076-6332(22)00140-4. [PMID: 35365399 DOI: 10.1016/j.acra.2022.03.001] [Reference Citation Analysis]
414 Jacob A, Raj R, Allison DB, Soares HP, Chauhan A. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN). Curr Treat Options in Oncol . [DOI: 10.1007/s11864-022-00968-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
415 Yang Z, Shi G, Zhang P. Development and Validation of Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pancreatic Adenosquamous Carcinoma. Front Oncol 2022;12:831649. [PMID: 35330710 DOI: 10.3389/fonc.2022.831649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
416 Feng JY, Li XP, Wu ZY, Ying LP, Xin C, Dai ZZ, Shen Y, Wu YF. Sarcomatoid intrahepatic cholangiocarcinoma with good patient prognosis after treatment with Huaier granules following hepatectomy: A case report. World J Clin Cases 2022;10:2829-35. [PMID: 35434085 DOI: 10.12998/wjcc.v10.i9.2829] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
417 Fortunati E, Argalia G, Zanoni L, Fanti S, Ambrosini V. New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms. Curr Treat Options Oncol 2022. [PMID: 35325412 DOI: 10.1007/s11864-022-00967-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
418 Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Santos Marques H, de Brito BB, França da Silva FA, Souza CL, Oliveira MV, de Melo FF. From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response. World J Clin Oncol 2022; 13(3): 186-199 [DOI: 10.5306/wjco.v13.i3.186] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
419 Wang Q, Wang X, Zhang Q, Chen J, Zhou Y, Tang Z, Wang R, Chen H, Chen H, Li X. ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing. Front Oncol 2022;12:769709. [DOI: 10.3389/fonc.2022.769709] [Reference Citation Analysis]
420 Mori N, Hongo M, Takemura S, Sugitani Y, Nakamura F, Tani M, Nishida A, Inatomi O, Andoh A, Ban H. Mixed neuroendocrine–non‐neuroendocrine neoplasm associated with autoimmune gastritis. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5640] [Reference Citation Analysis]
421 Wang Y, Zhu GQ, Zhou CW, Li N, Yang C, Zeng MS. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors. Eur Radiol 2022. [PMID: 35316365 DOI: 10.1007/s00330-022-08691-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
422 Gallo C, Rossi RE, Cavalcoli F, Barbaro F, Boškoski I, Invernizzi P, Massironi S. Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance. World J Gastroenterol 2022; 28(11): 1123-1138 [DOI: 10.3748/wjg.v28.i11.1123] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
423 Fu Q, Liu P, Jin S, Zhang X, Liu C, Hu M, Wang Y, Zhang H, Qin T. A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case. Front Oncol 2022;12:829235. [PMID: 35299731 DOI: 10.3389/fonc.2022.829235] [Reference Citation Analysis]
424 Ma J, Meng Y, Zhou X, Guo L, Fu W. The Prognostic Significance and Gene Expression Characteristics of Gastric Signet-Ring Cell Carcinoma: A Study Based on the SEER and TCGA Databases. Front Surg 2022;9:819018. [DOI: 10.3389/fsurg.2022.819018] [Reference Citation Analysis]
425 Lombardi PM, Mazzola M, Nicastro V, Giacopuzzi S, Baiocchi GL, Castoro C, Rosati R, Fumagalli Romario U, Bonavina L, Staderini F, Gockel I, Gregori D, De Martini P, Gualtierotti M, Danieli M, Beretta S, Mutignani M, Forti E, Ferrari G. The iGreenGO Study: The Clinical Role of Indocyanine Green Imaging Fluorescence in Modifying the Surgeon’s Conduct During the Surgical Treatment of Advanced Gastric Cancer—Study Protocol for an International Multicenter Prospective Study. Front Oncol 2022;12:854754. [DOI: 10.3389/fonc.2022.854754] [Reference Citation Analysis]
426 Ning YZ, Liu GY, Rao XL, Ma YC, Rong L. Synchronized early gastric cancer occurred in a patient with serrated polyposis syndrome: A case report. World J Clin Cases 2022; 10(8): 2644-2649 [DOI: 10.12998/wjcc.v10.i8.2644] [Reference Citation Analysis]
427 Carballal S, Balaguer F, IJspeert JEG. Serrated polyposis syndrome; epidemiology and management. Best Pract Res Clin Gastroenterol 2022;58-59:101791. [PMID: 35988960 DOI: 10.1016/j.bpg.2022.101791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Molasy B, Zemła P, Kuśnierz K. Skin Metastases of Gastrointestinal Neuroendocrine Tumors – Literature Review. Pol Przegl Chir 2022;94:60-65. [DOI: 10.5604/01.3001.0015.7958] [Reference Citation Analysis]
429 Xie Y, Zhang S, Liu X, Huang X, Zhou Q, Luo Y, Niu Q, Zhou J. Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors. Jpn J Radiol. [DOI: 10.1007/s11604-022-01262-5] [Reference Citation Analysis]
430 Deng M, Li S, Wang Q, Zhao R, Zou J, Lin W, Mei J, Wei W, Guo R. Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy. Ann Med 2022;54:803-11. [PMID: 35272564 DOI: 10.1080/07853890.2022.2048416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
431 Zhou J, Zhao R, Pan Y, Ju H, Huang X, Jiang Y, Jin J, Zhang Y. The Diagnostic and Grading Accuracy of 68Ga-DOTATATE and 18F-FDG PET/MR for Pancreatic Neuroendocrine Neoplasms. Front Oncol 2022;12:796391. [PMID: 35273910 DOI: 10.3389/fonc.2022.796391] [Reference Citation Analysis]
432 de Sousa MJ, Gervaso L, Meneses-Medina MI, Spada F, Abdel-Rahman O, Fazio N. Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside. Curr Oncol Rep 2022. [PMID: 35262877 DOI: 10.1007/s11912-022-01251-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
433 Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol 2022;14:175883592210830. [DOI: 10.1177/17588359221083049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
434 Zakaria A, Al-Share B, Klapman JB, Dam A. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers (Basel) 2022;14:1373. [PMID: 35326524 DOI: 10.3390/cancers14061373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
435 Chen Y, Lu Q, Zhang W, Cao J, Dong Y, Wang W. Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators. Front Oncol 2022;12:757774. [PMID: 35242699 DOI: 10.3389/fonc.2022.757774] [Reference Citation Analysis]
436 Davydov MM, Zeynalovа PA, Fedenko AA, Ibragimov EK, Chekiny DA, Filimonov AA, Dementievа EV. Effective application of integrative approach in treatment of neuroendocrine colon cancer. Clinical case. jour 2022;2:28-32. [DOI: 10.17650/2782-3202-2022-2-1-28-32] [Reference Citation Analysis]
437 Thivacaren S, Suganthan N, Sujanitha V, Sutharshan V. Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.22819] [Reference Citation Analysis]
438 Meunier C, Lisotti A, Gupta V, Lemaistre AI, Fumex F, Gincul R, Lefort C, Lepillez V, Bourdariat R, Napoléon B. Oral anticoagulants but not antiplatelet agents increase the risk of delayed bleeding after endoscopic papillectomy: a large study in a tertiary referral center. Surg Endosc 2022. [PMID: 35233659 DOI: 10.1007/s00464-022-09138-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
439 Lan W, Fang N, Tiantian D, Ci Y, Ming L, Yuanyuan L. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions. CH 2022. [DOI: 10.3233/ch-221397] [Reference Citation Analysis]
440 Liu S, Jin J. Radiotherapy guidelines for rectal cancer in China (2020 Edition). Precision Radiation Oncology. [DOI: 10.1002/pro6.1141] [Reference Citation Analysis]
441 Yang X, Wang H, Dong Q, Xu Y, Liu H, Ma X, Yan J, Li Q, Yang C, Li X. An artificial intelligence system for distinguishing between gastrointestinal stromal tumors and leiomyomas using endoscopic ultrasonography. Endoscopy 2022;54:251-61. [PMID: 33827140 DOI: 10.1055/a-1476-8931] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
442 Yoshizawa T, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Kinugawa Y, Nagaya T, Kamakura M, Shimizu A, Kubota K, Notake T, Masuo H, Hosoda K, Sakai H, Hayashi H, Umemura K, Kamachi A, Goto T, Tomida H, Yamazaki S, Ota H, Soejima Y. Correlation of LGR5 expression and clinicopathological features in intrahepatic cholangiocarcinoma. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153832] [Reference Citation Analysis]
443 Topal U, Dal F, Sözüer EM, Akyüz M, İsaoğulları ŞY, Gök M, Deniz K. Clinicopathological Features and Surgical Outcomes in Patients Undergoing Radical Resection for Gastric Cancer with Undifferentiated Carcinoma, Neuroendocrine Tumor, and Gastrointestinal Stromal Tumor Histology. eamr 2022;38:5-13. [DOI: 10.4274/eamr.galenos.2020.86648] [Reference Citation Analysis]
444 Wang W, Yang CX, Yu XZ, Zhang SL, Wang J, Wang J. Clinicopathological characteristics and prognostic factors of patients with primary gallbladder neuroendocrine carcinomas. J Dig Dis 2022;23:166-73. [PMID: 35187836 DOI: 10.1111/1751-2980.13088] [Reference Citation Analysis]
445 Tustumi F, Marques SSB, Barros EF, Henriques AC, Waisberg J, Dias AR. THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY. Arq Gastroenterol 2022;59:53-7. [DOI: 10.1590/s0004-2803.202200001-10] [Reference Citation Analysis]
446 Minczeles NS, van Eijck CHJ, van Gils MJ, van Velthuysen MF, Nieveen van Dijkum EJM, Feelders RA, de Herder WW, Brabander T, Hofland J. Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients. Eur J Nucl Med Mol Imaging 2022. [PMID: 35230492 DOI: 10.1007/s00259-022-05734-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
447 Li J, Huang WF, Zhang JY. A rare case of duodenal neuroendocrine tumor with hepatic metastasis. Clin Res Hepatol Gastroenterol 2022;46:101850. [PMID: 34923182 DOI: 10.1016/j.clinre.2021.101850] [Reference Citation Analysis]
448 Desjonqueres E, Campani C, Marra F, Zucman-Rossi J, Nault JC. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice. Liver Int 2022;42:492-506. [PMID: 34982503 DOI: 10.1111/liv.15152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
449 Elpek GO. Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update. World J Gastroenterol 2022; 28(8): 794-810 [DOI: 10.3748/wjg.v28.i8.794] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
450 Levy S, Verbeek WH, Eskens FA, van den Berg JG, de Groot DJA, van Leerdam ME, Tesselaar ME. First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial. Ther Adv Med Oncol 2022;14:175883592210770. [DOI: 10.1177/17588359221077088] [Reference Citation Analysis]
451 Li YQ, Pan SB, Yan SS, Jin ZD, Huang HJ, Sun LQ. Impact of parenchyma-preserving surgical methods on treating patients with solid pseudopapillary neoplasms: A retrospective study with a large sample size. World J Gastrointest Surg 2022; 14(2): 174-184 [DOI: 10.4240/wjgs.v14.i2.174] [Reference Citation Analysis]
452 Dong XF, Wang Y, Tang CH, Huang BF, Du Z, Wang Q, Shao JK, Lu HJ, Wang CQ. Upregulated WTAP expression in colorectal cancer correlates with tumor site and differentiation. PLoS One 2022;17:e0263749. [PMID: 35143566 DOI: 10.1371/journal.pone.0263749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
453 Heo JH, Choi EJ, Yu SJ, Park YH, Choi JS. Neuroendocrine Tumor with Metachronous Gastrointestinal Stromal Tumor in a Patient: A Case Report. Korean J Gastroenterol 2022;79:72-6. [PMID: 35232922 DOI: 10.4166/kjg.2022.020] [Reference Citation Analysis]
454 Chen K, Wang H, Collins G, Hollands E, Law IYJ, Toh JWT. Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer. Current Oncology 2022;29:1370-89. [DOI: 10.3390/curroncol29030116] [Reference Citation Analysis]
455 Qu D, Wang Y, Xia Q, Chang J, Jiang X, Zhang H. Intratumoral Microbiome of Human Primary Liver Cancer. Hepatol Commun 2022. [PMID: 35191218 DOI: 10.1002/hep4.1908] [Reference Citation Analysis]
456 Maruyama H, Tanoue K, Ishikawa-kakiya Y, Yamamura M, Higashimori A, Ominami M, Nadatani Y, Fukunaga S, Otani K, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Ohira G, Kimura K, Amano R, Fujiwara Y. Clinical Implication of Preoperative C-Reactive Protein/Albumin Ratio in Malignant Transformation of Intraductal Papillary Mucinous Neoplasm: A Propensity Score Analysis. Diagnostics 2022;12:554. [DOI: 10.3390/diagnostics12020554] [Reference Citation Analysis]
457 Masui T, Ito T, Komoto I, Kojima S, Kasai Y, Tanabe M, Hara K, Hirano S, Okusaka T, Ichikawa Y, Kinugasa Y, Kokudo N, Kudo A, Sakurai A, Sugihara K, Date H, Haruma K, Hijioka S, Hirata K, Yamano H, Sakamine M, Kikuchi T, Fukushima M, Imamura M, Uemoto S. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan. Int J Clin Oncol 2022. [PMID: 35178624 DOI: 10.1007/s10147-022-02130-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Lamarca A, Frizziero M, Barriuso J, Kapacee Z, Mansoor W, Mcnamara MG, Hubner RA, Valle JW. Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice. Cancers 2022;14:1017. [DOI: 10.3390/cancers14041017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
459 Nakao E, Namikawa K, Hirasawa T, Nakano K, Tokai Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Nunobe S, Fujisaki J. Risk factors for lymph node metastasis and indication of local resection in duodenal neuroendocrine tumors. JGH Open. [DOI: 10.1002/jgh3.12718] [Reference Citation Analysis]
460 Laudicella R, Comelli A, Liberini V, Vento A, Stefano A, Spataro A, Crocè L, Baldari S, Bambaci M, Deandreis D, Arico’ D, Ippolito M, Gaeta M, Alongi P, Minutoli F, Burger IA, Baldari S. [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept. Cancers 2022;14:984. [DOI: 10.3390/cancers14040984] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
461 Ye J, Lin Y, Gao X, Lu L, Huang X, Huang S, Bai T, Wu G, Li Y, Luo X, Liang R. Prognosis-related molecular subtypes and immune features associated with hepatocellular carcinoma.. [DOI: 10.1101/2022.02.13.22270902] [Reference Citation Analysis]
462 Gambella A, Falco EC, Benazzo G, Osella-abate S, Senetta R, Castellano I, Bertero L, Cassoni P. The Importance of Being “That” Colorectal pT1: A Combined Clinico-Pathological Predictive Score to Improve Nodal Risk Stratification. Front Med 2022;9:837876. [DOI: 10.3389/fmed.2022.837876] [Reference Citation Analysis]
463 Bober B, Saracyn M, Zaręba K, Lubas A, Mazurkiewicz P, Wilińska E, Kamiński G. Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study. J Clin Med 2022;11:919. [PMID: 35207193 DOI: 10.3390/jcm11040919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
464 Safi SA, Haeberle L, Goering W, Keitel V, Fluegen G, Stoecklein N, Rehders A, Knoefel WT, Esposito I. Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head. Cancers (Basel) 2022;14:850. [PMID: 35159117 DOI: 10.3390/cancers14030850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
465 Marji N, Dhillon J, Lauwers GY, Feuerlein S, Nikfar R, Chatwal M, Vosoughi A, Wu MLC. Colonic Adenocarcinoma with Plasmacytoid Feature: Histopathology and Molecular Characteristics of a Rare Neoplasm with an Unusual Presentation. Case Reports in Pathology 2022;2022:1-5. [DOI: 10.1155/2022/2640456] [Reference Citation Analysis]
466 Li SP, Wang P, Deng KX. Imaging presentation of biliary adenofibroma: A case report. World J Clin Cases 2022; 10(4): 1366-1372 [DOI: 10.12998/wjcc.v10.i4.1366] [Reference Citation Analysis]
467 Prisciandaro M, Antista M, Raimondi A, Corti F, Morano F, Centonze G, Sabella G, Mangogna A, Randon G, Pagani F, Prinzi N, Niger M, Corallo S, Castiglioni di Caronno E, Massafra M, Bartolomeo MD, Braud FD, Milione M, Pusceddu S. Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective. Front Oncol 2022;12:780716. [DOI: 10.3389/fonc.2022.780716] [Reference Citation Analysis]
468 Watanabe H, Fujishima F, Komoto I, Imamura M, Hijioka S, Hara K, Yatabe Y, Kudo A, Masui T, Tsuchikawa T, Sakamoto K, Shiga H, Nakamura T, Nakaya N, Motoi F, Unno M, Sasano H. Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors. Cancers (Basel) 2022;14:775. [PMID: 35159042 DOI: 10.3390/cancers14030775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
469 Lopes A, de Mello ES, Mendoza Lopez RV, Leonardi PC, Ribeiro U Jr. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. J Surg Res 2022;274:68-76. [PMID: 35123285 DOI: 10.1016/j.jss.2022.01.001] [Reference Citation Analysis]
470 Li D, Xie J, Hong D, Liu G, Wang R, Jiang C, Ye Z, Xu B, Wang W. Efficacy and safety of ligation-assisted endoscopic submucosal resection combined with endoscopic ultrasonography for treatment of rectal neuroendocrine tumors. Scand J Gastroenterol 2022;:1-6. [PMID: 35108155 DOI: 10.1080/00365521.2022.2033828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
471 Zhu H, Wang G, Zheng J, Zhu H, Huang J, Luo E, Hu X, Wei Y, Wang C, Xu A, He X. Preoperative prediction for lymph node metastasis in early gastric cancer by interpretable machine learning models: A multicenter study. Surgery 2022. [DOI: 10.1016/j.surg.2021.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
472 Shuyao W, Mingyang B, Feifei M, Xiaoqin H. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC. J Gastrointest Surg 2022;26:341-51. [PMID: 34506016 DOI: 10.1007/s11605-021-05107-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Su R, Cai L, Xiong P, Liu Z, Chen S, Liu X, Lin R, Lei Z, Tian D, Su M. TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma. JIR 2022;Volume 15:1437-56. [DOI: 10.2147/jir.s348786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
474 Babu BI, Shapiro AMJ. Current Evidence in the Management of Premalignant Cystic Lesions of the Pancreas in Patients Undergoing Liver Transplantation. Pancreas 2022;51:117-20. [PMID: 35404885 DOI: 10.1097/MPA.0000000000001974] [Reference Citation Analysis]
475 Balitzer D, Kakar S. Diagnostic challenges and risk stratification of hepatocellular adenoma. Diagnostic Histopathology 2022;28:89-102. [DOI: 10.1016/j.mpdhp.2021.11.003] [Reference Citation Analysis]
476 Nam JY, Chung HJ, Choi KS, Lee H, Kim TJ, Soh H, Kang EA, Cho SJ, Ye JC, Im JP, Kim SG, Kim JS, Chung H, Lee JH. Deep learning model for diagnosing gastric mucosal lesions using endoscopic images: development, validation, and method comparison. Gastrointest Endosc 2022;95:258-268.e10. [PMID: 34492271 DOI: 10.1016/j.gie.2021.08.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
477 Goeppert B, Stichel D, Toth R, Fritzsche S, Loeffler MA, Schlitter AM, Neumann O, Assenov Y, Vogel MN, Mehrabi A, Hoffmann K, Köhler B, Springfeld C, Weichenhan D, Plass C, Esposito I, Schirmacher P, von Deimling A, Roessler S. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis. Gut 2022;71:391-401. [PMID: 33468537 DOI: 10.1136/gutjnl-2020-322983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
478 Cheng T, Gamage SMK, Lu C, Aktar S, Gopalan V, Lam AK. Polymorphisms in PAH metabolising enzyme CYP1A1 in colorectal cancer and their clinicopathological correlations. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153801] [Reference Citation Analysis]
479 Nikas IP, Proctor T, Seide S, Chatziioannou SS, Reynolds JP, Ntourakis D. Diagnostic Performance of Pancreatic Cytology with the Papanicolaou Society of Cytopathology System: A Systematic Review, before Shifting into the Upcoming WHO International System. Int J Mol Sci 2022;23:1650. [PMID: 35163571 DOI: 10.3390/ijms23031650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
480 Inaba Y, Hijioka S, Iwama I, Asai T, Miyamura H, Chatani S, Hasegawa T, Murata S, Kato M, Sato Y, Yamaura H, Onaya H, Shimizu J, Hara K. Clinical usefulness of Somatostatin Receptor Scintigraphy in the Diagnosis of Neuroendocrine Neoplasms. Asia Ocean J Nucl Med Biol. 2022;10:1-13. [PMID: 35083344 DOI: 10.22038/aojnmb.2021.56254.1390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
481 Xiang Z, He Q, Huang L, Xiong B, Xiang Q. Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation. Front Oncol 2021;11:818869. [PMID: 35083162 DOI: 10.3389/fonc.2021.818869] [Reference Citation Analysis]
482 Matli VVK, Wellman G, Jaganmohan S, Koticha K. Ampullary and Pancreatic Neuroendocrine Tumors: A Series of Cases and Review of the Literature. Cureus 2022. [DOI: 10.7759/cureus.21657] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
483 Liu YH, Fan ZH, Yin SS, Yan K, Sun LQ, Jiang BB. Diagnostic value of color parametric imaging and contrast-enhanced ultrasound in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Clin Ultrasound 2022. [PMID: 35084048 DOI: 10.1002/jcu.23138] [Reference Citation Analysis]
484 Al-toubah T, Morse B, Strosberg J. Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors. Current Oncology 2022;29:510-5. [DOI: 10.3390/curroncol29020046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Gkountakos A, Simbolo M, Bariani E, Scarpa A, Luchini C. Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology. Int J Mol Sci 2022;23:1283. [PMID: 35163206 DOI: 10.3390/ijms23031283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
486 Kaewput C, Vinjamuri S. Role of Combined 68Ga DOTA-Peptides and 18F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms. Diagnostics 2022;12:280. [DOI: 10.3390/diagnostics12020280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
487 El Dein Mohameda AS, El-Rebey HS, AboElnasr LSA, Abdou AG. The role and relationship between programmed death ligand 1 and cytotoxic T lymphocyte-associated antigen-4 immunohistochemical expression in colorectal carcinoma patients: an impact on outcome. Ecancermedicalscience 2021;15:1323. [PMID: 35047074 DOI: 10.3332/ecancer.2021.1323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
488 Liu X, Wang W, Liu X, Zhang Z, Yu L, Li R, Guo D, Cai W, Quan X, Wu H, Dai M, Liang Z. Multi‐omics analysis of intra‐tumoural and inter‐tumoural heterogeneity in pancreatic ductal adenocarcinoma. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
489 Exarchou K, Stephens NA, Moore AR, Howes NR, Pritchard DM. New Developments in Gastric Neuroendocrine Neoplasms. Curr Oncol Rep. [DOI: 10.1007/s11912-021-01175-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
490 Kuwano H, Yokobori T, Ide M, Saeki H, Sohda M, Sakai M, Yoshida T, Kuriyama K, Ogata K, Ogawa H, Okada T, Miyazaki T, Takahashi S, Shirabe K. Coexistence of superficial carcinogenesis of resident epithelium besides neuroendocrine neoplasm of the digestive tract. Cancer Med 2022. [PMID: 35048546 DOI: 10.1002/cam4.4485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Kang X, Zhang R, Kwong TN, Lui RN, Wu WK, Sung JJ, Yu J, Wong SH. Serrated neoplasia in the colorectum: gut microbiota and molecular pathways. Gut Microbes 2021;13:1-12. [PMID: 33382354 DOI: 10.1080/19490976.2020.1863135] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
492 LA Barba G, Pacilio CA, Binda C, Fappiano F, Fabbri C, Ercolani G. INTRAHEPATIC BILIARY STRICTURES WITH UNDERLYING PRE-MALIGNANT BILIARY LESIONS: IS IT TIME TO BUILD GUIDELINES ON DIAGNOSIS AND MANAGEMENT? Arq Bras Cir Dig 2022;34:e1613. [PMID: 35019125 DOI: 10.1590/0102-672020210002e1613] [Reference Citation Analysis]
493 Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, Lurje G, Pelzer U, Pratschke J, Schmelzle M, Schöning W. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach. Cancers (Basel) 2022;14:362. [PMID: 35053523 DOI: 10.3390/cancers14020362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
494 Wang H, Lu Y, Liu R, Wang L, Liu Q, Han S. A Non-Invasive Nomogram for Preoperative Prediction of Microvascular Invasion Risk in Hepatocellular Carcinoma. Front Oncol 2021;11:745085. [PMID: 35004273 DOI: 10.3389/fonc.2021.745085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
495 Li G, Ma S, Wu Q, Kong D, Yang Z, Gu Z, Feng L, Zhang K, Cheng S, Tian Y, Zhang W. Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing. Cell Death Discov 2022;8:6. [PMID: 35013129 DOI: 10.1038/s41420-021-00803-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 Li Z, Chen F, Zhang S, Ma X, Xia Y, Shen F, Lu Y, Shao C. The feasibility of MRI-based radiomics model in presurgical evaluation of tumor budding in locally advanced rectal cancer. Abdom Radiol (NY) 2022;47:56-65. [PMID: 34673995 DOI: 10.1007/s00261-021-03311-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
497 Vaiphei K. Interpretation of Endoscopic Mucosal Biopsy for Gastric Carcinoma. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_13] [Reference Citation Analysis]
498 Bodei L, Jayaprakasam VS, Kidd M, Gilardi L, Volterrani D, Paganelli G, Grana CM, Modlin IM. Diagnostic Applications of Nuclear Medicine: Neuroendocrine Tumors. Nuclear Oncology 2022. [DOI: 10.1007/978-3-031-05494-5_18] [Reference Citation Analysis]
499 Kriger A, Gorin D, Akhtanin E, Glotov A, Panteleev V. A rare variant of pancreatic serous cystadenoma. Khir Z im N I Pirogova 2022. [DOI: 10.17116/hirurgia202207194] [Reference Citation Analysis]
500 Cui H, Ding X, Zhang J, Huang D, Wang Y, You Q, Zhang B, Wang Y, Zhao J. Research on Multi-label of Gastritis Pathological Images Based on Weakly Supervised Deep Learning. Lecture Notes in Electrical Engineering 2022. [DOI: 10.1007/978-981-16-6963-7_1] [Reference Citation Analysis]
501 Cacciato Insilla A, Giordano M, Campani D. Molecular Pathology of Acinar Cystic Transformation. Pathology of the Pancreas 2022. [DOI: 10.1007/978-3-030-62416-3_5578] [Reference Citation Analysis]
502 Vaiphei K. Controversies in the Diagnosis of Early Gastric Cancer. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_11] [Reference Citation Analysis]
503 Tan SA, Stocchi L. Appendiceal Neoplasms. The ASCRS Textbook of Colon and Rectal Surgery 2022. [DOI: 10.1007/978-3-030-66049-9_33] [Reference Citation Analysis]
504 Tabacchi E, Nanni C, Bossert I, Maffione AM, Fanti S. Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer. Nuclear Oncology 2022. [DOI: 10.1007/978-3-319-26067-9_17-4] [Reference Citation Analysis]
505 Prado-wohlwend S, Bernal-vergara J, Utrera-costero A, Cañón-sánchez J, Agudelo-cifuentes M, Bello-arques P. Terapia con péptidos radiomarcados con [177Lu]Lu-DOTA-TATE. Revista Española de Medicina Nuclear e Imagen Molecular 2022;41:55-65. [DOI: 10.1016/j.remn.2021.11.001] [Reference Citation Analysis]
506 Castro ÁG, Iglesias HL. Histopathological diagnosis of CRC. Foundations of Colorectal Cancer 2022. [DOI: 10.1016/b978-0-323-90055-3.00050-8] [Reference Citation Analysis]
507 Sasaki A, Shimizuguchi R, Takao A, Shibata S, Natsume S, Horiguchi S, Nakano D, Yamaguchi T, Koizumi K. Endoscopic Scoring System for T2 Invasion in Colorectal Cancer. Techniques and Innovations in Gastrointestinal Endoscopy 2022;24:121-126. [DOI: 10.1016/j.tige.2021.11.005] [Reference Citation Analysis]
508 Rivero-Sánchez L, Gavric A, Herrero J, Remedios D, Alvarez V, Albéniz E, Gordillo J, Puig I, López-Vicente J, Huerta A, López-Cerón M, Salces I, Peñas B, Parejo S, Rodriguez E, Herraiz M, Carretero C, Gimeno-Garcia AZ, Saperas E, Alvarez C, Arnau-Collell C, Ortiz O, Sánchez A, Jung G, Balaguer F, Pellisé M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. Endoscopy 2022;54:27-34. [PMID: 33271604 DOI: 10.1055/a-1328-5405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Minciuna C, Tanase M, Manuc TE, Tudor S, Herlea V, Dragomir MP, Calin GA, Vasilescu C. The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers. Computational and Structural Biotechnology Journal 2022;20:5065-75. [DOI: 10.1016/j.csbj.2022.09.010] [Reference Citation Analysis]
510 Lew D, Srinivas S, Kwok K. Approach to the Patient with a Pancreatic Mass. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_26] [Reference Citation Analysis]
511 Hormati A, Hajrezaei Z, Jazi K, Aslani Kolur Z, Rezvan S, Ahmadpour S. Gastrointestinal and Pancratohepatobiliary Cancers: A Comprehensive Review on Epidemiology and Risk Factors Worldwide. Middle East J Dig Dis 2022;14:5-23. [PMID: 36619733 DOI: 10.34172/mejdd.2022.251] [Reference Citation Analysis]
512 Liao T, Su T, Huang L, Li B, Feng LH. Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms. Scand J Gastroenterol 2022;57:85-90. [PMID: 34592854 DOI: 10.1080/00365521.2021.1984571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
513 Vaiphei K. Gastric Carcinoma—Early and Advanced Carcinomas. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_14] [Reference Citation Analysis]
514 Bou Zerdan M, Hamouche R, Bouferraa Y, Chouairy C, Gholam D. Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report. SAGE Open Medical Case Reports 2022;10:2050313X2211069. [DOI: 10.1177/2050313x221106987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
515 Yeo MK, Kang SH, Jeong KB, Lee HS, Jeon HJ, Eun HS, Lee ES, Moon HS, Kim SH, Sung JK, Lee BS, Jeong HY. Comparison of Gene Expression Profiles of Signet Ring Cell Carcinoma and Poorly Cohesive Carcinoma in Early Gastric Cancer. Clin Med Insights Oncol 2022;16:117955492210979. [DOI: 10.1177/11795549221097941] [Reference Citation Analysis]
516 Souza D, Queiroga E, de T, Cunha K, Dias E. Stromal scoring in advanced colon and rectal cancer: Stroma-rich tumors and their association with aggressive phenotypes. Arch Oncol 2022;28:1-6. [DOI: 10.2298/aoo210403003s] [Reference Citation Analysis]
517 Valente M, Covre A, Giacomo AMD, Maio M. Personalized Medicine for Patients with Liver, Biliary Tract, and Pancreatic Cancer. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_50] [Reference Citation Analysis]
518 Anand A, Ali M, Qayoom S, Singh G. Primary small-cell neuroendocrine carcinoma of the gallbladder with bone metastasis: A rare presentation. Oncol J India 2022;6:33. [DOI: 10.4103/oji.oji_24_21] [Reference Citation Analysis]
519 Martinez RB, Gavane S, Lu Y. PET imaging of gastric cancer. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00141-1] [Reference Citation Analysis]
520 Duchateau NM, Canovai E, Vianna RM, Vanuytsel T, Verslype C, Mazariegos GV, Monbaliu D, Pirenne J, Ceulemans LJ. Combined liver-intestinal and multivisceral transplantation for neuroendocrine tumors extending beyond the liver: A systematic literature review. Transplantation Reviews 2022. [DOI: 10.1016/j.trre.2022.100678] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
521 Veiga A, Queipo F, Bou G, Cepeda-emiliani A, Concha Á. Diagnostic, prognostic, predictive and therapeutic molecular biomarkers in CRC: Understanding the present and foreseeing the future. Foundations of Colorectal Cancer 2022. [DOI: 10.1016/b978-0-323-90055-3.00049-1] [Reference Citation Analysis]
522 Liu L, Yao X, Wang Y, Hu R, Fan C, Gong H, Liu J, Guo Y. Physins in digestive system neoplasms. Advances in Clinical Chemistry 2022. [DOI: 10.1016/bs.acc.2022.08.002] [Reference Citation Analysis]
523 Khalin K, Agapov M, Fedorov E, Zvereva L, Ogurchyonok N, Stegnii K, Ivanova E, Dvoinikova E, Gorbachev E. Endoscopic vs optical biopsy for patients with colorectal lesions: prospective multicentral trial. Dok gastroenterol 2022;11:11. [DOI: 10.17116/dokgastro20221103111] [Reference Citation Analysis]
524 Bodei L, Jayaprakasam VS, Kidd M, Gilardi L, Volterrani D, Paganelli G, Grana CM, Modlin IM. Diagnostic Applications of Nuclear Medicine: Neuroendocrine Tumors. Nuclear Oncology 2022. [DOI: 10.1007/978-3-319-26067-9_18-2] [Reference Citation Analysis]
525 Lamba M, Brown I, Bettington M, Ryan K, Hanigan K, Lasenby K, Dixon A, Grimpen F, Gan C, Tutticci N, Appleyard M, Leggett B. Clinicopathological Correlates of Dysplastic Sessile Serrated Lesion: A Prospective Cohort Study With a High Detection Rate. Gastro Hep Advances 2022;1:313-320. [DOI: 10.1016/j.gastha.2021.12.010] [Reference Citation Analysis]
526 Kuvaev R, Kashin S, Kraynova E, Nikonov E. Gastric adenocarcinoma of the fundic gland (chief cell predominant type): challenges in endoscopic and morphological diagnosis. Dok gastroenterol 2022;11:86. [DOI: 10.17116/dokgastro20221104186] [Reference Citation Analysis]
527 Nagano S, Mokutani Y, Hirose H, Yoshioka S, Takeda M. Mixed Neuroendocrine-non-neuroendocrine Neoplasm of the Sigmoid Colon. Journal of Japan Society of Coloproctology 2022;75:285-290. [DOI: 10.3862/jcoloproctology.75.285] [Reference Citation Analysis]
528 Fanti S, Ambrosini V. PET Imaging in Neuro-Endocrine Neoplasms (NEN). Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00034-x] [Reference Citation Analysis]
529 Flood MP, Lawrentschuk N, Heriot AG. Malignant Gastrointestinal Conditions. Men’s Health and Wellbeing 2022. [DOI: 10.1007/978-3-030-84752-4_15] [Reference Citation Analysis]
530 Gambella A, Scabini S, Zoppoli G, De Silvestri A, Pigozzi S, Paudice M, Campora M, Fiocca R, Grillo F, Mastracci L. HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet. Histochem Cell Biol 2022;158:535-43. [PMID: 35902421 DOI: 10.1007/s00418-022-02141-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
531 Takeuchi Y, Kato H, Horiguchi S, Oyama A, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A. Study Protocol for a Trial: A Single-Arm, Open-Labeled Study Evaluating Transcatheter Arterial Embolization Plus Everolimus Combination Therapy for Patients With Liver Metastasis of Gastroenteropancreatic Neuroendocrine Tumors. Clin Med Insights Oncol 2022;16:117955492211277. [DOI: 10.1177/11795549221127750] [Reference Citation Analysis]
532 Cavestro GM, Bonura GF. Advanced Techniques in Colonoscopy in Inherited Cancer Conditions. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2022. [DOI: 10.1007/978-3-030-56993-8_28] [Reference Citation Analysis]
533 Sato C, Takahashi K, Sato H, Naruse T, Nakajima N, Takatsuna M, Mizuno K, Hashimoto S, Takeuchi M, Yokoyama J, Kobayashi M, Terai S. Endoscopic Findings and Treatment of Gastric Neoplasms in Familial Adenomatous Polyposis. J Gastric Cancer 2022;22:e30. [DOI: 10.5230/jgc.2022.22.e30] [Reference Citation Analysis]
534 王 登. Research Progress in Pancreatic Cancer. ACM 2022;12:5181-5188. [DOI: 10.12677/acm.2022.126751] [Reference Citation Analysis]
535 Vaiphei K. Morphological Aspect of Gastric Carcinomas. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_15] [Reference Citation Analysis]
536 Sorrentino L, De Ruvo N, Serra F, Salati M, Ricciardolo AA, Bonetti LR, Gelmini R. Role of poorly differentiated cluster in gastric cancer: is it a new prognosis factor? Scand J Gastroenterol 2022;57:44-9. [PMID: 34524049 DOI: 10.1080/00365521.2021.1974932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
537 Sanvito F, Gallotti A, Cobianchi L, Vanoli A, Cho NS, Preda L. Magnetic Resonance Diffusion-Weighted Imaging for Detecting Fundal Intracholecystic Papillary Neoplasm inside Rokitansky-Aschoff Sinuses: A Comparison of Two Cases and a Literature Review. Radiation 2022;2:52-61. [DOI: 10.3390/radiation2010004] [Reference Citation Analysis]
538 Colagrande A, Cazzato G, Fedele S, Andriola V, Ingravallo G, Resta L, Vincenti L. A Unique Case of the Transformation of a Hepatic Leiomyoma into Leiomyosarcoma with Pancreatic Metastases: Review of the Literature with Case Presentation. Reports 2021;5:2. [DOI: 10.3390/reports5010002] [Reference Citation Analysis]
539 Saiki Y, Jiang C, Ohmuraya M, Furukawa T. Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models. Cancers (Basel) 2021;14:71. [PMID: 35008235 DOI: 10.3390/cancers14010071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
540 van der Wel MJ, Klaver E, Pouw RE, Brosens LAA, Biermann K, Doukas M, Huysentruyt C, Karrenbeld A, Ten Kate FJW, Kats-Ugurlu G, van der Laan J, van Lijnschoten I, Moll FCP, Offerhaus GJA, Ooms AHAG, Seldenrijk CA, Visser M, Tijssen JG, Meijer SL, Bergman JJGHM. Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement. Dis Esophagus 2021;34:doab034. [PMID: 34100554 DOI: 10.1093/dote/doab034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
541 Kohno S, Ikegami M, Ikegami T, Aoki H, Ogawa M, Yano F, Eto K. Risk Factors Associated with the Development of Metastases in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis. JCM 2021;11:60. [DOI: 10.3390/jcm11010060] [Reference Citation Analysis]
542 Quach DT, Tran LT, Tran TL, Tran VL, Le NQ, Hiyama T. Age Cutoff and Yield of Prompt Esophagogastroduodenoscopy to Detect Malignancy in Vietnamese with Upper Gastrointestinal Symptoms: An Endoscopic Database Review of 472,744 Patients from 2014 to 2019. Can J Gastroenterol Hepatol 2021;2021:1184848. [PMID: 34931167 DOI: 10.1155/2021/1184848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
543 Natalicchio A, Faggiano A, Zatelli MC, Argentiero A, D'Oronzo S, Marrano N, Beretta GD, Acquati S, Adinolfi V, Di Bartolo P, Danesi R, Ferrari P, Gori S, Morviducci L, Russo A, Tuveri E, Montagnani M, Gallo M, Silvestris N, Giorgino F. Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper. Crit Rev Oncol Hematol 2021;:103572. [PMID: 34954047 DOI: 10.1016/j.critrevonc.2021.103572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
544 Chen X, Lu Y, Shi X, Chen X, Rong D, Han G, Zhang L, Ni C, Zhao J, Gao Y, Wang X. Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma. J Oncol 2021;2021:3002480. [PMID: 34925507 DOI: 10.1155/2021/3002480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
545 Harvitkar RU, Peri H, Zallipalli SN, Joseph SJ, Gattupalli GB, Ansari K. Non-Cancer Causes of Death in Patients With Pancreatic Adenocarcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Based Study. Cureus 2021;13:e20289. [PMID: 34926091 DOI: 10.7759/cureus.20289] [Reference Citation Analysis]
546 Csanyi-bastien M, Blanchard F, Lamy A, Sabourin J. A case of Pseudomyxoma Peritonei of an unexpected origin. Diagn Pathol 2021;16. [DOI: 10.1186/s13000-021-01179-z] [Reference Citation Analysis]
547 Li S, Niu M, Deng W, Li N, Wei C, Zhang C, Luo S. Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study. Cancer Manag Res 2021;13:9085-93. [PMID: 34916851 DOI: 10.2147/CMAR.S343572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
548 Li J, Wang J, Su D, Nie X, Liu Y, Teng L, Pang J, Wu H, Liang Z, Sakai E. p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms. Gastroenterology Research and Practice 2021;2021:1-9. [DOI: 10.1155/2021/2510195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
549 Theiler D, Cattaneo M, Dierickx LO, Igaz P, Grozinsky-Glasberg S, Bournaud C, O'Dorisio T, O'Dorisio MS, Wild D, Christ E, Nicolas GP. Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers (Basel) 2021;13:6290. [PMID: 34944910 DOI: 10.3390/cancers13246290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
550 Prado-Wohlwend S, Bernal-Vergara JC, Utrera-Costero A, Cañón-Sánchez JR, Agudelo-Cifuentes M, Bello-Arques P; Endocrinology Working Group of the SEMNIM. Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021:S2253-8089(21)00164-6. [PMID: 34920969 DOI: 10.1016/j.remnie.2021.11.001] [Reference Citation Analysis]
551 Chen K, Collins G, Wang H, Toh JWT. Pathological Features and Prognostication in Colorectal Cancer. Curr Oncol 2021;28:5356-83. [PMID: 34940086 DOI: 10.3390/curroncol28060447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
552 Jeong BS, Hwang HW, Kim JW, Hwang IG, Park JY. Gastric Mixed Adenoneuroendocrine Carcinoma with Revised Diagnosis after Retrospective Pathologic Review. Korean J Helicobacter Up Gastrointest Res 2021;21:343-8. [DOI: 10.7704/kjhugr.2021.0047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
553 Liu C, Hua X, Yang Z, Guo Y, Wu L, Cai J, Li L, Zhang Y, Fan N. Case Report: Response With Immunotherapy in a Patient With Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gallbladder. Front Oncol 2021;11:770156. [PMID: 34869003 DOI: 10.3389/fonc.2021.770156] [Reference Citation Analysis]
554 Singhal S, Patel G, Singh RB, Potdar R. Grade 3 Neuroendocrine Tumor (G3NET): An Unusual Tumor With A Histochemical Surprise. Cureus 2021;13:e19103. [PMID: 34868755 DOI: 10.7759/cureus.19103] [Reference Citation Analysis]
555 Li Y, Zhong Y, Xu Q, Zhu Z, Tian Y. Prognostic Significance of Signet Ring Cells in Gastric Cancer: The Higher Proportion, The Better Survival. Front Oncol 2021;11:713587. [PMID: 34858807 DOI: 10.3389/fonc.2021.713587] [Reference Citation Analysis]
556 Yang Z, Shi G. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study. Cancer Med 2021. [PMID: 34862762 DOI: 10.1002/cam4.4474] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
557 Yan C, Yang H, Chen L, Liu R, Shang W, Yuan W, Yang F, Sun Q, Xia L. Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study. BMC Cancer 2021;21:1286. [PMID: 34852768 DOI: 10.1186/s12885-021-09031-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
558 Marini I, Sansovini M, Bongiovanni A, Nicolini S, Grassi I, Ranallo N, Monti M, DI Iorio V, Germanò L, Caroli P, Sarnelli A, Paganelli G, Severi S. Theragnostic in neuroendocrine tumors. Q J Nucl Med Mol Imaging 2021;65:342-52. [PMID: 34881852 DOI: 10.23736/S1824-4785.21.03426-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
559 Matsueda K, Kanesaka T, Kitamura M, Shichijo S, Maekawa A, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Michida T, Honma K, Miyashiro I, Ishihara R. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor. J Gastroenterol Hepatol 2021;36:3329-36. [PMID: 34142385 DOI: 10.1111/jgh.15586] [Reference Citation Analysis]
560 Kameyama A, Ye J, Shimomura A, Yokohira M, Nakano-Narusawa Y, Yamakawa K, Mukai Y, Sanomura T, Okuyama H, Miyatake N, Furihata M, Tanaka C, Kitazawa R, Bando Y, Suemitsu Y, Kojima M, Mino-Kenudson M, Suzuki Y, Okano K, Matsuda Y. Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreatic ductal adenocarcinoma. Pancreatology 2021;21:1506-15. [PMID: 34563448 DOI: 10.1016/j.pan.2021.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
561 White JR, Ortiz-Fernández-Sordo J, Santiago-García J, Reddiar D, Learoyd A, De Caestecker J, Cole A, Kaye P, Ragunath K. Endoscopic management of Barrett's dysplasia and early neoplasia: efficacy, safety and long-term outcomes in a UK tertiary centre. Eur J Gastroenterol Hepatol 2021;33:e413-22. [PMID: 33731587 DOI: 10.1097/MEG.0000000000002121] [Reference Citation Analysis]
562 Kaiser J, Scheifele C, Hinz U, Leonhardt C, Hank T, Koenig A, Tjaden C, Hackert T, Bergmann F, Büchler MW, Strobel O. IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy. European Journal of Surgical Oncology 2021. [DOI: 10.1016/j.ejso.2021.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
563 Basukala S, Bhusal U, Sharma S, Tamang A, Gurung S. An incidental finding of ANET in a patient with perforated appendix: A case report. Int J Surg Case Rep 2021;89:106625. [PMID: 34839114 DOI: 10.1016/j.ijscr.2021.106625] [Reference Citation Analysis]
564 Zhang Z, Guo T, Huang X, Xie P, Wang L, Yu Y. Age-specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder. Cancer Med 2021. [PMID: 34841738 DOI: 10.1002/cam4.4463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
565 Kiczmer P, Mielcarska S, Chrabańska M, Dawidowicz M, Kula A, Rynkiewicz M, Seńkowska AP, Waniczek D, Piecuch J, Jopek J, Kajor M, Świętochowska E. The Concentration of CMKLR1 Expression on Clinicopathological Parameters of Colorectal Cancer: A Preliminary Study. Medicina (Kaunas) 2021;57:1299. [PMID: 34946244 DOI: 10.3390/medicina57121299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
566 Takashina Y, Kudo SE, Ichimasa K, Kouyama Y, Mochizuki K, Akimoto Y, Maeda Y, Mori Y, Misawa M, Ogata N, Kudo T, Hisayuki T, Hayashi T, Wakamura K, Sawada N, Baba T, Ishida F, Yokoyama K, Daita M, Nemoto T, Miyachi H. Clinicopathological features of small T1 colorectal cancers. World J Clin Cases 2021; 9(33): 10088-10097 [PMID: 34904078 DOI: 10.12998/wjcc.v9.i33.10088] [Reference Citation Analysis]
567 Lin DL, Wang LL, Zhao P, Ran WW, Wang W, Zhang LX, Han M, Bao H, Liu K, Wu X, Shao Y, Xing XM. Gastrointestinal Goblet Cell Adenocarcinomas Harbor Distinctive Clinicopathological, Immune, and Genomic Landscape. Front Oncol 2021;11:758643. [PMID: 34804955 DOI: 10.3389/fonc.2021.758643] [Reference Citation Analysis]
568 Jin Y, Xu Y, Li Y, Chen R, Cai W. Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients. Front Oncol 2021;11:755271. [PMID: 34804945 DOI: 10.3389/fonc.2021.755271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
569 Sweed D, Sultan MM, Mosbeh A, Fayed YA, Abdelsameea E, Ehsan NA, Abdel-Rahman MH, Waked I. Lymphoepithelioma-like Hepatocellular Carcinoma: a Case Report and Review of Literature. J Gastrointest Cancer 2021. [PMID: 34813031 DOI: 10.1007/s12029-021-00757-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
570 Ren S, Li Q, Liu S, Qi Q, Duan S, Mao B, Li X, Wu Y, Zhang L. Clinical Value of Machine Learning-Based Ultrasomics in Preoperative Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Multicenter Study. Front Oncol 2021;11:749137. [PMID: 34804935 DOI: 10.3389/fonc.2021.749137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
571 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
572 Hanbuli HME, Amer SII, Ibrahim HA. Expression of Septin 2 and Her2/neu in Colorectal Cancer. J Microsc Ultrastruct 2022;10:197-203. [PMID: 36687331 DOI: 10.4103/jmau.jmau_38_21] [Reference Citation Analysis]
573 Chen J, Wang P, Lv K, Zhou W. Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm? Diagn Pathol 2021;16:108. [PMID: 34801052 DOI: 10.1186/s13000-021-01165-5] [Reference Citation Analysis]
574 Cruz M, Moutinho-ribeiro P, Costa-moreira P, Macedo G. Solid Pseudopapillary Neoplasm of the Pancreas: Unfolding an Intriguing Condition. GE Port J Gastroenterol. [DOI: 10.1159/000519933] [Reference Citation Analysis]
575 Alzahrani SM, Al Doghaither HA, Al-Ghafari AB. General insight into cancer: An overview of colorectal cancer (Review). Mol Clin Oncol 2021;15:271. [PMID: 34790355 DOI: 10.3892/mco.2021.2433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
576 Jacob S, Bösch F, Schoenberg MB, Pretzsch E, Lampert C, Haoyu R, Renz BW, Michl M, Kumbrink J, Kirchner T, Werner J, Angele MK, Neumann J. Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis. BMC Cancer 2021;21:1243. [PMID: 34794407 DOI: 10.1186/s12885-021-08927-w] [Reference Citation Analysis]
577 Kim H, Yoon H, Thakur N, Hwang G, Lee EJ, Kim C, Chong Y. Deep learning-based histopathological segmentation for whole slide images of colorectal cancer in a compressed domain. Sci Rep 2021;11:22520. [PMID: 34795365 DOI: 10.1038/s41598-021-01905-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
578 Silva RMSD, Collaço PMC, Cunha KS, Dias EP. Diagnosis of Advanced Disease in Cases of Colorectal Cancer in a Developing Country. Journal of Coloproctology. [DOI: 10.1055/s-0041-1736517] [Reference Citation Analysis]
579 Maldonado-García EL, Álvarez-Barragán AF, Acevedo-Aguirre CE, Galicia-Alemán B, Arellano-Gutiérrez G. Neuroendocrine tumor of the ileocecal valve: A case report and review of the literature. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00123-7. [PMID: 34794925 DOI: 10.1016/j.rgmxen.2021.11.008] [Reference Citation Analysis]
580 Gebauer L, Moltz JH, Mühlberg A, Holch JW, Huber T, Enke J, Jäger N, Haas M, Kruger S, Boeck S, Sühling M, Katzmann A, Hahn H, Kunz WG, Heinemann V, Nörenberg D, Maurus S. Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer. Cancers (Basel) 2021;13:5732. [PMID: 34830885 DOI: 10.3390/cancers13225732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
581 Li Y, Pan F, Sun G, Wang ZK, Meng K, Peng LH, Lu ZS, Dou Y, Yan B, Liu QS. Risk Factors and Clinical Outcomes of 54 Cases of Rectal Neuroendocrine Tumors with Incomplete Resection: A Retrospective Single-Center Study. Ther Clin Risk Manag 2021;17:1153-61. [PMID: 34764651 DOI: 10.2147/TCRM.S332838] [Reference Citation Analysis]
582 Ciobanu OA, Martin S, Fica S. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review). Exp Ther Med 2021;22:1479. [PMID: 34765020 DOI: 10.3892/etm.2021.10914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
583 Yu WM, Li R, Sun BL, Du JK, Tuo HF. Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review. Int J Surg Case Rep 2021;89:106590. [PMID: 34784532 DOI: 10.1016/j.ijscr.2021.106590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
584 Zenovia S, Neculae E, Trifan AV, Dimache M, Fotea V, Sîngeap AM. Duodenal large-cell neuroendocrine carcinoma as unusual cause of acute pancreatitis. Arch Clin Cases 2020;7:15-21. [PMID: 34754922 DOI: 10.22551/2020.26.0701.10167] [Reference Citation Analysis]
585 Tang YY, Zhao YN, Zhang T, Chen ZY, Ma XL. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma. World J Gastroenterol 2021; 27(41): 7173-7189 [PMID: 34887636 DOI: 10.3748/wjg.v27.i41.7173] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
586 Liang L, Fang J, Han X, Zhai X, Song Y, Lu Y, Zhang Q, Ma R. Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei. Front Oncol 2021;11:594763. [PMID: 34733775 DOI: 10.3389/fonc.2021.594763] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
587 Refardt J, Hofland J, Wild D, Christ E. New Directions in Imaging Neuroendocrine Neoplasms. Curr Oncol Rep 2021;23:143. [PMID: 34735669 DOI: 10.1007/s11912-021-01139-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
588 Stensbøl AB, Krogh J, Holmager P, Klose M, Oturai P, Kjaer A, Hansen CP, Federspiel B, Langer SW, Knigge U, Andreassen M. Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors. Diagnostics (Basel) 2021;11:2030. [PMID: 34829377 DOI: 10.3390/diagnostics11112030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
589 Wei Y, Ke X, Yu J, Jing Q, Bu H, Zeng X, Wei B. Clinical and genomic analyses of neuroendocrine neoplasms of the breast. Mod Pathol 2021. [PMID: 34728787 DOI: 10.1038/s41379-021-00965-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
590 Li F, Zhu H, Tao K, Xia Y, Liu M, Wang Y, Sun Y, Cao T, Chai J, Ni F, Shi B, Xu H. Mucosal microbial microenvironment in early gastric neoplasia and non-neoplastic gastric disease. J Gastroenterol Hepatol 2021;36:3092-101. [PMID: 34089623 DOI: 10.1111/jgh.15565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
591 Lisotti A, Napoleon B, Facciorusso A, Cominardi A, Crinò SF, Brighi N, Gincul R, Kitano M, Yamashita Y, Marchegiani G, Fusaroli P. Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis. Gastrointest Endosc 2021;94:881-889.e5. [PMID: 34217751 DOI: 10.1016/j.gie.2021.06.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
592 Chakraborty S, Ecker BL, Seier K, Aveson VG, Balachandran VP, Drebin JA, D'Angelica MI, Kingham TP, Sigel CS, Soares KC, Vakiani E, Wei AC, Chandwani R, Gonen M, Shen R, Jarnagin WR. Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care. Clin Cancer Res 2021;27:5891-9. [PMID: 34433650 DOI: 10.1158/1078-0432.CCR-21-1906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
593 Fang X, Liu F, Li J, Cao K, Wang T, Zhang H, Li Q, Meng Y, Yu J, Feng X, Jiang H, Wang L, Lu J, Shao C, Bian Y. Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreas. Abdom Radiol (NY) 2021;46:5218-28. [PMID: 34409514 DOI: 10.1007/s00261-021-03247-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
594 Medved V, Husieva A, Duda K, Shevchenko A. Epithelioid hemangioendothelioma of the liver and pregnancy (Literature review and clinical case). RHW 2021. [DOI: 10.30841/2708-8731.7-8.2021.250838] [Reference Citation Analysis]
595 Murtha-Lemekhova A, Fuchs J, Schulz E, Sterkenburg AS, Mayer P, Pfeiffenberger J, Hoffmann K. Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features. J Hepatocell Carcinoma 2021;8:1269-79. [PMID: 34712626 DOI: 10.2147/JHC.S328198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
596 Wang H, Jiang H, Zhao J, Liu X, Li T, Chai J, Meng M, Pan T, Xu K, Wang F. Acupuncture therapy for gastric ulcer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27656. [PMID: 34713858 DOI: 10.1097/MD.0000000000027656] [Reference Citation Analysis]
597 Li X, Ai S, Lu X, Liu S, Guan W. Nanotechnology-based strategies for gastric cancer imaging and treatment. RSC Adv 2021;11:35392-407. [PMID: 35493171 DOI: 10.1039/d1ra01947c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
598 Zhang X, Xiao R, Lu B, Wu H, Jiang C, Li P, Huang J. Kinase DYRK2 acts as a regulator of autophagy and an indicator of favorable prognosis in gastric carcinoma. Colloids Surf B Biointerfaces 2021;209:112182. [PMID: 34749023 DOI: 10.1016/j.colsurfb.2021.112182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
599 Egal ESA, Jacenik D, Soares HP, Beswick EJ. Translational challenges in pancreatic neuroendocrine tumor immunotherapy. Biochim Biophys Acta Rev Cancer 2021;1876:188640. [PMID: 34695532 DOI: 10.1016/j.bbcan.2021.188640] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
600 Touloupas C, Faron M, Hadoux J, Deschamps F, Roux C, Ronot M, Yevich S, Joskin J, Gelli M, Barbé R, Lamartina L, Tissot H, Scoazec JY, Malka D, Ducreux M, Baudin E, de Baère T, Tselikas L. Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience. Cancers (Basel) 2021;13:5366. [PMID: 34771531 DOI: 10.3390/cancers13215366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
601 Shen B, Sun K. Exosomal circular RNAs: A new frontier in the metastasis of digestive system tumors. Oncol Lett 2021;22:826. [PMID: 34691253 DOI: 10.3892/ol.2021.13087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
602 Shi M, Fan Z, Xu J, Yang J, Li Y, Gao C, Su P, Wang X, Zhan H. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs. Biochim Biophys Acta Rev Cancer 2021;1876:188637. [PMID: 34678439 DOI: 10.1016/j.bbcan.2021.188637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
603 Dobashi A, Ono S, Furuhashi H, Futakuchi T, Tamai N, Yamauchi T, Suka M, Sumiyama K. Texture and Color Enhancement Imaging Increases Color Changes and Improves Visibility for Squamous Cell Carcinoma Suspicious Lesions in the Pharynx and Esophagus. Diagnostics (Basel) 2021;11:1971. [PMID: 34829318 DOI: 10.3390/diagnostics11111971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
604 Tong C, Wang W, Xia Y, He C. A potential novel biomarker in predicting lymph node metastasis of gastric signet ring cell carcinoma: A derived monocyte to lymphocyte ratio. Am J Surg 2021:S0002-9610(21)00618-8. [PMID: 34702491 DOI: 10.1016/j.amjsurg.2021.10.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
605 Tanaka H, Yoshii M, Imai T, Tamura T, Toyokawa T, Muguruma K, Hirakawa K, Ohira M. Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer. Mol Clin Oncol 2021;15:234. [PMID: 34650801 DOI: 10.3892/mco.2021.2397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
606 Amorim LC, Ferreira AR, Perez RO, Peixoto RD. Localized Well-Differentiated Rectal Neuroendocrine Tumors - Where Are We in 2021? Clin Colorectal Cancer 2021:S1533-0028(21)00101-8. [PMID: 34838461 DOI: 10.1016/j.clcc.2021.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
607 Yozgat A, Kekilli M, Altay M. Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours. World J Clin Cases 2021; 9(29): 8627-8646 [PMID: 34734042 DOI: 10.12998/wjcc.v9.i29.8627] [Reference Citation Analysis]
608 Cao GJ, Wang D, Zeng ZP, Wang GX, Hu CJ, Xing ZF. Direct interaction between Rab5a and Rab4a enhanced epidermal growth factor-stimulated proliferation of gastric cancer cells. World J Gastrointest Oncol 2021; 13(10): 1492-1505 [PMID: 34721780 DOI: 10.4251/wjgo.v13.i10.1492] [Reference Citation Analysis]
609 Fujisawa M, Matsushima M, Carreras J, Hirabayashi K, Y Kikuti Y, Ueda T, Kaneko M, Fujimoto R, Sano M, Teramura E, Monma M, Nakae H, Suzuki T, Suzuki H, Nakamura N. Whole-genome copy number and immunohistochemical analyses on surgically resected intracholecystic papillary neoplasms. Pathol Int 2021. [PMID: 34643317 DOI: 10.1111/pin.13177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
610 Qi J, Liu X, Yan P, He S, Lin Y, Huang Z, Zhang S, Xie S, Li Y, Lu X, Wu Y, Zhou Y, Yuan J, Cai T, Zheng X, Ding Y, Yang W. Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4+ T Cells in the Central Region of pMMR CRC. Front Oncol 2021;11:724232. [PMID: 34631551 DOI: 10.3389/fonc.2021.724232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
611 Maharjan CK, Ear PH, Tran CG, Howe JR, Chandrasekharan C, Quelle DE. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers (Basel) 2021;13:5117. [PMID: 34680266 DOI: 10.3390/cancers13205117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
612 Yang KC, Kalloger SE, Aird JJ, Lee MKC, Rushton C, Mungall KL, Mungall AJ, Gao D, Chow C, Xu J, Karasinska JM, Colborne S, Jones SJM, Schrader J, Morin RD, Loree JM, Marra MA, Renouf DJ, Morin GB, Schaeffer DF, Gorski SM. Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms. Cell Rep 2021;37:109817. [PMID: 34644566 DOI: 10.1016/j.celrep.2021.109817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
613 Sato H, Saito T, Horii H, Kajiura M, Kikuchi N, Takada N, Taguchi K, Yoshida M, Hasegawa M, Taguchi H, Yoshida Y, Ando K, Fujiya M, Omori Y, Hank T, Liss AS, Gala MK, Makita Y, Ono Y, Mizukami Y, Okumura T. Case Report: A Rare Case of Esophagogastric Junctional Squamous Cell Carcinoma After the Successful Treatment of Neuroendocrine Carcinoma: Clonal Tumor Evolution Revealed by Genetic Analysis. Front Genet 2021;12:608324. [PMID: 34616420 DOI: 10.3389/fgene.2021.608324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
614 Truong LH, Pauklin S. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches. Cancers (Basel) 2021;13:5028. [PMID: 34638513 DOI: 10.3390/cancers13195028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
615 Silva DJ, Dos Santos J, Vaz AP, Mesquita A. Rectal mixed adenoneuroendocrine carcinoma: Case report. Medicine (Baltimore) 2021;100:e27348. [PMID: 34622834 DOI: 10.1097/MD.0000000000027348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
616 Jiang W, Wu T, Shi X, Xu J. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma. Bioengineered 2021;12:7941-9. [PMID: 34612781 DOI: 10.1080/21655979.2021.1982844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
617 Kriger AG. [Actual issues of pancreatic tumor surgery]. Khirurgiia (Mosk) 2021;:5-12. [PMID: 34608775 DOI: 10.17116/hirurgia20211015] [Reference Citation Analysis]
618 Carvão J, Dinis-Ribeiro M, Pimentel-Nunes P, Libânio D. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists. GE Port J Gastroenterol 2021;28:336-48. [PMID: 34604465 DOI: 10.1159/000512089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
619 Park JH, Yoon JY, Hwang SW, Park SH, Yang DH, Ye BD, Myung SJ, Yang SK, Byeon JS. A Surveillance Endoscopy Strategy Based on Local Recurrence Rates after Colorectal Endoscopic Submucosal Dissection. J Clin Med 2021;10:4591. [PMID: 34640609 DOI: 10.3390/jcm10194591] [Reference Citation Analysis]
620 Li Z, Dou L, Zhang Y, He S, Zhao D, Hao C, Song G, Zhang W, Liu Y, Wang G. Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma. Front Cell Infect Microbiol 2021;11:714162. [PMID: 34604107 DOI: 10.3389/fcimb.2021.714162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
621 Low RRJ, Lim WW, Nguyen PM, Lee B, Christie M, Burgess AW, Gibbs P, Grimmond SM, Hollande F, Putoczki TL. The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids. Cancers (Basel) 2021;13:4979. [PMID: 34638463 DOI: 10.3390/cancers13194979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
622 Sobhrakhshankhah E, Sohrabi M, Norouzi HR, Zamani F, Ajdarkosh H, Nikkhah M, Khoonsari MR, Faraji AH. Tissue Sampling through Endoscopic Ultrasound-Guided Fine Needle Aspiration versus Endoscopic Retrograde Cholangiopancreatographic Brushing Cytology Technique in Suspicious Malignant Biliary Stricture. Middle East J Dig Dis 2021;13:294-301. [PMID: 36606017 DOI: 10.34172/mejdd.2021.238] [Reference Citation Analysis]
623 Holmberg M, Ghorbani P, Gilg S, Del Chiaro M, Arnelo U, Löhr JM, Sparrelid E. Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma. Pancreatology 2021;21:1371-7. [PMID: 34426077 DOI: 10.1016/j.pan.2021.07.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
624 Chang LC, Hsu YC, Chiu HM, Ueda K, Wu MS, Kao CH, Shen TL. Exploration of the Proteomic Landscape of Small Extracellular Vesicles in Serum as Biomarkers for Early Detection of Colorectal Neoplasia. Front Oncol 2021;11:732743. [PMID: 34589434 DOI: 10.3389/fonc.2021.732743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
625 Noh JH, Kim DH, Yoon H, Hsing LC, Na HK, Ahn JY, Lee JH, Jung KW, Choi KD, Song HJ, Lee GH, Jung HY. Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine Tumor. J Gastrointest Surg 2021;25:2495-502. [PMID: 33825119 DOI: 10.1007/s11605-021-04997-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
626 Prall OWJ. Malignant Pleural Mesothelioma-Does Ki67 Make the Grade? JTO Clin Res Rep 2021;2:100170. [PMID: 34590021 DOI: 10.1016/j.jtocrr.2021.100170] [Reference Citation Analysis]
627 Ogasawara N, Kikuchi D, Inoshita N, Nakayama A, Kohno K, Ochiai Y, Hayasaka J, Suzuki Y, Dan N, Okamura T, Mitsunaga Y, Tanaka M, Nomura K, Odagiri H, Yamashita S, Matsui A, Hoteya S, Iizuka T. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation. Esophagus 2021;18:806-16. [PMID: 33974189 DOI: 10.1007/s10388-021-00848-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
628 Das S, Du L, Lee CL, Arhin ND, Chan JA, Kohn EC, Halperin DM, Berlin J, LaFerriere H, Singh S, Kunz PL, Dasari A. Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020. JAMA Netw Open 2021;4:e2131744. [PMID: 34705010 DOI: 10.1001/jamanetworkopen.2021.31744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
629 Van Herck Y, Feyaerts A, Alibhai S, Papamichael D, Decoster L, Lambrechts Y, Pinchuk M, Bechter O, Herrera-caceres J, Bibeau F, Desmedt C, Hatse S, Wildiers H. Is cancer biology different in older patients? The Lancet Healthy Longevity 2021;2:e663-77. [DOI: 10.1016/s2666-7568(21)00179-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
630 de la Fouchardiere C, Decoster L, Samalin E, Terret C, Kenis C, Droz JP, Coutzac C, Smyth E. Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature. Cancer Treat Rev 2021;100:102289. [PMID: 34583303 DOI: 10.1016/j.ctrv.2021.102289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
631 Das S, Al-Toubah T, Strosberg J. Chemotherapy in Neuroendocrine Tumors. Cancers (Basel) 2021;13:4872. [PMID: 34638356 DOI: 10.3390/cancers13194872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
632 Li K, Yuan J, Li Y, Zhang H, Liu X, Ke N. Successful Neoadjuvant Chemotherapy for Small-Cell Neuroendocrine Carcinoma of the Pancreas: A Case Report. Front Oncol 2021;11:719422. [PMID: 34568048 DOI: 10.3389/fonc.2021.719422] [Reference Citation Analysis]
633 Yuan B, Shi Y, Li Y, Tan H, Jiao P, Su W, Liu M, Qi Z, Tan H, Luo J. Ki-67 index of 5% could better predict the clinical prognosis of well-differentiated pancreatic neuroendocrine tumours. Jpn J Clin Oncol 2021:hyab144. [PMID: 34580725 DOI: 10.1093/jjco/hyab144] [Reference Citation Analysis]
634 Gao R, Zhao S, Aishanjiang K, Cai H, Wei T, Zhang Y, Liu Z, Zhou J, Han B, Wang J, Ding H, Liu Y, Xu X, Yu Z, Gu J. Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data. J Hematol Oncol 2021;14:154. [PMID: 34565412 DOI: 10.1186/s13045-021-01167-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
635 Lin YH, Yao W, Fei Q, Wang Y. Gastric cancer with calcifications: A case report. World J Clin Cases 2021; 9(27): 8135-8141 [PMID: 34621872 DOI: 10.12998/wjcc.v9.i27.8135] [Reference Citation Analysis]
636 Chen I, Zhang D, Velez M, Kovar S, Liao X. Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases. Pathol Res Pract 2021;226:153614. [PMID: 34555651 DOI: 10.1016/j.prp.2021.153614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
637 Jacob A, Gabriel G, Ramirez RA, Wang Y, Anthony L, Chauhan A. How I Treat Neuroendocrine Tumors. Indian J Med Paediatr Oncol 2021;42:470-8. [DOI: 10.1055/s-0041-1732833] [Reference Citation Analysis]
638 Zhou Z, Wang Z, Zhang B, Wu Y, Li G, Wang Z. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors. Front Endocrinol (Lausanne) 2021;12:727327. [PMID: 34539577 DOI: 10.3389/fendo.2021.727327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
639 Do MY, Jang SI, Kang HP, Kim EJ, Lee KJ, Park GE, Lee SJ, Lee DK, Woo SM, Cho JH. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis. Cancers (Basel) 2021;13:4713. [PMID: 34572940 DOI: 10.3390/cancers13184713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
640 Zang C, Li S, Chi B, Chen S, Ye Z. An intraductal papillary mucinous neoplasm associated tubular adenocarcinoma with sarcomatoid component: A case report. Radiol Case Rep 2021;16:3494-8. [PMID: 34539943 DOI: 10.1016/j.radcr.2021.08.040] [Reference Citation Analysis]
641 Clairet CDMAV, De Aquino JLB, Clairet LM. Evaluation of the Serrated Lesions Detection Rate and Its Role as a Colonoscopy Quality Criteria. Journal of Coloproctology 2021;41:228-33. [DOI: 10.1055/s-0041-1730261] [Reference Citation Analysis]
642 Chi Z, Lin Y, Huang J, Lv M, Chen J, Chen X, Zhang B, Chen Y, Hu J, He X, Lan P. Risk factors for recurrence of colorectal conventional adenoma and serrated polyp. Gastroenterology Report 2021. [DOI: 10.1093/gastro/goab038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Mathews AA, Draganov PV, Yang D. Endoscopic management of colorectal polyps: From benign to malignant polyps. World J Gastrointest Endosc 2021; 13(9): 356-370 [PMID: 34630886 DOI: 10.4253/wjge.v13.i9.356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
644 Goutas D, Goutas N, Theocharis S. Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance. Cancers (Basel) 2021;13:4634. [PMID: 34572861 DOI: 10.3390/cancers13184634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
645 Walter F, Fuchs F, Gerum S, Rottler MC, Erdelkamp R, Neumann J, Nierer L, Guba M, De Toni EN, Seidensticker M, Ricke J, Belka C, Corradini S. HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience. Front Oncol 2021;11:717792. [PMID: 34513694 DOI: 10.3389/fonc.2021.717792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
646 Corbett V, Arnold S, Anthony L, Chauhan A. Management of Large Cell Neuroendocrine Carcinoma. Front Oncol 2021;11:653162. [PMID: 34513663 DOI: 10.3389/fonc.2021.653162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
647 Trovato A, Turshudzhyan A, Tadros M. Serrated lesions: A challenging enemy. World J Gastroenterol 2021; 27(34): 5625-5629 [PMID: 34629791 DOI: 10.3748/wjg.v27.i34.5625] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
648 You Z, Peng D, Cao Y, Zhu Y, Yin J, Zhang G, Peng X. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization. J Cell Mol Med 2021;25:9168-82. [PMID: 34510715 DOI: 10.1111/jcmm.16792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
649 Uccelli L, Boschi A, Cittanti C, Martini P, Panareo S, Tonini E, Nieri A, Urso L, Caracciolo M, Lodi L, Carnevale A, Giganti M, Bartolomei M. 90Y/177Lu-DOTATOC: From Preclinical Studies to Application in Humans. Pharmaceutics 2021;13:1463. [PMID: 34575538 DOI: 10.3390/pharmaceutics13091463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
650 Lithgow K, Venkataraman H, Hughes S, Shah H, Kemp-Blake J, Vickrage S, Smith S, Humphries S, Elshafie M, Taniere P, Diaz-Cano S, Dasari BVM, Almond M, Ford S, Ayuk J, Shetty S, Shah T, Geh I. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort. Sci Rep 2021;11:17947. [PMID: 34504148 DOI: 10.1038/s41598-021-97247-x] [Reference Citation Analysis]
651 Wei W, Liu C, Yao R, Tan Q, Wang Q, Tian H. miR‑486‑5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9. Mol Med Rep 2021;24:771. [PMID: 34490480 DOI: 10.3892/mmr.2021.12411] [Reference Citation Analysis]
652 Hashimoto M, Uesugi N, Osakabe M, Yanagawa N, Otsuka K, Kajiwara Y, Ueno H, Sasaki A, Sugai T. Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers. Front Oncol 2021;11:690816. [PMID: 34490089 DOI: 10.3389/fonc.2021.690816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
653 Roviello F, Marano L, Ambrosio MR, Resca L, D'Ignazio A, Petrelli F, Petrioli R, Costantini M, Polom K, Macchiarelli R, Biviano I, Marrelli D. Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival. Eur J Surg Oncol 2021:S0748-7983(21)00726-5. [PMID: 34511269 DOI: 10.1016/j.ejso.2021.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
654 Li Z, Wang J, Ji Y, Song F. Expression Characteristics and Clinical Correlations of BRD1 in Colorectal Cancer Samples. Technol Cancer Res Treat 2021;20:15330338211039678. [PMID: 34482774 DOI: 10.1177/15330338211039678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
655 Xu J. Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs). Ther Adv Med Oncol 2021;13:17588359211042689. [PMID: 34484432 DOI: 10.1177/17588359211042689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
656 Kim YM, Kim JH, Park JS. Reply to the letter by Junjie Jiang et al. regarding our manuscript "Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study". Gastric Cancer 2021;24:1372-3. [PMID: 34480658 DOI: 10.1007/s10120-021-01245-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
657 Rossi RE, Elli L, Branchi F, Conte D, Massironi S. Double-Balloon Enteroscopy in Detecting Small-Bowel Neuroendocrine Neoplasms: A Single-Center Prospective Study. Digestion 2021;102:722-30. [PMID: 33361694 DOI: 10.1159/000511850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
658 Deliwala SS, Ponnapalli A, Gakhal I, Modi V, Haykal T, Bachuwa G, Chawla S. When Variants Collide: An Unusual Presentation of Metastatic Gastric Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm. ACG Case Rep J 2021;8:e00569. [PMID: 34476269 DOI: 10.14309/crj.0000000000000569] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
659 Murugesan K, Sharaf R, Montesion M, Moore JA, Pao J, Pavlick DC, Frampton GM, Upadhyay VA, Alexander BM, Miller VA, Javle MM, Bekaii Saab TS, Albacker LA, Ross JS, Ali SM. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma. JCO Precis Oncol 2021;5:PO. [PMID: 34476330 DOI: 10.1200/PO.20.00397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
660 Khanam R, Pachika PS, Arya P, Bierenbaum J, Kane K, Saha P. "A Tale of 2 Demons"-Concomitant Presence of Hepatocellular Carcinoma and Primary Neuroendocrine Tumor of Liver: A Case Report and Review of Literatures. J Investig Med High Impact Case Rep 2021;9:23247096211043397. [PMID: 34472368 DOI: 10.1177/23247096211043397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
661 Elzein S, Bao F, Lin R, Schnickel G, Lowy AM, Botta GP. Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC). BMC Gastroenterol 2021;21:340. [PMID: 34479480 DOI: 10.1186/s12876-021-01901-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
662 Kole C, Charalampakis N, Vailas M, Tolia M, Sotiropoulou M, Tsakatikas S, Kouris NI, Tsoli M, Koumarianou A, Karamouzis MV, Schizas D. Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update. Cancer Immunol Immunother 2021. [PMID: 34471940 DOI: 10.1007/s00262-021-03046-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
663 Galgano SJ, Wei B, Rose JB. PET Imaging of Neuroendocrine Tumors. Radiol Clin North Am 2021;59:789-99. [PMID: 34392919 DOI: 10.1016/j.rcl.2021.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
664 Kim YM, Kim JH, Park JS, Baik SJ, Chun J, Youn YH, Park H. Correction to: Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric Cancer 2021. [PMID: 34463823 DOI: 10.1007/s10120-021-01240-2] [Reference Citation Analysis]
665 Yang Y, Li Y, Du X. Prognostic Analysis of Gastric Signet Ring Cell Carcinoma and Hepatoid Adenocarcinoma of the Stomach: A Propensity Score-Matched Study. Front Oncol 2021;11:716962. [PMID: 34458152 DOI: 10.3389/fonc.2021.716962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
666 Chen Q, Ning Z, Liu Z, Zhou Y, He Q, Tian Y, Hao H, Lin W, Jiang L, Zhao G, Li P, Zheng C, Huang C; Study Group for Gastric Neuroendocrine Tumors. Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma: A large multicenter sample analysis. Chin J Cancer Res 2021;33:433-46. [PMID: 34584369 DOI: 10.21147/j.issn.1000-9604.2021.04.01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
667 Diaconescu S, Gîlcă-Blanariu GE, Poamaneagra S, Marginean O, Paduraru G, Stefanescu G. Could the burden of pancreatic cancer originate in childhood? World J Gastroenterol 2021; 27(32): 5322-5340 [PMID: 34539135 DOI: 10.3748/wjg.v27.i32.5322] [Reference Citation Analysis]
668 Brito HP, Torres IT, Turke KC, Parada AA, Waisberg J, Botelho RV. Comparison of endoscopic resection techniques for duodenal neuroendocrine tumors: systematic review. Endosc Int Open 2021;9:E1214-21. [PMID: 34447867 DOI: 10.1055/a-1487-5594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
669 Jungels C, Deleporte A. State of the art and future directions in the systemic treatment of neuroendocrine neoplasms. Curr Opin Oncol 2021;33:378-85. [PMID: 33973550 DOI: 10.1097/CCO.0000000000000740] [Reference Citation Analysis]
670 Sowińska-Przepiera E, Starzyński D, Syrenicz A, Dziuba I, Wiszniewska B, Rzeszotek S. Neuroendocrine Tumors: Clinical, Histological and Immunohistochemical Perspectives and Case Report-Mature Teratoma in a 16-Year-Old Girl. Pathophysiology 2021;28:373-86. [PMID: 35366281 DOI: 10.3390/pathophysiology28030025] [Reference Citation Analysis]
671 Jiang J, Teng L. Comment on: "Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric cancer, 2021 Aug 5" by Kim et al. Gastric Cancer 2021;24:1370-1. [PMID: 34426941 DOI: 10.1007/s10120-021-01232-2] [Reference Citation Analysis]
672 Starmans MP, Timbergen MJ, Vos M, Padmos GA, Grünhagen DJ, Verhoef C, Sleijfer S, van Leenders GJ, Buisman FE, Willemssen FE, Koerkamp BG, Angus L, van der Veldt AA, Rajicic A, Odink AE, Renckens M, Doukas M, de Man RA, Ijzermans JN, Miclea RL, Vermeulen PB, Thomeer MG, Visser JJ, Niessen WJ, Klein S. The WORC database: MRI and CT scans, segmentations, and clinical labels for 930 patients from six radiomics studies.. [DOI: 10.1101/2021.08.19.21262238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
673 Ma G, Li G, Xiao Z, Gou A, Xu Y, Song S, Guo K, Liu Z. Narrative review of intraductal papillary mucinous neoplasms: pathogenesis, diagnosis, and treatment of a true precancerous lesion. Gland Surg 2021;10:2313-24. [PMID: 34422602 DOI: 10.21037/gs-21-450] [Reference Citation Analysis]
674 Lang SA, Bednarsch J, Czigany Z, Joechle K, Kroh A, Amygdalos I, Strnad P, Bruns T, Heise D, Ulmer F, Neumann UP. Liver transplantation in malignant disease. World J Clin Oncol 2021; 12(8): 623-645 [PMID: 34513597 DOI: 10.5306/wjco.v12.i8.623] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
675 Wege H, Schulze K, von Felden J, Calderaro J, Reig M; rare liver tumors working group of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. Eur J Med Genet 2021;64:104313. [PMID: 34418585 DOI: 10.1016/j.ejmg.2021.104313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
676 Chen G, Xu R, Yue B, Jia M, Li P, Ji M, Zhang S. A Parallel Comparison Method of Early Gastric Cancer: The Light Transmission-Assisted Pathological Examination of Specimens of Endoscopic Submucosal Dissection. Front Oncol 2021;11:705418. [PMID: 34414114 DOI: 10.3389/fonc.2021.705418] [Reference Citation Analysis]
677 Takada R, Minaga K, Hara A, Otsuka Y, Omoto S, Kamata K, Yamao K, Takenaka M, Hagiwara S, Honjo H, Matsui S, Chikugo T, Watanabe T, Kudo M. Diagnostic Value of EUS-Guided Fine-Needle Aspiration Biopsy for Gastric Linitis Plastica with Negative Endoscopic Biopsy. J Clin Med 2021;10:3716. [PMID: 34442011 DOI: 10.3390/jcm10163716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
678 Uprak TK, Akmercan A, Coşkun M, Attaallah W. Gastric medullary carcinoma: clinicopathological features and prognosis-a single-center study. ANZ J Surg 2021;91:2425-9. [PMID: 34405504 DOI: 10.1111/ans.17129] [Reference Citation Analysis]
679 Ooki A, Yamaguchi K. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration. Gastric Cancer 2021. [PMID: 34398359 DOI: 10.1007/s10120-021-01235-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
680 Christensen AW, Goldberg AF. Mitotic count of fine needle aspiration material of gastrointestinal stromal tumours of the stomach underestimates actual mitotic count. Cytopathology 2021. [PMID: 34390589 DOI: 10.1111/cyt.13050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
681 He L, Wang W, Shi H, Jiang C, Yao H, Zhang Y, Qian W, Lin R. THBS4/integrin α2 axis mediates BM-MSCs to promote angiogenesis in gastric cancer associated with chronic Helicobacter pylori infection. Aging (Albany NY) 2021;13:19375-96. [PMID: 34390328 DOI: 10.18632/aging.203334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
682 Regmi P, Paudyal A, Paudyal P, Hu HJ, Liu F, Ma WJ, Jin YW, Li FY. Prognostic significance of tumor budding in biliary tract cancer. Eur J Surg Oncol 2021:S0748-7983(21)00678-8. [PMID: 34412954 DOI: 10.1016/j.ejso.2021.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
683 Vullierme MP, Gregory J, Rebours V, Cros J, Abelhady-Attia Y, Vilgrain V, Aguilera-Munoz L, Laurent L, Levy P, Sauvanet A, Ronot M. MRI is useful to suggest and exclude malignancy in mucinous cystic neoplasms of the pancreas. Eur Radiol 2021. [PMID: 34374801 DOI: 10.1007/s00330-021-08091-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
684 Starmans MP, Miclea RL, Vilgrain V, Ronot M, Purcell Y, Verbeek J, Niessen WJ, Ijzermans JN, de Man RA, Doukas M, Klein S, Thomeer MG. Automated differentiation of malignant and benign primary solid liver lesions on MRI: an externally validated radiomics model.. [DOI: 10.1101/2021.08.10.21261827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
685 Lin J, Peng X, Dong K, Long J, Guo X, Li H, Bai Y, Yang X, Wang D, Lu X, Mao Y, Sang X, Ji X, Zhao H, Liang H. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nat Commun 2021;12:4753. [PMID: 34362903 DOI: 10.1038/s41467-021-25012-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
686 Rao YY, Zhang HJ, Wang XJ, Li MF. Primary hepatic neuroendocrine tumor — 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings: A case report. World J Clin Cases 2021; 9(22): 6450-6456 [PMID: 34435011 DOI: 10.12998/wjcc.v9.i22.6450] [Reference Citation Analysis]
687 Folkestad O, Wasmuth HH, Mjønes P, Fougner R, Hauso Ø, Fossmark R. Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours-A Single Centre Cohort. Cancers (Basel) 2021;13:3985. [PMID: 34439140 DOI: 10.3390/cancers13163985] [Reference Citation Analysis]
688 Kitasaki N, Abe T, Oshita A, Hanada K, Noriyuki T, Nakahara M. Pyloric adenomatous carcinoma of the gallbladder following laparoscopic cholecystectomy: A case report. Int J Surg Case Rep 2021;85:106278. [PMID: 34388892 DOI: 10.1016/j.ijscr.2021.106278] [Reference Citation Analysis]
689 Glückstein MI, Dintner S, Arndt TT, Vlasenko D, Schenkirsch G, Agaimy A, Müller G, Märkl B, Grosser B. Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric Carcinomas. Cancers (Basel) 2021;13:3894. [PMID: 34359794 DOI: 10.3390/cancers13153894] [Reference Citation Analysis]
690 Cannella R, Cunha GM, Catania R, Chupetlovska K, Borhani AA, Fowler KJ, Furlan A. Magnetic Resonance Imaging of Nonhepatocellular Malignancies in Chronic Liver Disease. Magn Reson Imaging Clin N Am 2021;29:404-18. [PMID: 34243926 DOI: 10.1016/j.mric.2021.05.009] [Reference Citation Analysis]
691 van Riet J, van de Werken HJG, Cuppen E, Eskens FALM, Tesselaar M, van Veenendaal LM, Klümpen HJ, Dercksen MW, Valk GD, Lolkema MP, Sleijfer S, Mostert B. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. Nat Commun 2021;12:4612. [PMID: 34326338 DOI: 10.1038/s41467-021-24812-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
692 Basile D, Simionato F, Calvetti L, Cappetta A, Pesavento A, Mongillo M, Roviello G, Rosati G, Rossi G, Aprile G. Comparing immunotherapies to other frequently used treatments of gastric cancer. Expert Rev Clin Pharmacol 2021;:1-12. [PMID: 34114518 DOI: 10.1080/17512433.2021.1938546] [Reference Citation Analysis]
693 Pellat A, Cottereau AS, Terris B, Coriat R. Neuroendocrine Carcinomas of the Digestive Tract: What Is New? Cancers (Basel) 2021;13:3766. [PMID: 34359666 DOI: 10.3390/cancers13153766] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
694 Holmager P, Langer SW, Federspiel B, Willemoe GL, Garbyal RS, Melchior L, Klose M, Kjaer A, Hansen CP, Andreassen M, Knigge U. Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasms. J Neuroendocrinol 2021;33:e13018. [PMID: 34414612 DOI: 10.1111/jne.13018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
695 Sahakyan MA, Verbeke CS, Tholfsen T, Ignjatovic D, Kleive D, Buanes T, Lassen K, Røsok BI, Labori KJ, Edwin B. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma. Ann Surg Oncol 2021. [PMID: 34296358 DOI: 10.1245/s10434-021-10464-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
696 Wang Y, Zhang Y, Lin H, Xu M, Zhou X, Zhuang J, Yang Y, Chen B, Liu X, Guan G. Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data. J Surg Oncol 2021. [PMID: 34291822 DOI: 10.1002/jso.26615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
697 Trillo Aliaga P, Spada F, Peveri G, Bagnardi V, Fumagalli C, Laffi A, Rubino M, Gervaso L, Guerini Rocco E, Pisa E, Curigliano G, Fazio N. Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis. Cancer Treat Rev 2021;99:102261. [PMID: 34332293 DOI: 10.1016/j.ctrv.2021.102261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
698 Fragkou N, Sideras L, Panas P, Emmanouilides C, Sinakos E. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence? World J Gastroenterol 2021; 27(27): 4252-4275 [PMID: 34366604 DOI: 10.3748/wjg.v27.i27.4252] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
699 Karnaukhov NS, Khomeriki SG, Derizhanova IS, Mantsov AA, Izrailov RE, Tsvirkun VV, Khatkov IE. [Poorly cohesive gastric carcinoma. Validity of using the term; translation variants]. Arkh Patol 2021;83:69-72. [PMID: 34278764 DOI: 10.17116/patol20218304169] [Reference Citation Analysis]
700 Wei YY, Li Y, Shi YJ, Li XT, Sun YS. Primary extra-pancreatic pancreatic-type acinar cell carcinoma in the right perinephric space: A case report and review of literature. World J Clin Cases 2021; 9(20): 5637-5646 [PMID: 34307619 DOI: 10.12998/wjcc.v9.i20.5637] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
701 Chan DKH, Buczacki SJA. Tumour heterogeneity and evolutionary dynamics in colorectal cancer. Oncogenesis 2021;10:53. [PMID: 34272358 DOI: 10.1038/s41389-021-00342-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
702 Wang Z, Liu Z, Wen Z, Li R, An K, Mei S, Chen J, Shen H, Li J, Zhao F, Wei F, Xiao T, Liu Q. Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study. Eur J Surg Oncol 2021:S0748-7983(21)00631-4. [PMID: 34294465 DOI: 10.1016/j.ejso.2021.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
703 Wang M, Ding D, Qin T, Wang H, Liu Y, Liu J, Liu J, Zhang H, Zhao J, Wu CH, Javed A, Wolfgang C, Guo S, Chen Q, Zhao W, Shi W, Zhu F, Guo X, Li X, He R, Xu S, Edil B, Tien YW, Jin G, Zheng L, He J, Qin R; Minimally Invasive Pancreas Treatment Group in the Pancreatic Disease Branch of China's International Exchange and Promotion Association for Medicine and Healthcare. New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification []. Cancer Lett 2021;518:207-13. [PMID: 34271105 DOI: 10.1016/j.canlet.2021.07.018] [Reference Citation Analysis]
704 Lan J, Guo D, Qin X, Chen B, Liu Q. Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review. Front Surg 2021;8:678853. [PMID: 34336917 DOI: 10.3389/fsurg.2021.678853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
705 Kahraman S, Yalcin S. Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer. Onco Targets Ther 2021;14:4149-62. [PMID: 34285507 DOI: 10.2147/OTT.S315252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
706 Huang C, Luo H, Huang Y, Fang C, Zhao L, Li P, Zhong C, Liu F. AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis. Int J Gen Med 2021;14:3295-312. [PMID: 34285555 DOI: 10.2147/IJGM.S318077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
707 Katabathina VS, Marji H, Khanna L, Ramani N, Yedururi S, Dasyam A, Menias CO, Prasad SR. Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies. Radiographics 2020;40:1600-26. [PMID: 33001791 DOI: 10.1148/rg.2020200042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
708 Islam F, Gopalan V, Lu CT, Pillai S, Lam AK. Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer. Cancer Med 2021;10:5557-73. [PMID: 34250767 DOI: 10.1002/cam4.4116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
709 Gogna S, Samson D, Gachabayov M, Rojas A, Felsenreich DM, Koo D, Gu K, Quintero L, Miller KR, Azim A, Da Eric Dong X. Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome. Langenbecks Arch Surg 2021. [PMID: 34236488 DOI: 10.1007/s00423-021-02256-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
710 Magris R, De Re V, Maiero S, Fornasarig M, Guarnieri G, Caggiari L, Mazzon C, Zanette G, Steffan A, Canzonieri V, Cannizzaro R. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors. Clin Transl Gastroenterol 2020;11:e00238. [PMID: 33094954 DOI: 10.14309/ctg.0000000000000238] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
711 Kang DW, Kim BH, Kim JM, Kim J, Chang HJ, Chang MS, Sohn JH, Cho MY, Jin SY, Chang HK, Han HS, Kim JY, Kim HS, Park DY, Park HY, Lee SJ, Lee W, Lee HS, Kang YN, Choi Y; Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms. J Pathol Transl Med 2021;55:247-64. [PMID: 34233112 DOI: 10.4132/jptm.2021.05.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
712 Gu J, Xie S, Wang S, Xue L, Zhou J, Li M, Fan Z, Chen R, Middleton DRS, Hao C, Wang J, Li B, Li X, Wei W. Surveillance of premalignant gastric cardia lesions: A population-based prospective cohort study in China. Int J Cancer 2021;149:1639-48. [PMID: 34181269 DOI: 10.1002/ijc.33720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
713 Kasuga K, Yamada M, Shida D, Tagawa T, Takamaru H, Sekiguchi M, Sakamoto T, Uraoka T, Sekine S, Kanemitsu Y, Saito Y. Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis. United European Gastroenterol J 2021. [PMID: 34232561 DOI: 10.1002/ueg2.12118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
714 Hemachandran N, Goyal A, Bhattacharjee HK, Sharma R. Radiology of anal and lower rectal cancers. Clin Radiol 2021:S0009-9260(21)00312-3. [PMID: 34246493 DOI: 10.1016/j.crad.2021.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
715 Kang HJ, Kim H, Lee DH, Hur BY, Hwang YJ, Suh KS, Han JK. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery. Radiology 2021;:204352. [PMID: 34227881 DOI: 10.1148/radiol.2021204352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
716 Grewal JS, Berger E, Garner J, Mayer SL, Beaty JS. Surveillance Colonoscopy Revealing Asymptomatic Low-Grade Appendiceal Mucinous Neoplasm. Cureus 2021;13:e16222. [PMID: 34367822 DOI: 10.7759/cureus.16222] [Reference Citation Analysis]
717 Celayir OM, Selcukbiricik F, Tanik C, Altuntas Y. Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer. Sisli Etfal Hastan Tip Bul 2021;55:224-31. [PMID: 34349600 DOI: 10.14744/SEMB.2021.23356] [Reference Citation Analysis]
718 Renzulli M, Ramai D, Singh J, Sinha S, Brandi N, Ierardi AM, Albertini E, Sacco R, Facciorusso A, Golfieri R. Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma. Cancers (Basel) 2021;13:3336. [PMID: 34283065 DOI: 10.3390/cancers13133336] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
719 Jackson T, Darwish M, Cho E, Nagatomo K, Osman H, Jeyarajah DR. 68Ga-DOTATATE PET/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis? Abdom Radiol (NY) 2021;46:3179-83. [PMID: 33665733 DOI: 10.1007/s00261-021-02990-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
720 Li H, Qu L, Zhang H, Liu J, Zhang X. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients. Sci Rep 2021;11:13713. [PMID: 34211100 DOI: 10.1038/s41598-021-93250-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
721 Ismail A, Lall V, Ayonrinde OT. Should the high prevalence of sessile serrated lesions in patients aged below 50 years influence screening colonoscopy recommendations? J Gastroenterol Hepatol 2021;36:2022-3. [PMID: 33783871 DOI: 10.1111/jgh.15511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
722 Zhu Y, Weng S, Li Y, Yan C, Ye R, Wen L, Zhou L, Gao L. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3139-48. [PMID: 33641018 DOI: 10.1007/s00261-021-02989-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
723 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 55.5] [Reference Citation Analysis]
724 Kim CW, Cha JM, Kwak MS. Identification of Potential Biomarkers and Biological Pathways for Poor Clinical Outcome in Mucinous Colorectal Adenocarcinoma. Cancers (Basel) 2021;13:3280. [PMID: 34208938 DOI: 10.3390/cancers13133280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
725 Kanavati F, Ichihara S, Rambeau M, Iizuka O, Arihiro K, Tsuneki M. Deep Learning Models for Gastric Signet Ring Cell Carcinoma Classification in Whole Slide Images. Technol Cancer Res Treat 2021;20:15330338211027901. [PMID: 34191660 DOI: 10.1177/15330338211027901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
726 Lu X, Yan S, Koral KA, Chen Z. Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors. Expert Rev Anticancer Ther 2021;21:917-26. [PMID: 34142932 DOI: 10.1080/14737140.2021.1944110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
727 Li HL, Wang Y, Ren YB, Yang XS, Wang L, Zhang L, Lin XC. Pyloric gland adenoma with low-grade intraepithelial neoplasia: A case report and literature review. Medicine (Baltimore) 2021;100:e26378. [PMID: 34160413 DOI: 10.1097/MD.0000000000026378] [Reference Citation Analysis]
728 Xu P, Xu X, Zhang L, Li Z, Qiang J, Yao J, Xu A. hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer. Oncol Lett 2021;22:619. [PMID: 34257727 DOI: 10.3892/ol.2021.12880] [Reference Citation Analysis]
729 Lu J, Ding Y, Chen Y, Jiang J, Chen Y, Huang Y, Wu M, Li C, Kong M, Zhao W, Wang H, Zhang J, Li Z, Lu Y, Yu X, Jin K, Zhou D, Zhou T, Teng F, Zhang H, Zhou Z, Wang H, Teng L. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets. Nat Commun 2021;12:3946. [PMID: 34168152 DOI: 10.1038/s41467-021-24170-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
730 Mas L, Lupinacci RM, Cros J, Bachet JB, Coulet F, Svrcek M. Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. Int J Mol Sci 2021;22:6756. [PMID: 34201897 DOI: 10.3390/ijms22136756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
731 Matsuo S, Amano T, Miyamatsu Y, Hayashi D, Yamashita S, Momosaki S, Kawabe K, Nakamizo A. Discrepancy in the Ki67 labeling index of brain and orbital metastatic lesions from gastrointestinal neuroendocrine tumors: A case report. Neurocirugia (Astur) 2021:S1130-1473(21)00052-X. [PMID: 34154907 DOI: 10.1016/j.neucir.2021.04.003] [Reference Citation Analysis]
732 Karls S, Gold R, Kravets S, Wang Y, Cheng S, Perez K, Chan J, Jacene H. Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms. Ann Nucl Med 2021;35:1066-77. [PMID: 34146243 DOI: 10.1007/s12149-021-01642-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
733 Giannis D, Morsy S, Geropoulos G, Esagian SM, Sioutas GS, Moris D. The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis. In Vivo 2021;35:393-9. [PMID: 33402488 DOI: 10.21873/invivo.12270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
734 Caramaschi S, Mangogna A, Salviato T, Ammendola S, Barresi V, Manco G, Canu PG, Zanelli G, Bonetti LR. Cytoproliferative activity in colorectal poorly differentiated clusters: Biological significance in tumor setting. Ann Diagn Pathol 2021;53:151772. [PMID: 34153686 DOI: 10.1016/j.anndiagpath.2021.151772] [Reference Citation Analysis]
735 Kühl Svoboda Baldin R, Austrália Paredes Marcondes Ribas C, de Noronha L, Veloso da Silva-Camargo CC, Santos Sotomaior V, Martins Sebastião AP, Vasconcelos de Castilho AP, Rodrigues Montemor Netto M. Expression of Parkin, APC, APE1, and Bcl-xL in Colorectal Polyps. J Histochem Cytochem 2021;69:437-49. [PMID: 34126796 DOI: 10.1369/00221554211026296] [Reference Citation Analysis]
736 Melita G, Pallio S, Tortora A, Crinò SF, Macrì A, Dionigi G. Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms. J Clin Med 2021;10:2638. [PMID: 34203922 DOI: 10.3390/jcm10122638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
737 Tramontano L, Cavaliere C, Salvatore M, Brancato V. The Role of Non-Gaussian Models of Diffusion Weighted MRI in Hepatocellular Carcinoma: A Systematic Review. J Clin Med 2021;10:2641. [PMID: 34203995 DOI: 10.3390/jcm10122641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
738 Exarchou K, Kamieniarz L, Tsoli M, Victor A, Oleinikov K, Khan MS, Srirajaskanthan R, Mandair D, Grozinsky-Glasberg S, Kaltsas G, Howes N, Pritchard DM, Toumpanakis C. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms? Endocrine 2021. [PMID: 34120313 DOI: 10.1007/s12020-021-02775-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
739 Liu LL, Sun JD, Xiang ZL. A nomogram to predict the prognosis of patients with unresected rectal adenocarcinoma undergoing chemoradiotherapy: a population-based study. J Cancer 2021;12:4745-61. [PMID: 34234846 DOI: 10.7150/jca.61642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
740 Hiltunen N, Väyrynen JP, Böhm J, Helminen O. CD3+, CD8+, CD4+ and FOXP3+ T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors. Diseases 2021;9:42. [PMID: 34208144 DOI: 10.3390/diseases9020042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
741 Lu L, Shang Y, Zechner D, Mullins CS, Linnebacher M, Zhang X, Gong P. Development and Validation of a Score for Screening Suicide of Patients With Neuroendocrine Neoplasms. Front Psychiatry 2021;12:638152. [PMID: 34177643 DOI: 10.3389/fpsyt.2021.638152] [Reference Citation Analysis]
742 Mollazadegan K, Welin S, Crona J. Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma. Curr Treat Options Oncol 2021;22:68. [PMID: 34110508 DOI: 10.1007/s11864-021-00866-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
743 Søreide JA, Kvaløy JT, Lea D, Sandvik OM, Al-Saiddi M, Haslerud TM, Garresori H, Karlsen LN, Gudlaugsson E, Søreide K. The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study. Cancer Rep (Hoboken) 2021;:e1462. [PMID: 34105314 DOI: 10.1002/cnr2.1462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
744 Tryapitsyn AV, Malkov VA, Gasanov EM, Belyakov I. Chronic gastritis and precancerous diseases of the stomach: Is there a chance of a correct diagnosis? HERALD of North-Western State Medical University named after I I Mechnikov 2021;13:85-102. [DOI: 10.17816/mechnikov60431] [Reference Citation Analysis]
745 Becker A, Schalin-Jäntti C, Itkonen O. Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms. J Endocr Soc 2021;5:bvab106. [PMID: 34195530 DOI: 10.1210/jendso/bvab106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
746 Han D, Li YL, Zhou ZW, Yin F, Chen J, Liu F, Shi YF, Wang W, Zhang Y, Yu XJ, Xu JM, Yang RX, Tian C, Luo J, Tan HY. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms. World J Gastroenterol 2021; 27(21): 2895-2909 [PMID: 34135560 DOI: 10.3748/wjg.v27.i21.2895] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
747 Okasha HH, Awad A, El-meligui A, Ezzat R, Aboubakr A, AbouElenin S, El-Husseiny R, Alzamzamy A. Cystic pancreatic lesions, the endless dilemma. World J Gastroenterol 2021; 27(21): 2664-2680 [PMID: 34135548 DOI: 10.3748/wjg.v27.i21.2664] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
748 Marchegiani G, Salvia R; Verona EBM 2020 on IPMN. Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey. Gastroenterology 2021;160:2234-8. [PMID: 33609506 DOI: 10.1053/j.gastro.2021.02.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
749 Petrelli F, Spagnoli L, Giusti A, Perotti B, Cavazzana A, Arganini M, Ambrosio MR. Jejunal gastrointestinal stromal tumor with rectal lymph nodes metastases synchronous to intestinal adenocarcinoma: a possible common origin. Dig Liver Dis 2021;53:796-8. [PMID: 33896750 DOI: 10.1016/j.dld.2021.03.032] [Reference Citation Analysis]
750 Fazio N, Spada F, Bertani E. Looking for the right TNM staging system for pancreatic neuroendocrine tumors. Hepatobiliary Surg Nutr 2021;10:382-4. [PMID: 34159169 DOI: 10.21037/hbsn-2021-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
751 Xu X, Peng C, Tong R, Dong M, Deng J. An extremely rare phenomenon of mucinous cystic neoplasm of the liver: spontaneous rupture. Hepatobiliary Surg Nutr 2021;10:424-7. [PMID: 34159183 DOI: 10.21037/hbsn-21-102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
752 Laenkholm IT, Langer SW, Andreassen M, Holmager P, Kjaer A, Klose M, Federspiel BH, Hansen CP, Knigge U. A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN). Acta Oncol 2021;60:808-12. [PMID: 33779475 DOI: 10.1080/0284186X.2021.1903077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
753 Wang R, Mohapatra S, Jovani M, Akshintala VS, Kamal A, Brewer OG, Kumbhari V, Shin EJ, Canto MI, Khashab MA, Singh VK, Lennon AM, Kalloo AN, Ngamruengphong S. Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results program. Gastrointest Endosc 2021;93:1384-92. [PMID: 33347833 DOI: 10.1016/j.gie.2020.12.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
754 Traub B, Link KH, Kornmann M. Curing pancreatic cancer. Semin Cancer Biol 2021:S1044-579X(21)00160-7. [PMID: 34062264 DOI: 10.1016/j.semcancer.2021.05.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
755 Zhou YJ, Wang QW, Zhang QW, Chen JN, Wang XY, Gao YJ, Li XB. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment. Front Endocrinol (Lausanne) 2021;12:658392. [PMID: 34122337 DOI: 10.3389/fendo.2021.658392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
756 Toledo PF, Berger Z, Carreño L, Cardenas G, Castillo J, Orellana O. Sarcomatoid carcinoma of the pancreas — a rare tumor with an uncommon presentation and course: A case report and review of literature. World J Clin Cases 2021; 9(15): 3716-3725 [PMID: 34046475 DOI: 10.12998/wjcc.v9.i15.3716] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
757 Choi SH, Jeon SK, Lee SS, Lee JM, Hur BY, Kang HJ, Kim H, Park Y. Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI. Eur Radiol 2021. [PMID: 34037829 DOI: 10.1007/s00330-021-07984-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
758 Sakamoto A, Nozawa H, Sonoda H, Hinata M, Ishii H, Emoto S, Anzai H, Yokoyama Y, Murono K, Sasaki K, Kawai K, Ushiku T, Ishihara S. Rectal neuroendocrine tumor with extracapsular lymph node metastasis: a case report. Clin J Gastroenterol 2021. [PMID: 34028785 DOI: 10.1007/s12328-021-01447-x] [Reference Citation Analysis]
759 Li Z, Li S, Zang S, Ma X, Chen F, Xia Y, Chen L, Shen F, Lu Y, Lu J. Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Mucinous Adenocarcinoma Using an MRI-Based Radiomics Nomogram. Front Oncol 2021;11:671636. [PMID: 34109121 DOI: 10.3389/fonc.2021.671636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
760 Kriegsmann M, Kriegsmann K, Steinbuss G, Zgorzelski C, Kraft A, Gaida MM. Deep Learning in Pancreatic Tissue: Identification of Anatomical Structures, Pancreatic Intraepithelial Neoplasia, and Ductal Adenocarcinoma. Int J Mol Sci 2021;22:5385. [PMID: 34065423 DOI: 10.3390/ijms22105385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
761 Son J, Park IJ, Yang DH, Kim J, Kim KJ, Byeon JS, Hong SM, Kim YI, Kim JB, Lim SB, Yu CS, Kim JC. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study. Surg Endosc 2021. [PMID: 34009477 DOI: 10.1007/s00464-021-08527-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
762 Pellat A, Cottereau AS, Palmieri LJ, Soyer P, Marchese U, Brezault C, Coriat R. Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions. Cancers (Basel) 2021;13:2448. [PMID: 34070035 DOI: 10.3390/cancers13102448] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
763 Bongiovanni A, Maiorano BA, Azzali I, Liverani C, Bocchini M, Fausti V, Di Menna G, Grassi I, Sansovini M, Riva N, Ibrahim T. Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel) 2021;14:476. [PMID: 34067837 DOI: 10.3390/ph14050476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
764 Zhang Z, Zhao G, Jiang B, Li B, Wang Y. Clinicopathological features and differential diagnosis of gastrofibromatosis-like undifferentiated carcinoma. J Int Med Res 2020;48:300060520974463. [PMID: 33373269 DOI: 10.1177/0300060520974463] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
765 Jawlakh H, Velikyan I, Welin S, Sundin A. 68 Ga-DOTATOC-PET/MRI and 11 C-5-HTP-PET/MRI are superior to 68 Ga-DOTATOC-PET/CT for neuroendocrine tumour imaging. J Neuroendocrinol 2021;33:e12981. [PMID: 34046974 DOI: 10.1111/jne.12981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
766 Hinterleitner M, Sipos B, Wagner V, Grottenthaler JM, Lauer UM, Zender L, Hinterleitner C. Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies. Cancers (Basel) 2021;13:2286. [PMID: 34064565 DOI: 10.3390/cancers13102286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
767 Lee SW, Lee T, Sul HJ, Park KC, Park J. Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients. J Clin Med 2021;10:2038. [PMID: 34068652 DOI: 10.3390/jcm10092038] [Reference Citation Analysis]
768 Chevalier B, Dupuis H, Jannin A, Lemaitre M, Do Cao C, Cardot-Bauters C, Espiard S, Vantyghem MC. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations. Front Endocrinol (Lausanne) 2021;12:678869. [PMID: 34025587 DOI: 10.3389/fendo.2021.678869] [Reference Citation Analysis]
769 Myroshnychenko MS, Dyadyk OO, Kapustnyk NV, Fedulenkova YY, Borzenkova IV, Astapieva OM, Selivanova LI, Zakharenko VV, Lytvynenko OY, Molodan DV, Paskevych OI, Akritova KO, Melnik BI, Bobrova VM. MALIGNANT TUMORS OF THE APPENDIX: CLINICAL AND MORPHOLOGICAL ANALYSIS OF CASES FROM THE PRACTICE. Wiad Lek 2021;74:1277-1280. [DOI: 10.36740/wlek202105143] [Reference Citation Analysis]
770 Mounajjed T. Hepatocellular Adenoma and Focal Nodular Hyperplasia. Clin Liver Dis (Hoboken) 2021;17:244-8. [PMID: 33968383 DOI: 10.1002/cld.1069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
771 Pietropaolo G, Scarno G, Stabile H, Grimaldi A, Gismondi A, Santoni A, Sciumè G. NK cell and ILC heterogeneity in colorectal cancer. New perspectives from high dimensional data. Mol Aspects Med 2021;:100967. [PMID: 33941383 DOI: 10.1016/j.mam.2021.100967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
772 Kong XX, Li XL, Tian Y, Ye QC, Xu XM, Liu Y, Yang Q, Zhang LN, Mei YX, Wen JH, Xiao Q, Li JS, Ding KF, Li J. The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study. Front Oncol 2021;11:635537. [PMID: 33996549 DOI: 10.3389/fonc.2021.635537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
773 Massaras D, Masourou Z, Papazian M, Psarras G, Polydorou A. Solid Pseudopapillary Tumor of the Pancreas in a 25-Year-Old Female: A Rare Entity of Pancreatic Tumors. Cureus 2021;13:e14747. [PMID: 34084675 DOI: 10.7759/cureus.14747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
774 Venugopal A, Gillick-Walker J, Michalczyk A, Khasraw M, Ackland ML. mRNA profiling of a well-differentiated G1 pancreatic NET correlates with immunohistochemistry profile: a case report. BMC Gastroenterol 2021;21:194. [PMID: 33906633 DOI: 10.1186/s12876-021-01705-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
775 Maekawa A, Kudo A, Kishino M, Murase Y, Watanabe S, Ishikawa Y, Ueda H, Akahoshi K, Ogawa K, Ono H, Tanaka S, Kinowaki Y, Tanabe M. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy. J Cancer Res Clin Oncol 2021. [PMID: 33904982 DOI: 10.1007/s00432-021-03650-2] [Reference Citation Analysis]
776 Dou D, Li XK, Xia QS, Chen YY, Li YL, Wang C, Qi ZR, Tan HY. Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms. BMC Gastroenterol 2021;21:188. [PMID: 33892648 DOI: 10.1186/s12876-021-01769-7] [Reference Citation Analysis]
777 Jeong H, Shin J, Jeong JH, Kim KP, Hong SM, Kim YI, Ryu JS, Ryoo BY, Yoo C. Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index <55%: single-arm phase II study. ESMO Open 2021;6:100119. [PMID: 33901869 DOI: 10.1016/j.esmoop.2021.100119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
778 Zhang F, Hu KS, Lu SX, Li M, Chen RX, Ren ZG, Shi YH, Yin X. Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinoma. Cancer Biomark 2021;31:211-25. [PMID: 33896819 DOI: 10.3233/CBM-200643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
779 Albertelli M, Grillo F, Lo Calzo F, Puliani G, Rainone C, Colao AAL, Faggiano A; NIKE group. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask. Front Endocrinol (Lausanne) 2021;12:680305. [PMID: 33967966 DOI: 10.3389/fendo.2021.680305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
780 Tashima T, Ryozawa S, Tanisaka Y, Fujita A, Miyaguchi K, Ogawa T, Mizuide M, Mashimo Y, Kawasaki T, Yasuda M. Endoscopic resection using an over-the-scope clip for duodenal neuroendocrine tumors. Endosc Int Open 2021;9:E659-66. [PMID: 33937505 DOI: 10.1055/a-1374-6141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
781 Mansour MM, Smith ZD, Ghouri Y, Tahan V. Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome: A Case Report and Literature Review. Cureus 2021;13:e14591. [PMID: 34036009 DOI: 10.7759/cureus.14591] [Reference Citation Analysis]
782 Schiroli D, Marraccini C, Zanetti E, Ragazzi M, Gianoncelli A, Quartieri E, Gasparini E, Iotti S, Baricchi R, Merolle L. Imbalance of Mg Homeostasis as a Potential Biomarker in Colon Cancer. Diagnostics (Basel) 2021;11:727. [PMID: 33923883 DOI: 10.3390/diagnostics11040727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
783 Gopalakrishnan G, Srinivas BH, Pottakkat B, Gnanasekaran S, Kalayarasan R. Perforated High-Grade Mixed Neuroendocrine Nonneuroendocrine Neoplasm of Cecum: Unusual Presentation of Rare Disease. Gastrointest Tumors 2021;8:128-33. [PMID: 34307311 DOI: 10.1159/000512237] [Reference Citation Analysis]
784 Allam M, Hidalgo Salinas C, Machairas N, Kostakis ID, Watkins J, Fusai GK. Solid Pseudopapillary Neoplasms of the Pancreas: a Single-Center Experience and Review of the Literature. J Gastrointest Cancer 2021. [PMID: 33877570 DOI: 10.1007/s12029-021-00638-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
785 Centonze G, Lagano V, Sabella G, Mangogna A, Garzone G, Filugelli M, Belmonte B, Cattaneo L, Crisafulli V, Pellegrinelli A, Simbolo M, Scarpa A, Spaggiari P, Brambilla T, Pusceddu S, Prinzi N, Anichini A, Tripodo C, Milione M. Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. J Clin Med 2021;10:1741. [PMID: 33920514 DOI: 10.3390/jcm10081741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
786 Marini F, Giusti F, Tonelli F, Brandi ML. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1. Int J Mol Sci 2021;22:4041. [PMID: 33919851 DOI: 10.3390/ijms22084041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
787 Bräutigam K, Rodriguez-Calero A, Kim-Fuchs C, Kollár A, Trepp R, Marinoni I, Perren A. Update on Histological Reporting Changes in Neuroendocrine Neoplasms. Curr Oncol Rep 2021;23:65. [PMID: 33855635 DOI: 10.1007/s11912-021-01062-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
788 Espinosa-Olarte P, La Salvia A, Riesco-Martinez MC, Anton-Pascual B, Garcia-Carbonero R. Chemotherapy in NEN: still has a role? Rev Endocr Metab Disord 2021;22:595-614. [PMID: 33843007 DOI: 10.1007/s11154-021-09638-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
789 Mowrey K, Northrup H, Rougeau P, Hashmi SS, Krueger DA, Ebrahimi-Fakhari D, Towbin AJ, Trout AT, Capal JK, Franz DN, Rodriguez-Buritica D. Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports. Front Neurol 2021;12:627672. [PMID: 33897589 DOI: 10.3389/fneur.2021.627672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
790 Chu H, Shi Y, Liu J, Huang D, Zhang J, Dou C. Update in clinical management for gallbladder neuroendocrine carcinoma. Medicine (Baltimore) 2021;100:e25449. [PMID: 33832150 DOI: 10.1097/MD.0000000000025449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
791 Bezzi C, Mapelli P, Presotto L, Neri I, Scifo P, Savi A, Bettinardi V, Partelli S, Gianolli L, Falconi M, Picchio M. Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance. Eur J Nucl Med Mol Imaging 2021. [PMID: 33835220 DOI: 10.1007/s00259-021-05338-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
792 Nishizawa T, Yoshida S, Toyoshima A, Yamada T, Sakaguchi Y, Irako T, Ebinuma H, Kanai T, Koike K, Toyoshima O. Endoscopic diagnosis for colorectal sessile serrated lesions. World J Gastroenterol 2021; 27(13): 1321-1329 [PMID: 33833485 DOI: 10.3748/wjg.v27.i13.1321] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
793 Katsura H, Hori T, Harada H, Matsumura K, Yamamoto M, Yamada M, Yazawa T, Sasaki B, Kuriyama K, Tani M, Sato A, Sasaki Y, Yamamoto H. Mucinous Cystic Adenoma of the Liver: A Thought-Provoking Case of an Uncommon Hepatic Neoplasm. Am J Case Rep 2021;22:e931368. [PMID: 33811210 DOI: 10.12659/AJCR.931368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
794 Rimassa L, Personeni N, Czauderna C, Foerster F, Galle P. Systemic treatment of HCC in special populations. J Hepatol 2021;74:931-43. [PMID: 33248171 DOI: 10.1016/j.jhep.2020.11.026] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
795 Zhang Y, Yu C. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in elderly patients with gastric cancer after surgery. J Gastrointest Oncol 2021;12:278-96. [PMID: 34012626 DOI: 10.21037/jgo-20-536] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
796 King DA, Rahalkar S, Bingham DB, Fisher GA. Pancreatic INI1-deficient undifferentiated rhabdoid carcinoma achieves complete clinical response on gemcitabine and nab-paclitaxel following immediate progression on FOLFIRINOX: a case report. J Gastrointest Oncol 2021;12:874-9. [PMID: 34012674 DOI: 10.21037/jgo-20-478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
797 Vanbiervliet G, Strijker M, Arvanitakis M, Aelvoet A, Arnelo U, Beyna T, Busch O, Deprez PH, Kunovsky L, Larghi A, Manes G, Moss A, Napoleon B, Nayar M, Pérez-Cuadrado-Robles E, Seewald S, Barthet M, van Hooft JE. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021;53:429-48. [PMID: 33728632 DOI: 10.1055/a-1397-3198] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 16.5] [Reference Citation Analysis]
798 Gile JJ, Liu AJ, McGarrah PW, Eiring RA, Hobday TJ, Starr JS, Sonbol MB, Halfdanarson TR. Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: Mayo Clinic Experience. Pancreas 2021;50:500-5. [PMID: 33939660 DOI: 10.1097/MPA.0000000000001794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
799 Cheng J, Liu Y, Huang W, Hong W, Wang L, Zhan X, Han Z, Ni D, Huang K, Zhang J. Computational Image Analysis Identifies Histopathological Image Features Associated With Somatic Mutations and Patient Survival in Gastric Adenocarcinoma. Front Oncol 2021;11:623382. [PMID: 33869007 DOI: 10.3389/fonc.2021.623382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
800 Teran S, Camara Jurado M, Nuñez Sobrino JA. A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature. Case Rep Oncol Med 2021;2021:8896254. [PMID: 33859853 DOI: 10.1155/2021/8896254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
801 Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf) 2021;9:91-104. [PMID: 34026216 DOI: 10.1093/gastro/goab010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
802 Kit OI, Fomenko YA, Karnaukhov NS, Lapteva TO, Voloshin MV, Vakulenko GY, Bosenko SZ, Suhar IA, Eremin KS, Kaminskij GV, Kuznecova MA. Using the digital archive of pathological reports of stomach cancer as internal quality control of coding according to the ICD-O system. jour 2021;2:26-34. [DOI: 10.37748/2686-9039-2021-2-1-3] [Reference Citation Analysis]
803 Ahn JH, Kwak MS, Lee HH, Cha JM, Shin HP, Jeon JW, Yoon JY. Development of a Novel Prognostic Model for Predicting Lymph Node Metastasis in Early Colorectal Cancer: Analysis Based on the Surveillance, Epidemiology, and End Results Database. Front Oncol 2021;11:614398. [PMID: 33842317 DOI: 10.3389/fonc.2021.614398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
804 Kan J, Tian Y, Shao Y, Xu H, Li X, Tang Q. Role of the ratio of NSE serum concentration in evaluating the therapeutic effect on metastatic neuroendocrine neoplasms of the liver. Tumori 2021;:3008916211002272. [PMID: 33759643 DOI: 10.1177/03008916211002272] [Reference Citation Analysis]
805 Mathai AM, Alexander J, Huang HY, Li CF, Jeng YM, Fung KM, Harris WP, Swanson PE, Truong C, Yeh MM. S100P as a marker for poor survival and advanced stage in gallbladder carcinoma. Ann Diagn Pathol 2021;52:151736. [PMID: 33798925 DOI: 10.1016/j.anndiagpath.2021.151736] [Reference Citation Analysis]
806 Kang G, Pyo JS, Kim NY, Kang DW. Clinicopathological Significances of Tumor-Stroma Ratio (TSR) in Colorectal Cancers: Prognostic Implication of TSR Compared to Hypoxia-Inducible Factor-1α Expression and Microvessel Density. Curr Oncol 2021;28:1314-24. [PMID: 33810015 DOI: 10.3390/curroncol28020125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
807 Lea D, Gudlaugsson EG, Skaland I, Lillesand M, Søreide K, Søreide JA. Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index. Appl Immunohistochem Mol Morphol 2021;29:499-505. [PMID: 33758143 DOI: 10.1097/PAI.0000000000000934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
808 Tikhonova VS, Karmazanovsky GG, Kondratyev EV, Gruzdev IS, Glotov AV. Influence of the low-dose CE-MDCT scanning protocol parameters on the results of pancreatic ductal adenocarcinoma radiomic analysis. Ann hir gepatol 2021;26:25-33. [DOI: 10.16931/1995-5464.2021125-33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
809 Ciarrocchi A, Rindi G, Pietroletti R. Diagnosis and Treatment of Primary Tumors of the Appendix: a Critical Review. J Gastrointest Cancer 2021;52:471-5. [PMID: 33740229 DOI: 10.1007/s12029-021-00628-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
810 Rebelo R, Polónia B, Santos LL, Vasconcelos MH, Xavier CPR. Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals (Basel) 2021;14:280. [PMID: 33804613 DOI: 10.3390/ph14030280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
811 Kitada T, Masui T, Kasai Y, Uchida Y, Ogiso S, Ito T, Ishii T, Seo S, Katsuragawa H, Uemoto S. A subcentimeter duodenal neuroendocrine neoplasm with a liver metastasis upgraded to G3: a case report. Surg Case Rep 2021;7:72. [PMID: 33742297 DOI: 10.1186/s40792-021-01155-1] [Reference Citation Analysis]
812 O'Connell E, Reynolds IS, McNamara DA, Burke JP, Prehn JHM. Resistance to Cell Death in Mucinous Colorectal Cancer-A Review. Cancers (Basel) 2021;13:1389. [PMID: 33808549 DOI: 10.3390/cancers13061389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
813 Wang Y, Wang X, Huang X, Zhang J, Hu J, Qi Y, Xiang B, Wang Q. Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis. J Cancer 2021;12:2993-3010. [PMID: 33854600 DOI: 10.7150/jca.56005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
814 Wang R, Liu H, Liang P, Zhao H, Li L, Gao J. Radiomics analysis of CT imaging for differentiating gastric neuroendocrine carcinomas from gastric adenocarcinomas. Eur J Radiol 2021;138:109662. [PMID: 33774440 DOI: 10.1016/j.ejrad.2021.109662] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
815 Schirren R, Novotny A, Slotta-Huspenina J, Friess H, Reim D. Novel Histologic Categorization Based on Lauren Histotypes Conveys Prognostic Information for Gastroesophageal Junction Cancers-Analysis from a Large Single Center Cohort in Germany. Cancers (Basel) 2021;13:1303. [PMID: 33804009 DOI: 10.3390/cancers13061303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
816 Fornaro L, Spallanzani A, de Vita F, D'Ugo D, Falcone A, Lorenzon L, Tirino G, Cascinu S; GAIN (GAstric Cancer Italian Network). Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel) 2021;13:1304. [PMID: 33804024 DOI: 10.3390/cancers13061304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
817 Minczeles NS, Hofland J, de Herder WW, Brabander T. Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy. Curr Oncol Rep 2021;23:46. [PMID: 33721105 DOI: 10.1007/s11912-021-01037-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
818 Lee S. Helicobacter pylori-negative Gastric Cancer. Korean J Helicobacter Up Gastrointest Res 2021;21:10-21. [DOI: 10.7704/kjhugr.2020.0036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
819 Baczewska M, Knapp P, Dobroch J, Bernaczyk P, Guzik P, Sitnik P, Bortnik W. Two Concurrent Cancers in a 19-Year-Old Patient: Yolk Sac Ovarian Tumor and Metastatic Gastrointestinal Tract Malignancy-Case Report. J Pediatr Adolesc Gynecol 2021;34:561-5. [PMID: 33689915 DOI: 10.1016/j.jpag.2021.02.104] [Reference Citation Analysis]
820 Qi X, Liu Z, Zhang Q, Yang M, Wan Y, Huang J, Xu L. Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma. J Cancer 2021;12:2537-49. [PMID: 33854615 DOI: 10.7150/jca.50407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
821 Rodrigues M, Winkler KK, Svirydenka H, Nilica B, Uprimny C, Virgolini I. Long-Term Survival and Value of 18F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with 177Lu-DOTATATE. Life (Basel) 2021;11:198. [PMID: 33806393 DOI: 10.3390/life11030198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
822 Vitali E, Piccini S, Trivellin G, Smiroldo V, Lavezzi E, Zerbi A, Pepe G, Lania AG. The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors. Mol Cell Endocrinol 2021;527:111226. [PMID: 33675866 DOI: 10.1016/j.mce.2021.111226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
823 Wagner BJ, Plum PS, Apel K, Scherer M, Buchner D, Brinkmann S, Buettner R, Stippel D, Quaas A, Drebber U. Protein-loss of SWI/SNF-complex core subunits influences prognosis dependent on histological subtypes of intra- and extrahepatic cholangiocarcinoma. Oncol Lett 2021;21:349. [PMID: 33747206 DOI: 10.3892/ol.2021.12610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
824 Kwak MS, Eun YG, Lee YC. Benefit of postoperative radiotherapy in patients with oropharyngeal squamous cell carcinoma in human papillomavirus (HPV) era: A Surveillance, Epidemiology, and End Results (SEER) database analysis. Surgery 2021;170:541-9. [PMID: 33663877 DOI: 10.1016/j.surg.2021.01.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
825 Rossi RE, Milanetto AC, Andreasi V, Campana D, Coppa J, Nappo G, Rinzivillo M, Invernizzi P, Modica R, David A, Partelli S, Lamberti G, Mazzaferro V, Zerbi A, Panzuto F, Pasquali C, Falconi M, Massironi S; ItaNet (Italian Association for Neuroendocrine Tumours) study group. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy. J Endocrinol Invest 2021;44:2227-34. [PMID: 33651317 DOI: 10.1007/s40618-021-01528-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
826 Lin H, Huang H, Yu Y, Chen W, Zhang S, Zhang Y. Nerve growth factor regulates liver cancer cell polarity and motility. Mol Med Rep 2021;23:288. [PMID: 33649819 DOI: 10.3892/mmr.2021.11927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
827 Lim JH, Song JH, Chung SJ, Chung GE, Kim JS. Characteristics of interval gastric neoplasms detected within two years after negative screening endoscopy among Koreans. BMC Cancer 2021;21:218. [PMID: 33653298 DOI: 10.1186/s12885-021-07929-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
828 Lv L, Liang X, Wu D, Wang F, Zhang Y, Cang H, Deng X, Li M. Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer. J Cancer 2021;12:2385-94. [PMID: 33758614 DOI: 10.7150/jca.51433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
829 Huang J, Yao H, Li Y, Dong M, Han C, He L, Huang X, Xia T, Yi Z, Wang H, Zhang Y, He J, Liang C, Liu Z. Development and validation of a CT-based radiomics nomogram for preoperative prediction of tumor histologic grade in gastric adenocarcinoma. Chin J Cancer Res 2021;33:69-78. [PMID: 33707930 DOI: 10.21147/j.issn.1000-9604.2021.01.08] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
830 Zheng K, Liu T, Zhao J, Meng P, Bian Y, Ni C, Wang H, Pan Y, Wu S, Jiang H, Jin G. Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing. Exp Ther Med 2021;21:415. [PMID: 33747156 DOI: 10.3892/etm.2021.9859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
831 Dhruv S, Anwar S, Polavarapu A, Liliane D. Gastric Carcinoid: The Invisible Tumor! Cureus 2021;13:e13556. [PMID: 33791175 DOI: 10.7759/cureus.13556] [Reference Citation Analysis]
832 Zhou H, Wang Y, Guo C, Li X, Cui W, Wang Z, Chen X. Microscopic Invasion of Nerve Is Associated With Aggressive Behaviors in Pancreatic Neuroendocrine Tumors. Front Oncol 2021;11:630316. [PMID: 33718210 DOI: 10.3389/fonc.2021.630316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
833 Peltrini R, Cantoni V, Green R, Lionetti R, D'Ambra M, Bartolini C, De Luca M, Bracale U, Cuocolo A, Corcione F. Risk of appendiceal neoplasm after interval appendectomy for complicated appendicitis: A systematic review and meta-analysis. Surgeon 2021:S1479-666X(21)00031-7. [PMID: 33640282 DOI: 10.1016/j.surge.2021.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
834 Lu A, Cho J, Vazmitzel M, Layfield L, Staveley-O'Carroll K, Gaballah A, Rao D. High-grade appendiceal mucinous neoplasm presenting as a giant appendiceal mucocele. Radiol Case Rep 2021;16:1051-6. [PMID: 33680275 DOI: 10.1016/j.radcr.2021.02.014] [Reference Citation Analysis]
835 Jiang H, Shao D, Zhao P, Wu Y. The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy. Front Oncol 2021;11:631995. [PMID: 33708632 DOI: 10.3389/fonc.2021.631995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
836 Manivannan S, Sharouf F, Lammie G, Leach P. Unusual cause of a painless soft tissue mass of the scalp: a rare presentation of primary intracranial neuroendocrine neoplasm. BMJ Case Rep 2021;14:e236856. [PMID: 33619129 DOI: 10.1136/bcr-2020-236856] [Reference Citation Analysis]
837 Huang YC, Yang NN, Chen HC, Huang YL, Yan WT, Yang RX, Li N, Zhang S, Yang PP, Feng ZZ. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients. World J Gastroenterol 2021; 27(7): 624-640 [PMID: 33642833 DOI: 10.3748/wjg.v27.i7.624] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
838 Im J, Nam SK, Lee HS. MicroRNA-552 expression in colorectal cancer and its clinicopathological significance. J Pathol Transl Med 2021;55:125-31. [PMID: 33596633 DOI: 10.4132/jptm.2021.01.17] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
839 Kaiser J, Hinz U, Mayer P, Hank T, Niesen W, Hackert T, Gaida MM, Büchler MW, Strobel O. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma. Eur J Surg Oncol 2021;47:1734-41. [PMID: 33622577 DOI: 10.1016/j.ejso.2021.02.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
840 Xiong X, Feng J, Yang X, Li H, Shi Q, Tao J, Chang J. Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer. Cancer Cell Int 2021;21:112. [PMID: 33593338 DOI: 10.1186/s12935-021-01812-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
841 Andhalgaonkar T, Sinha R. Mesenchymal Tumors and Lymphoproliferative Diseases of the Stomach and Duodenum. Journal of Gastrointestinal and Abdominal Radiology 2022;4:170-6. [DOI: 10.1055/s-0040-1722794] [Reference Citation Analysis]
842 Lichtenberger JP 3rd, Zeman MN, Dulberger AR, Alqutub S, Carter BW, Manning MA. Esophageal Neoplasms: Radiologic-Pathologic Correlation. Radiol Clin North Am 2021;59:205-17. [PMID: 33551082 DOI: 10.1016/j.rcl.2020.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
843 Rajlawot K, Jiang T, Zhou J, Lin C, Kuang S, Chen J, Zhang Y, Yang H, Deng Y, He B, Hernando D, Reeder SB, Wang J. Accuracies of Chemical Shift In/Opposed Phase and Chemical Shift Encoded Magnetic Resonance Imaging to Detect Intratumoral Fat in Hepatocellular Carcinoma. J Magn Reson Imaging 2021;53:1791-802. [PMID: 33580551 DOI: 10.1002/jmri.27539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
844 Souza da Silva RM, Queiroga EM, Paz AR, Neves FFP, Cunha KS, Dias EP. Standardized Assessment of the Tumor-Stroma Ratio in Colorectal Cancer: Interobserver Validation and Reproducibility of a Potential Prognostic Factor. Clin Pathol 2021;14:2632010X21989686. [PMID: 33634262 DOI: 10.1177/2632010X21989686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
845 Djordjevic V, Grubor N, Kovac JD, Micev M, Milic N, Knezevic D, Gregoric P, Lausevic Z, Kerkez M, Knezevic S, Radenkovic D. Comparison of Preoperative Evaluation with the Pathological Report in Intraductal Papillary Mucinous Neoplasms: A Single-Center Experience. J Clin Med 2021;10:678. [PMID: 33578680 DOI: 10.3390/jcm10040678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
846 Holmager P, Willemoe GL, Nielsen K, Grøndahl V, Klose M, Andreassen M, Langer SW, Hansen CP, Kjær A, Federspiel BH, Knigge U. Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of Excellence. Eur J Surg Oncol 2021;47:1357-63. [PMID: 33589240 DOI: 10.1016/j.ejso.2021.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
847 Li DH, Liu XY, Huang C, Deng CN, Zhang JL, Xu XW, Xu LB. Pathological Analysis and Endoscopic Characteristics of Colorectal Laterally Spreading Tumors. Cancer Manag Res 2021;13:1137-44. [PMID: 33603459 DOI: 10.2147/CMAR.S286039] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
848 Liu AJ, Ueberroth BE, McGarrah PW, Buckner Petty SA, Kendi AT, Starr J, Hobday TJ, Halfdanarson TR, Sonbol MB. Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors. Oncologist 2021;26:383-8. [PMID: 33496040 DOI: 10.1002/onco.13686] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
849 Guan X, Xu ZY, Chen R, Qin JJ, Cheng XD. Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients. Front Oncol 2020;10:629909. [PMID: 33628738 DOI: 10.3389/fonc.2020.629909] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
850 Chen K, Dong Y, Zhang W, Han H, Mao F, Zhang Q, Zheng Z, He W, Wang WP. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications. Clin Hemorheol Microcirc 2020;76:391-403. [PMID: 32675402 DOI: 10.3233/CH-200899] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
851 Zhu M, Jin Z, Hubbard JM. Management of Non-Colorectal Digestive Cancers with Microsatellite Instability. Cancers (Basel) 2021;13:651. [PMID: 33561950 DOI: 10.3390/cancers13040651] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
852 Tang Y, Zhang T, Zhao Y, Chen Z, Ma X. Development and validation of a comprehensive radiomics nomogram for prognostic prediction of primary hepatic sarcomatoid carcinoma after surgical resection. Int J Med Sci 2021;18:1711-20. [PMID: 33746587 DOI: 10.7150/ijms.53602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
853 Noh MG, Yoon Y, Kim G, Kim H, Lee E, Kim Y, Park C, Lee KH, Park H. Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer. Exp Mol Med 2021;53:223-34. [PMID: 33547412 DOI: 10.1038/s12276-021-00559-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
854 Akce M, Zakka K, Penley M, Jiang R, Khalil L, Alese OB, Shaib WL, Wu C, Behera M, El-Rayes BF. Impact of high-risk features for stage II adenocarcinoma of the appendix. Cancer Treat Res Commun 2021;27:100329. [PMID: 33609973 DOI: 10.1016/j.ctarc.2021.100329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
855 Wang M, Jing J, Li H, Liu J, Yuan Y, Sun L. The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer. PeerJ 2021;9:e10814. [PMID: 33604190 DOI: 10.7717/peerj.10814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
856 Zhang Q, Han Y, Zhang Y, Liu D, Ming J, Huang B, Qiu X. Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases. Front Oncol 2020;10:571308. [PMID: 33598420 DOI: 10.3389/fonc.2020.571308] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
857 Tomita H, Tanaka K, Hirata A, Okada H, Imai H, Shirakami Y, Ohnishi K, Sugie S, Aoki H, Hatano Y, Noguchi K, Kanayama T, Niwa A, Suzui N, Miyazaki T, Tanaka T, Akiyama H, Shimizu M, Yoshida K, Hara A. Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas. Cell Rep 2021;34:108772. [PMID: 33626352 DOI: 10.1016/j.celrep.2021.108772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
858 Leão B, Wen X, Duarte HO, Gullo I, Gonçalves G, Pontes P, Castelli C, Diniz F, Mereiter S, Gomes J, Carneiro F, Reis CA. Expression of Thomsen-Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability. Int J Mol Sci 2021;22:1340. [PMID: 33572915 DOI: 10.3390/ijms22031340] [Reference Citation Analysis]
859 Propst R, Chen Wongworawat Y, Choo E, Cobb C, Raza A. Metastatic prostate adenocarcinoma and high-grade appendiceal mucinous neoplasm mimicking acute appendicitis in a post-radiation therapy patient. SAGE Open Med Case Rep 2021;9:2050313X20988421. [PMID: 33796305 DOI: 10.1177/2050313X20988421] [Reference Citation Analysis]
860 Bal MM, Hubale B, Janu A, Patil A. Salivary duct carcinoma and small cell carcinoma ex-pleomorphic adenoma: A heretofore undescribed entity and the naming conundrum: MiNEN, combined, collision, or composite tumor? Oral Surg Oral Med Oral Pathol Oral Radiol 2021;132:e92-6. [PMID: 33741286 DOI: 10.1016/j.oooo.2021.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
861 Mapelli P, Partelli S, Salgarello M, Doraku J, Muffatti F, Schiavo Lena M, Pasetto S, Bezzi C, Bettinardi V, Andreasi V, Rancoita PMV, Gianolli L, Picchio M, Falconi M. Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms. Diagnostics (Basel) 2021;11:192. [PMID: 33525712 DOI: 10.3390/diagnostics11020192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
862 Lombardi PM, Mazzola M, Achilli P, Aquilano MC, De Martini P, Curaba A, Gualtierotti M, Bertoglio CL, Magistro C, Ferrari G. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience. J Surg Oncol 2021;123:923-31. [PMID: 33497471 DOI: 10.1002/jso.26391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
863 Magi L, Rinzivillo M, Panzuto F. Tumor Heterogenity in Gastro-Entero-Pancreatic Neuroendocrine Neoplasia. Endocrines 2021;2:28-36. [DOI: 10.3390/endocrines2010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
864 Pereira D, Kővári B, Brown I, Chaves P, Choi WT, Clauditz T, Ghayouri M, Jiang K, Miller GC, Nakanishi Y, Kim KM, Kim BH, Kumarasinghe MP, Kushima R, Ushiku T, Yozu M, Srivastava A, Goldblum JR, Pai RK, Lauwers GY. Non-conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum. Histopathology 2021;78:658-75. [PMID: 33124049 DOI: 10.1111/his.14294] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
865 Hidayat F, Labeda I, Sampetoding S, Pattelongi IJ, Lusikooy RE, Warsinggih, Dani MI, Mappincara, Kusuma MI, Uwuratuw JA, Syarifuddin E, Faruk M. Correlation of interleukin-6 and C-reactive protein levels in plasma with the stage and differentiation of colorectal cancer: A cross-sectional study in East Indonesia. Ann Med Surg (Lond) 2021;62:334-40. [PMID: 33552492 DOI: 10.1016/j.amsu.2021.01.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
866 Chatani PD, Agarwal SK, Sadowski SM. Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors. Front Endocrinol (Lausanne) 2020;11:575620. [PMID: 33537001 DOI: 10.3389/fendo.2020.575620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
867 Ahadi M, Sokolova A, Brown I, Chou A, Gill AJ. The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment. Pathology 2021;53:454-61. [PMID: 33461799 DOI: 10.1016/j.pathol.2020.10.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
868 Lee W, Chandan VS, Johnson C, Li X. Atypical Cells in Peritoneal Cleft: A Pitfall in Diagnosis of Colorectal Adenocarcinoma. Int J Surg Pathol 2021;29:506-9. [PMID: 33455512 DOI: 10.1177/1066896920988346] [Reference Citation Analysis]
869 Duan H, Baratto L, Laudicella R, Stracuzzi F, Baldari S, Iagaru A. Molecular imaging of pancreatic neoplasms. Clin Transl Imaging 2021;9:141-51. [DOI: 10.1007/s40336-020-00408-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
870 Liu H, Zhang Z, Xu Y, Wang N, Huang Y, Yang Z, Jiang R, Chen H. Use of BERT (Bidirectional Encoder Representations from Transformers)-Based Deep Learning Method for Extracting Evidences in Chinese Radiology Reports: Development of a Computer-Aided Liver Cancer Diagnosis Framework. J Med Internet Res 2021;23:e19689. [PMID: 33433395 DOI: 10.2196/19689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
871 Studer L, Wallau J, Dawson H, Zlobec I, Fischer A. Classification of Intestinal Gland Cell-Graphs Using Graph Neural Networks. 2020 25th International Conference on Pattern Recognition (ICPR) 2021. [DOI: 10.1109/icpr48806.2021.9412535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
872 Heidarian A, Das KK, Mino-Kenudson M, Fernandez-Del Castillo C, Pitman MB. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts. J Am Soc Cytopathol 2021;10:249-54. [PMID: 33541830 DOI: 10.1016/j.jasc.2021.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
873 Liverani C, Bongiovanni A, Mercatali L, Pieri F, Spadazzi C, Miserocchi G, Di Menna G, Foca F, Ravaioli S, De Vita A, Cocchi C, Rossi G, Recine F, Ibrahim T. Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Pathol 2021;32:309-17. [PMID: 33409812 DOI: 10.1007/s12022-020-09657-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
874 Muffatti F, Andreasi V, Partelli S, Falconi M. Non Functional Pancreatic Neuroendocrine Tumors. Neuroendocrine Tumors 2021. [DOI: 10.1007/978-3-030-62241-1_8] [Reference Citation Analysis]
875 Yue YM, Ling ZM, Bangwei ZM, Zhikui CP. Comparison of Diagnostic Efficacy of US, CT, and MRI for Pancreatic Intraductal Papillary Mucinous Neoplasms. Advanced Ultrasound in Diagnosis and Therapy 2021;5:291. [DOI: 10.37015/audt.2021.210008] [Reference Citation Analysis]
876 Wei J, Suriawinata A, Ren B, Liu X, Lisovsky M, Vaickus L, Brown C, Baker M, Tomita N, Torresani L, Wei J, Hassanpour S. A Petri Dish for Histopathology Image Analysis. Artificial Intelligence in Medicine 2021. [DOI: 10.1007/978-3-030-77211-6_2] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
877 Fazio N, Spada F, Rossi RE, Ambrosini V, Incorvaia L, Passiglia F, Cani M, Badalamenti G. Neuroendocrine Neoplasms (NENs). Practical Medical Oncology Textbook 2021. [DOI: 10.1007/978-3-030-56051-5_60] [Reference Citation Analysis]
878 Tageldin O, Shah V, Kalakota N, Lee H, Tadros M, Litynski J. Esophagus. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-71468-0_5] [Reference Citation Analysis]
879 Cavestro GM, Bonura GF. Advanced Techniques in Colonoscopy in Inherited Cancer Conditions. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2021. [DOI: 10.1007/978-3-030-29964-4_28-1] [Reference Citation Analysis]
880 Feng Y, Chang X, Zhao Y, Wu D, Meng Z, Wu X, Guo T, Jiang Q, Zhang S, Wang Q, Yang A. A new needle-based confocal laser endomicroscopy pattern of malignant pancreatic mucinous cystic lesions (with video). Endosc Ultrasound 2021;10:200-6. [PMID: 32655084 DOI: 10.4103/eus.eus_35_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
881 Naghi Vishteh M, Salmani TA, Javadi Mamaghani A, Seyyed Tabaei SJ, Kheirollahi M. Novel somatic variants in CTNNA1 gene in Iranian patients with diffuse gastric cancer. Gastroenterol Hepatol Bed Bench 2021;14:17-24. [PMID: 33868605] [Reference Citation Analysis]
882 Keutgen XM, Vaghaiwalla TM. Surgical Evaluation of Appendiceal Neuroendocrine Tumors. Neuroendocrine Tumors 2021. [DOI: 10.1007/978-3-030-62241-1_12] [Reference Citation Analysis]
883 Lew D, Srinivas S, Kwok K. Approach to the Patient with a Pancreatic Mass. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_26-1] [Reference Citation Analysis]
884 Aunan JR, Al-saiddi MS, Stutchfield B, Jamieson NB, Søreide K. Pancreatic Cystic Lesions and Risk of Cancer. Textbook of Pancreatic Cancer 2021. [DOI: 10.1007/978-3-030-53786-9_50] [Reference Citation Analysis]
885 Bennett SA, Law CHL, Assal A, Myrehaug S, Hallet J. Functional Pancreatic Neuroendocrine Tumors. Neuroendocrine Tumors 2021. [DOI: 10.1007/978-3-030-62241-1_9] [Reference Citation Analysis]
886 Bajetta E, De Toma D, Antonucci A, Bajetta R, Valente M. History of Neuroendocrine Neoplasia. Neuroendocrine Neoplasia Management 2021. [DOI: 10.1007/978-3-030-72830-4_1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
887 Rinke A, Denzer UW. Kolorektale NEN (ohne Fernmetastasen). Springer Reference Medizin 2021. [DOI: 10.1007/978-3-662-61724-3_48-1] [Reference Citation Analysis]
888 Pérez-soto RH, Trolle-silva AM, Herrera MF. Large Intestine NETs. Endocrine Surgery Comprehensive Board Exam Guide 2021. [DOI: 10.1007/978-3-030-84737-1_30] [Reference Citation Analysis]
889 De Vita F, Tirino G, Pompella L, Petrillo A. Gastric Cancer: Advanced/Metastatic Disease. Practical Medical Oncology Textbook 2021. [DOI: 10.1007/978-3-030-56051-5_36] [Reference Citation Analysis]
890 Valente M, Covre A, Di Giacomo AM, Maio M. Personalized Medicine for Patients with Liver, Biliary Tract, and Pancreatic Cancer. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_50-1] [Reference Citation Analysis]
891 Shoucair S, Wolfgang C. Surgical Procedure Steps and Key Points: Whipple Procedure, Enucleations, and Management of Complications. Endocrine Surgery Comprehensive Board Exam Guide 2021. [DOI: 10.1007/978-3-030-84737-1_31] [Reference Citation Analysis]
892 Raptis D, Savvides E, Langas G, Chatzimavroudis G, Papaziogas B. Neuroendocrine neoplasm of the cystic duct: report of two cases and literature review. Hippokratia 2021;25:141-4. [PMID: 36683907] [Reference Citation Analysis]
893 Goldmann A, Clerici T. Small Intestine NETs. Endocrine Surgery Comprehensive Board Exam Guide 2021. [DOI: 10.1007/978-3-030-84737-1_29] [Reference Citation Analysis]
894 Grewal J, Berger E, Garner J, Beaty J. Surveillance Colonoscopy Revealing Asymptomatic Low-Grade Appendiceal Mucinous Neoplasm. World J Colorectal Surg 2021;10:16. [DOI: 10.4103/wjcs.wjcs_7_21] [Reference Citation Analysis]
895 Stechman MJ, Bränström R. Neuroendocrine Tumors (Thymic and Gastroenteropancreatic): Anatomy, Endocrine Physiology, and Pathophysiology. Endocrine Surgery Comprehensive Board Exam Guide 2021. [DOI: 10.1007/978-3-030-84737-1_24] [Reference Citation Analysis]
896 Cacciato Insilla A, Giordano M, Campani D. Molecular Pathology of Acinar Cystic Transformation. Encyclopedia of Pathology 2021. [DOI: 10.1007/978-3-319-28845-1_5578-1] [Reference Citation Analysis]
897 Waraasawapati S, Deenonpoe R, Sa-ngiamwibool P, Chamgramol Y, Pairojkul C. Fluke-Associated Cholangiocarcinoma: A Regional Epidemic. Diagnosis and Management of Cholangiocarcinoma 2021. [DOI: 10.1007/978-3-030-70936-5_11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
898 Roalsø M, Søreide K. TNM Staging for Pancreatic Adenocarcinoma. Textbook of Pancreatic Cancer 2021. [DOI: 10.1007/978-3-030-53786-9_25] [Reference Citation Analysis]
899 Tang Y, Wang L, Teng F, Zhang T, Zhao Y, Chen Z. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis. Int J Med Sci 2021;18:187-98. [PMID: 33390787 DOI: 10.7150/ijms.50883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
900 Fields AC, Lu PW, Melnitchouk N. Colon and Rectal Neuroendocrine Tumors. Neuroendocrine Tumors 2021. [DOI: 10.1007/978-3-030-62241-1_11] [Reference Citation Analysis]
901 Baranova I. Preoperative diagnosis of pancreatic cystic lesions: examination of fine-needle aspiration puncture biopsy material. Onkol Z im P A Gercena 2021;10:61. [DOI: 10.17116/onkolog20211005161] [Reference Citation Analysis